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Chapter I General introduction 
1 Therapeutic antibodies 
With 29 US Food and Drug Administration (FDA)-approved mAbs, sales of monoclonal 
antibodies (mAbs) constitute 35 % of the total biologics market in 2009 (Aggarwal 2009). 
Nearly all of them are of the immunoglobulin isotype G (IgG) and the subclass IgG1 
(Nissim and Chernajovsky 2008; Piggee 2008). The foundation of this triumphal proces-
sion was the generation of the first murine mAb by using the hybridoma technology 
(Koehler and Milstein 1975). This was the initiation to make mAbs available in large-scale 
for the specific treatment of various diseases mainly in the field of transplantation, oncol-
ogy, inflammatory, infection and auto-immunogenicity. 
To date, cancer therapeutics dominate the field (Pavlou and Reichert 2004). Several 
technology improvements have provided different approaches to overcome drawbacks for 
the broad therapeutically application in man. Clinical studies revealed that mAbs of murine 
origin triggered human immune responses (Shawler et al. 1985). After the injection of 
mouse mAbs into humans it is very likely that a HAMA (Human Anti Mouse Antibody) 
response will be developed (Khazaeli et al. 1994), limiting therapeutic efficacy of the prod-
uct to the first or, at most, second dose administration. Moreover, it was realized that 
binding and hence affinity of the mAb to a specific antigen is not a sufficient condition for 
antitumor effect and efficacy. Mediated effector functions by Fc receptor binding are 
needed but are not fully provided by the murine mAb. These effector functions include on 
the one hand complement activation triggering a cascade of enzymatic reactions. This en-
zymatic reaction leads to a recruitment of phagocytes and a formation of a membrane-
attack complex resulting in lysis of tumor cells (Gelderman et al. 2004). This effector func-
tion is termed complement dependent cytotoxicity (CDC). On the other hand, effector 
cells like natural killer cells and other leucocytes can respond via antibody dependent cellu-
lar cytotoxicity (ADCC) (Hessell et al. 2007). After interaction of their Fcγ receptors with 
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the Fc proportion of the tumor cell-bound antibodies a lytic attack of the potentially cyto-
toxic cells leads to death of the targeted tumor cells. 
Genetic engineering provided a way to make these mechanisms accessible by imple-
menting a human Fc proportion in the molecule (Walsh 2003; Walsh 2004). The reshaping 
can end up in chimeric as well as in humanized molecules. Chimeric mAbs only include 
xenogenetic variable regions (VH and/ or VL) whereas humanized molecules have solely a 
hyper variable antigen-binding region (complementarity determining regions: CDR) of 
murine origin grafted into the human immunoglobulin scaffold (Saldanha 2007). See 
Figure I-1 for the general introduction to the structure of IgG. 
Figure I-1: General introduction to antibody structure and function 
IgG is a protein composed of two identical heavy chains (H, 50 kDA) and light 
chains (L, 25 kDa) assembled by disulfide bonds (dashed lines). The Fab frag-
ments (50 kDa) comprise the binding region for the specific antigen. The two an-
tigen-contacting domains of the Fab are the variable region of the heavy (VH) and 
light (VL) chain. Three complementarity determining regions (CDR) per variable 
chain form the surface composed of hyper variable loops. The constant domains 
CH3 and CH2 of the two heavy chains form the Fc proportion. CH2 mediates com-
plement activation and Protein A binding. It contains a polysaccharide compo-
nent at a conserved asparagine in each heavy chain (black ball). CH2 and CH3 to-
gether mediate the binding to cell surfaces and induce cellular immune responses. 
Usually humanized mAbs are significantly less immunogenic than chimeric molecules, 
however it is reported that some patients generate human antichimeric antibodies (HACA) 
after administration (Hwang and Foote 2005). Moreover, humanized mAbs show in most 
cases a concomitantly prolonged half-life but a compromized affinity in comparison to the 
chimeric ones (Luo et al. 2003). Humanized full length human antibodies can be obtained 
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by genetically engineering the immune system of the mouse. One basic idea was intro-
duced in the 1990s, to generate an immune response in IgG-knock-out mice after inserting 
human antibody gene repertoires into the mouse genome. Afterwards the hybridoma 
technology was used to fuse spleen cells of the transgenic mouse with myeloma cells 
(Roque et al. 2004). But none of the molecules derived from these mice have yet made it 
into the market. 
 The first entirely human recombinant IgG1 antibody was approved in 2006 
(Adalimumab, Humira©) inhibiting tumor necrosis factor alpha. The approach of genera-
ting a specific antibody from human antibody gene repertoires completely in vitro was 
applied by using the phage-display technology (Winter et al. 1994). The antibody fragments 
such as Fab or the single variable fragments VH or VL domains are cloned as a fusion with 
phage coat protein, resulting in libraries of phage, each displaying an antibody fragment. 
The selection of numerous antibody fragments of different specificity against a target is 
afterwards possible without the laborious generation of hybridoma cells. Moreover, the 
resulting link between phenotype and genotype (binding affinity and gene sequence) allows 
simultaneous recovery of the gene encoding the antibody of choice (Hoogenboom 2005). 
The choice of the expression system depends on the intended use, required yield, pre-
set costs and needed effector functions of the therapeutically used mAb. For the commer-
cial production of fully length antibodies today, mainly mammalian cell culture is applied 
beside transgenic organisms like plants or animals (Chadd and Chamow 2001; Roque et al. 
2004). For the production of the approved therapeutic chimeric or humanized therapeutic 
antibodies either Chinese Hamster Ovary (CHO) or mouse myeloma (NS0) cell lines are 
used (Chadd and Chamow 2001). 
Unlike for bacterial expression, the potential to produce glycosylation patterns of the 
Fc region similar to those resulting from human cells is given. The degree of galactosyla-
tion and fucosylation and the proportion of bisecting N-acetyl-glucosamine residues have 
all been implicated in modulating effector functions (Yamane-Ohnuki and Satho 2009). By 
glyco-engineering of CHO cells a glycosyltransferase (GnTIII) catalyzes the formation of 
bisecting N-acetyl-glucosamine residues inhibiting the introduction of the core fucose in 
the Fc N-glycans. This leads to improved ADCC (Ferrara et al. 2006; Umana et al. 1999). 
Further, a knockout CHO cell line has been developed which was shown to stably pro-
duce non-fucosylated antibodies with enhanced ADCC (Niwa et al. 2005). 
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2 The purification process of therapeutic antibodies 
The coding gen-sequence of mAbs is usually expressed in mammalian cells. In comparison 
to bacterial hosts which are capable to conduct some post-translational metabolic reactions 
such as lipidation, proteolysis or phosphorylation, mammalian cells have the ability to per-
form N- and O-glycosylation, too. Moreover, this expression system provides the target 
molecule usually properly folded and fully functional. The molecule is directly secreted 
into the cell culture medium and no disruption of the host cells and no solubilization and 
refolding is required in order to harvest the target protein. As a consequence, there are less 
isoforms, indigenous proteins expressed by the host cell (called host cell proteins: HCPs), 
DNA and cellular components present and hence the purification process is usually less 
complex compared to processes from bacterial hosts like E. coli (Prouty et al. 1975). 
On the other side both, mammalian cell culture systems and proteins produced in 
mammalian cell culture are generally more complex than those of bacterial origin. Various 
process supplements may have to be added to the culture media including vitamins, lipids, 
serum, growth hormones, mineral salts, amino acids or antibiotics (Birch and Racher 2006). 
The process to separate the target protein of interest from the cell free supernatant 
containing different impurities and to deliver the purified protein in a concentrated matrix 
required for administration is referred to as downstream processing (DSP). 
Impurities are usually defined as process and product related. Product related impuri-
ties are molecule variants arising during manufacturing or storage which do not have pro-
perties comparable to those of the desired product with respect to activity, efficacy, and 
safety. Truncated forms, aggregates, precursors, deamidated or oxidized species can be 
subsumed here. Process related impurities encompass those that are derived from the 
manufacturing process and which are related to the cell substrate, the cell culture or the 
purification process. Table I-1 shows a summary of the process and product related impu-
rities based on ICH Q6B guideline named “Specifications: Test procedures and acceptance 
criteria for biotechnological/ biological product” (ICH Q6B 1999a). 
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Classification according to 
ICH Q6B guideline 
Impurities related to Characteristics 
Process-related impurities Cell substrate Host Cell Proteins (HCPs) 
  Host Cell DNA 
  Proteases 
  Virus-like particles 
 Cell culture Process supplements 
  Cell culture media components 
 Downstream Chromatographic leachables, 
ligands (like Protein A) 
  Chemical and biochemical 
processing reagents 
  Inorganic salts 
  Solvents 
  Endotoxins 
   
Product-related impurities Manufacturing and/ or storage Truncated forms 
  Precursors 
  Other modified forms: 
deamidated, isomerized, S-S 
linked, oxidized or altered 
conjugated forms 
  Aggregates 
Table I-1: List of process- and product related impurities 
According to the ICH guideline Q6B. 
In addition, to product- and process related impurities, molecular entities and variants 
referring to the desired product can be removed or accumulated during manufacturing. 
These species are considered as product-related substances and can be formed during the 
manufacturing process or during storage. They have properties comparable to the product 
concerning activity, efficacy and safety. Due to the biosynthetic process used by living 
organisms an inherent degree of structural heterogeneity is predefined in protein products. 
Therefore, the desired product can be a mixture of defined product and product-related 
substances which are e.g. glycoforms occurring due to incomplete post-translational modi-
fication. 
Finally, foreign contaminants introduced during the manufacturing process, such as 
microbial species, e.g. adventitious viruses or mycoplasma, as well as their chemical and 
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biochemical products (e.g. microbial proteases) need to be removed during the several 
steps of the DSP. 
The level of process-related impurities like HCPs has to be significantly reduced dur-
ing downstream processing. Since these impurities are potentially antigenic and thus elicit 
an undesirable immune response in the patient (Eaton 1995), they have to be eliminated or 
reduced to a level that will not cause an immune response. Regulatory guidelines require 
that HCP levels have to be routinely monitored using suitable analytical assays but it is 
impossible to set a common limit for all approved products due to the fact that reagents of 
the analytical test used are product and production system related and their sensitivity and 
selectivity is not comparable (CPMP 1997). 
Residual host cell DNA from continuous mammalian cell lines (CCLs) was con-
sidered to be a risk factor for safety because of concerns that residual host DNA may be 
tumorigenic. Data published in the 1990s revealed that milligram amounts of human tu-
mor cell DNA containing an activated oncogene did not cause tumors in primates 
(Wierenga et al. 1995). Hence, CCL DNA possesses much less a risk than thought and 
should be therefore considered today as a general impurity. For this, the removal to a low 
level up to 10 ng of residual CCL DNA per dose of the purified product is considered 
acceptable (CPMP 2001; WHO Expert Committee 1998). 
Beside purity, the primary considerations during DSP are yield, robustness, reliability 
and scalability which are mandatory for a well-developed purification process. 
2.1 Preparative chromatography 
There are a variety of preparative modes of chromatography which have been employed 
for the process-scale purification. A purification strategy for any protein can be divided 
into three sequential stages: capture, intermediate purification and polishing. 
2.1.1 Capture 
In this stage the target protein is initially separated from the harvested cell culture fluid. 
The major goal is to concentrate the target protein and to concomitantly remove as much 
of the contaminants as possible. 
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In the purification of full length mAbs, affinity chromatography applying bacterial Fc 
receptors is the most common technique (Huse et al. 2002). Numerous cells and viruses 
have proteins on their surfaces which bind selectively to the Fc part of the immunoglobu-
lin. 
Different bacterial Fc receptors have been described including Protein A from 
Staphylococcus aureus and Protein G from Streptococcus subspecies. Today, mostly Pro-
tein A is used as an affinity ligand in preparative chromatography. IgG of human origin 
and most animal derived ones bind well, with exception of mouse IgG1. Generally, all IgG 
subclasses bind with high affinity except for IgG 3 which is weakly bound (Huse et al. 
2002; Langone 1982). 
Both, the native Protein A and a recombinant one from E. coli are applicable. Beside 
the full sequenced ligand, the recombinantly derived fragment without the cell wall domain 
is available (Hammond et al. 1990). Moreover, a tetramer of the IgG binding domains of 
Protein A is commonly used, since amino acids particularly sensitive to alkali were substi-
tuted for more stable ones in this construct. 
Protein A has been immobilized via different linkers to all macro-porous chroma-
tographic matrices suited for protein chromatography, such as cross linked agarose, poly-
methacrylate, polystyrene-divenylbenzene or porous glass (Boschetti and Jungbauer 2000; 
Hahn et al. 2003). After matrix activation several linkers can be covalently bound to the 
matrix via a large number of hydroxyl groups carried on the surface. Initially, Protein A 
was immobilized on CNBr activated agarose. Today, coupling of Protein A is commonly 
carried out by applying epoxy chemistry. Here, the matrix is activated by using bis-oxirane 
1,4 bis-(2,3-epoxypropoxy-)butane. Afterwards the ligand is attached to the matrix via a C-
terminal cystein favoring an orientated thioether coupling. A description of activating 
agents used with hydroxyl-containing matrices explaining the different ligand coupling 
reactions, mostly based on nucleophilic reactions, is detailed elsewhere (Boschetti 1994). 
Especially, engineered Protein A derived recombinantly from E. coli is stable over a 
wide pH range of 2 to 11 and is able to refold after denaturation. This is important since 
urea, guanidine salts or sodium hydroxide are applied for regeneration and cleaning in 
place of the chromatographic resin. 
Association between IgG and Protein A is affected by pH (Cuatrecasas and Anfinsen 
1971). Binding conditions in Protein A chromatography are usually at pH 5-7, whereas 
protein desorption is performed at more acidic pH values of 3.0-4.5 (Shukla et al. 2007). 
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The interaction of Protein A with the IgG molecule is characterized by hydrophobic 
interaction together with some hydrogen bonds and two salt bridges (Li et al. 1998b). A 
positively charged histidyl residue at a pH < 6 located in both, the binding site of the Fc 
proportion and the Protein A, is involved in the dissociation of the two molecules, based 
on electrostatic repulsion (Burton 1985; Lindmark et al. 1977). Concomitantly, the hydro-
phobic counteract between the molecules is weakened. At alkaline or neutral pH the hy-
drophobic character of the uncharged imidazole rings contributes to net hydrophobicity at 
the interface of the two molecules, strengthening association. 
The lower the pH, the higher the yield during elution. Concomitantly, the risk to af-
fect conformational integrity or increase aggregation or fragmentation increases (Arakawa 
et al. 2004; Ejima et al. 2006; Vermeer and Norde 2000). Therefore, defined desorption 
conditions have to be individually optimized for every molecule to improve yield and con-
comitantly ensure stability. 
Several attempts have been described to avoid the low pH elution by adding cha-
otropic salts, hydrophobic competitors to the dilution buffer like ethylene glycol, or argin-
ine and arginine derivates (Arakawa et al. 2004; Ejima et al. 2005; Shukla et al. 2005). Only 
limited success was achieved on the one hand due to reduced yield and prolonged elution 
times in the case of arginine and arginine derivatives. On the other hand conformational 
changes of the eluted protein in the case of chaotropic salts like guanidine hydrochloride 
are reported. 
2.1.2 Intermediate purification and polishing 
Once the target protein has been captured, usually small amounts of impurities are present 
in the capture pool of a mAb purification process. After optimized Protein A chromatog-
raphy frequently an overall purity of nearly 97-99 % can be achieved according to analyti-
cal size exclusion chromatography (Fahrner et al. 1999). During the subsequent steps puri-
fication has to be completed. In most mAb manufacturing processes Protein A affinity 
chromatography is followed by two further chromatography steps for intermediate purifi-
cation and polishing (Shukla et al. 2007). 
Chromatography techniques used should resolve the target protein from impurities 
on the basis of small differences in a single physicochemical attribute. High yield and high 
resolution are additionally important (Williams 2005). 
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Ion-exchange (IEX) chromatography is widely used after capturing the target protein. 
IEX chromatography separates biomolecules on the basis of charge characteristics. 
Charged groups on the surface of a protein interact with oppositely charged groups im-
mobilized on the chromatographic medium. The charge of a protein depends on the pH 
of the environment. When operating at pH above the isoelectric point (IP) of the target 
protein, the target protein will be negatively charged and should bind to anion-exchange 
media which are positively charged. At an operating pH lower than the IP, the target pro-
tein will be positively charged and should bind to cation-exchange media which are nega-
tively charged. Therefore, the IP of the target protein is the key to develop an IEX chro-
matography step. 
Instead of binding the target protein to the matrix, binding of the impurities is possi-
ble while the target protein remains in the flow-through (Williams and Frasca 2001). 
Therefore, it is also valuable to know the IP of the impurities present. In both cases the 
conditions for binding and elution have to be optimized regarding pH and conductivity to 
ensure the separation of the target protein. Moreover, resolution, capacity and yield have 
to be optimized. 
During anion-exchange (AEX) chromatography host cell DNA, virus-like particles, 
leached Protein A, HCPs or endotoxins can be removed. For removal of DNA, endotoxin 
and retrovirus-like particles, mostly product flow-through applications are effective (Curtis 
et al. 2003; Strauss et al. 2009b) since these impurities are negatively charged and bind to 
these resins while the mAbs do not. Leached Protein A and HCPs can also be effectively 
reduced in product-binding mode using the ability to elute the mAb within a sodium chlo-
ride gradient at much lower conductivity than HCPs or Protein A. At a pH near the IP of 
the mAb which is usually between pH 8 and 9, these impurities are much more negatively 
charged than the mAb due to their IP of around 5 (Sjoequist et al. 1972). Hence, a higher 
amount of salt is needed to remove them from the column compared to the removal of 
the mAb. 
Conversely, an operating pH of around 8 leads to affinity complexes of IgG and Pro-
tein A complicating purification (Gagnon 2007). Moreover, product-binding mode is often 
limited by lower capacity and operating at a pH above 7 elevates the risk of deamidation 
and proteolysis (Geiger and Clarke 1987; Robinson and Rudd 1974). 
Cation-exchange (CEX) chromatography in product-binding mode is usually per-
formed at pH of 4.5-5.5. At this pH range a high product binding capacity is achieved due 
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to the enhanced positive net charge of the mAb. Concomitantly, a charge complementarity 
to strongly electronegative impurities is enhanced as well. This leads to stable charge com-
plexes between the mAb and the polyphosphorylated impurity DNA. Therefore, CEX 
chromatography is effective in Protein A, HCPs and aggregate removal but not in DNA 
removal (Ansaldi and Lester 2005).  
Hydrophobic interaction chromatography (HIC) is highly effective in aggregate re-
moval (Guse et al. 1994; Lu et al. 2009). Considering the manufacturing of biomolecules 
mostly aqueous salt solutions are used here as mobile phase. Retention is achieved through 
interactions between non-polar ligands and hydrophobic patches accessible on the surface 
of the native protein (Jungbauer 2005). By increasing the salt concentration these hydro-
phobic portions of the molecule can interact with the HIC ligand, encompassing func-
tional groups like phenyl- or butyl-residues. Operated in product flow-through mode the 
salt concentration can be reduced. Impurities such as HCPs and aggregates bind to the 
HIC media at reduced salt concentration due to their higher hydrophobicity (Wang and 
Ghosh 2008). 
Ceramic hydroxyapatite (CHT) which is a special form of calcium phosphate sintered 
to a spherical particle, has been applied for protein purification (Giovannini and Freitag 
2001; Jungbauer 2005). Protein binding is mediated by electrostatic interactions of car-
boxyl- and amino functions with calcium and phosphate groups of the chromatographic 
matrix. The majority of applications use a phosphate or chloride gradient to remove 
leached Protein A, DNA, virus-like particles and endotoxin (Gagnon 2009b). Elution with 
a chloride gradient in the presence of low phosphate concentration is known to remove 
IgG aggregates (Guerrier et al. 2001). A constant low level of phosphate between 5-15 mM 
weakens calcium affinity interactions but leaves ionic interactions relatively unaffected. 
During chloride gradient elution ionic bonds can be dissociated. The native IgG elutes 
before the aggregated species do. 
Size exclusion chromatography (SEC) is a very robust technique to remove aggregates 
by a size based separation mechanism. Therefore, it is usually used for product quality 
monitoring during DSP development. However, its use for preparative purposes is limited. 
Since only 5-10 % of the column volume can be applied to the column, the huge column 
dimensions required at manufacturing scale are difficult to handle. 
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2.2 Viral clearance 
Viral contaminants in the final product can arise either from adventitious introduction of 
viruses during processing or from the rodent cell expressing copies of endogenous retroviral 
genomes (Lieber et al. 1973). Retrovirus-like particles from CHO cells are not infectious and 
have not been associated with any disease in humans. However, murine-derived retroviral 
agents have been linked to tumorigenesis (Donahue et al. 1992). In order to minimize the 
presence of viral contaminants complementary approaches to inactivate and remove viral 
impurities are used in accordance to the ICH guideline “Viral safety evaluation of biotech-
nology products derived from cell lines of human or animal origin” (ICH Q5A (R1) 1999b) 
and the “Points to Consider” (PTC) of the FDA (CBER 1993; CBER 1997). 
Usually, subsequent to Protein A chromatography the pH of the pool material is low-
ered to < 3.7 over ≥ 30 minutes at room temperature to inactivate especially lipid-enveloped 
viruses, e.g. xenotropic murine leukemia virus (X-MuLV), a model for rodent endogenous 
retrovirus (Brorson et al. 2003). Beside low pH treatment, other solvents as well as deter-
gents are applied to inactivate potential viral impurities. In the blood plasma industry deter-
gents like Polysorbate 80, Triton X-100 or solvent additives like tri-n-butyl phosphate 
(TNBP) are applied for virus inactivation (Roberts 2008; Roberts and Dunkerley 2003). 
Moreover, inactivation by heat or UV-C irradiation, as well as removal by nano-
filtration are possible steps within the purification process which are in addition dedicated 
to viral clearance but can potentially introduce demage to the molecule (Li et al. 2005; 
Marques et al. 2009). 
The virus removal capacity of chromatographic steps has been demonstrated, al-
though by some health authorities they are not considered as robust as solvent/ detergent 
inactivation, inactivation by heat or nano-filtration (CBER 1997) since the virus reduction 
factor can vary with pH and/ or conductivity of column buffer. Protein A affinity chroma-
tography and anion-exchange chromatography can provide 104-fold of viral clearance ca-
pacity (Fahrner et al. 2001). Anion-exchange chromatography is known to remove a wide 
range of viruses including rodent viruses like minute virus of mice (MVM) or X-MuLV, as 
well as other model viruses like simian virus 40 (SV40) (Strauss et al. 2009a). Mostly prod-
uct flow-through mode is applied (Strauss et al. 2009b). In general, the purification process 
has to provide a safety margin of ≥ 106 for the patients treated, e.g. less than 1 in 106 doses 
may potentially contain one retrovirus-like particle. 
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2.3 Filtration 
Normal flow filtration (NFF) in which the feed flow is going perpendicular to the filter 
surface, is frequently employed during the purification process. Microfiltration membranes 
with a pore size of 0.1-0.2 µm are used to reduce the bioburden of process intermediates 
and to support sterility of the final formulated drug product. In addition, particles can be 
removed which is helpful to prevent fouling of the chromatographic columns. Moreover, 
nano-filtration is conducted in order to remove viral contaminants by using a pore size of 
20 (-50) nm. Depth filtration can remove particles and larger aggregates of product or 
process related impurities like HCPs or DNA. Due to interception, internal impaction and 
diffusion, particles as small as 0.01 µm can be retained mainly in the depth of the filter 
matrix (Cheryan 1998). 
2.3.1 Tangential flow filtration 
In tangential flow filtration (TFF) the feed is going tangentially to the length of the mem-
brane surface. Thus, as an alternative term for TFF, cross flow filtration is frequently used. 
Two streams are leaving the filtration device, the so-called retentate and the permeate. The 
nominal molecular weight cut-off (NMWC) determines which molecules remain in the 
cycled retentate and which molecules pass through the membrane and enter the permeate. 
Figure I-2 shows a schematic presentation of a TFF process. 
Figure I-2 Schematic presentation of a TFF process 
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In mAb purification processes usually the mAb is in the retentate whereas buffer ions and 
other diffusible compounds form the permeate. During the multi-step purification of 
therapeutic IgG ultrafiltration (UF) membranes with a normal molecular weight cut-off 
(NMWC) of 10–50 kDa are frequently applied. This ensures the reliable retention of the 
mAb in the retentate due to its molecular weight of about 150 kDa. UF operations are 
usually conducted between orthogonal chromatographic steps or prior to final formulation 
to concentrate the protein, exchange buffer, remove low molecular weight impurities or 
simply salts (Herb and Raghunath 2007). During UF concentration and diafiltration a high 
throughput is desired to allow short process time (Ahrer et al. 2006). The throughput of 
non-retained components like water and buffer solutes is termed permeate flux and is in-
fluenced by physical and physico-chemical factors. Physical factors refer to the system 
hydrodynamics while physico-chemical factors include properties of the membrane and 
the feed solution (Huisman et al. 2000). 
2.3.2 System hydrodynamics 
Especially during concentration processes retained protein or particles are concentrated at 
the membrane surface, causing a decrease in permeate flux over time. These compounds, 
being largely rejected by the membrane, tend to deposit on the surface and thus their local 
concentration increases. This concentration polarization is installing an additional layer on 
the membrane surface which is known as gel layer or cake layer (Howell and Velicangil 
1982; Suki et al. 1984; Suki et al. 1986). In addition, solutes diffuse back to the bulk solu-
tion where the concentration is lower according to Fick’s law of diffusion (Wilkes 2006). 
The film theory is the simplest and most widely used theory to model permeate flux 
in mass transfer controlled UF which is shown schematically in Figure I-3. The well 
known schema as well the following Equations I-1, I 2 and I-3 are taken according to 
Cheryan and Porter (Cheryan 1998; Porter 1972). 
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Figure I-3: Film theory model schematically 
Concentration polarization of colloidal and macromolecular solutes on a mem-
brane surface during UF: The build-up of the gel layer of a concentration cg and 
the associated boundary layer is shown. Cb is the concentration of the bulk solu-
tion. 
The model assumes that permeate flux (J) is controlled by the gel layer resistance when the 
convective transport Jcon (J ⋅ c) of retained solutes to the membrane surface is equal to back-
diffusive transport Jback (D (dc/dx)). This steady state can be described as: 
dx
dc
DcJ =⋅  Equation I-1 
Where c is the concentration of retained species in the bulk and 
dx
dc
 is the concentration 
gradient. Integrating equation (1) over the boundary layer ends in: 
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Where δ is the thickness of the polarization boundary layer over which the concentration 
gradient exists, cg is the concentration of the gel layer and k is the mass transfer coefficient 
calculated as: 
δ
D
k =  Equation I-3 
D is the diffusion coefficient of Brownian motion. Since the values of cg and cb are mostly 
fixed by physicochemical properties of the feed, the permeate flux can only be improved 
J
cb
membrane gel 
layer
polarization 
boundary 
layer
bulk
cg
convective 
transport
back 
diffusive 
transport 
tangential 
bulk flow
x
c
δ
2 The purification process of therapeutic antibodies 
27 
by increasing k and thus reducing the thickness of the boundary layer. It is important that 
this model does not consider the hydrodynamic action of particles in the concentrated 
layer due to shear flow of the layer during tangential flow operations (Davis and Leighton 
1987). 
In NFF there are on the one hand permeation drag and sedimentation forcing the re-
tained solutes to deposit on the surface. On the other hand, diffusive transport of solutes 
back into the bulk solution is based on Brownian motion (Chan 2002). Beside the hydro-
dynamic forces acting on the retained solutes in NFF, TFF results in additional forces. 
Figure I-4 shows schematically the hydrodynamic forces acting on retained solutes during 
TFF. 
 
Figure I-4: Hydrodynamic forces acting on retained solutes during TFF 
 
Shear-induced hydrodynamic diffusion processes are lifting particles in the concentrated 
layer away from the membrane exceeding by far the diffusion coefficient for Brownian 
motion. An axial drag results from tangential feed flow causing the retained solutes to 
move over the length of the membrane. When shear induced diffusion is sufficient to off-
set opposing sedimentation and permeation drag the polarization boundary layer on the 
membrane is reduced thus resulting in higher permeate flux (Belfort et al. 1994). 
In membrane filtration processes the system hydrodynamics are directly affected by 
operating parameters like transmembrane pressure (TMP) (Aimar et al. 1989; Bacchin and 
Aimar 2005), permeate flux (Kim et al. 1992) and retentate (cross flow) velocity (Meireles 
et al. 1991). Thus, the adjustment of these parameters affects solute deposition on the 
membrane surface. 
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Permeation drag is mainly influenced by the TMP: 
( )
p
oi p
pp
TMP −
+
=
2
 Equation I-4 
Where pi is the inlet (feed) pressure, po is the outlet (retentate) pressure and pp is the perme-
ate pressure. According to Darcy´s law (Equation I-5) the permeate flux increases propor-
tionally with TMP: 
R
TMP
J
µ
=  Equation I-5 
Whereas an increase in intrinsic membrane resistance RM (the product of bare membrane 
resistance R and viscosity µ of the permeate) results in permeate flux decline. RM increases 
with filtration time due to concentration polarization and gel layer formation. This is ac-
counted for by the addition of a further resistance term, RG , referring to the gel layer, fol-
lowing the resistance model (Cheryan 1998): 
GM RR
TMP
J
+
=  Equation I-6 
The proportional relation between permeate flux and TMP is only valid if low pressure 
values and low feed concentration are applied. Increasing permeate flux due to increased 
TMP results in high permeation drag forcing retained solutes to deposit on the membrane 
surface. Hence the built up of the gel layer is enforced and flux becomes independent of 
pressure. Then the mass transfer limited model (film theory model) adequately reflects the 
factor influencing permeate throughput, i.e. the thickness of the boundary layer, as de-
scribed above. 
Figure I-5 shows the correlation of applied TMP and permeate flux depending on the 
concentration of the protein in the retentate. Flux increases linearly with increased TMP, 
according to Equation I-6. Beyond a certain TMP, a higher TMP does not result in in-
creased permeate flux. The gel layer is formed and overall resistance increases. Conse-
quently, at high TMP, the permeate flux reaches a maximum and becomes constant and 
independent from pressure. The complete constitution of the gel layer varies with concen-
tration at a constant tangential feed flow rate. 
The knee-point of the curve can be used to identify the actual values of TMP beyond 
which the permeate flux remains constant. Moreover, every deviation from the straight 
line of clean water flux indicates the onset of gel layer build-up. This can be used to iden-
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tify critical flux values beyond which the permeation drag forces the retained solutes to 
deposit on the membrane surface. Hereby, critical flux values can be determined by con-
sidering the slope deviation which is than called critical flux identification in the strong form. If 
the slope deviation is neglected and solely the knee-point is considered, this refers to critical 
flux identification in the weak form (Field et al. 1995; Wu et al. 1999). 
Figure I-5 : The correlation of applied TMP and permeate flux (J) with increasing pro-
tein concentration in the retentate (c1 > c2 > c3) is shown schematically 
The permeate flux increases with increasing protein concentration at a constant 
feed flow rate Q1. 
The thickness of the boundary layer can be reduced by increasing axial drag and hydrody-
namic diffusion processes. In TFF operations this is achieved by increasing the feed flow 
rate (Q) and/ or the pressure drop (∆p) between feed (pi) and retentate (po). Equation I-7 
shows the proportional relation between Q and ∆p according to the Poiseuille equation for 
laminar flow (Tutunjian 1983): 
4
1
d
QLk
p
µ
=∆  Equation I-7 
Where µ is the viscosity of the retentate solution, L the length of the membrane, d the 
height of the fluid channel and k1 is a constant depending on channel geometry. In addi-
tion, the proportional relation between ∆p and the retentate flow Qr is based on Equa-
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tion I-7 as well. Figure I-6 shows the correlation of permeate flux and TMP depending on 
the applied feed flow rate Q. 
Figure I-6 : The correlation of applied TMP and permeate flux (J) with increasing feed 
flow rate (Q1 > Q2 > Q3) is shown schematically 
The permeate flux increases with increasing feed flow rate at a constant protein 
concentration c3 in the retentate. 
Permeate flux increases linearly at lower TMP and becomes constant at higher levels when 
the gel layer is completely built up. The level of final pemeate flux increases with tangential 
feed flow rate due to increased mass transfer, according to Equation I-3. 
2.3.3 Physico-chemical effects 
Beside hydrodynamics of the process, the physico-chemical properties of the membrane 
and the feed solution are the main factors which have influence on the deposition of re-
tained solutes on the membrane and hence the permeate flux (Huisman et al. 2000; Mon-
dor et al. 2004). 
Due to attractive protein-membrane and protein-protein interactions the deposition 
of protein on the membrane can be affected. Electrostatic interactions, as well as hydro-
phobic interactions can be involved. Electrostatic interactions between the individual pro-
tein molecules and between the protein and the membrane depend on the prevailing solu-
tion conditions (Fane et al. 1983; Palecek and Zydney 1994). At pH values above or below 
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the IP of the protein the net charge of the protein increases with the distance of pH away 
from the IP. Hence, electrostatic charge repulsion between the protein molecules and 
charged membrane surfaces results in reduced deposition. Moreover, the charge repulsion 
between the protein occupied membrane and non-adsorbed protein reduces ongoing 
deposition on the surface. 
Usually commercially available membrane materials used for UF steps during manu-
facturing of therapeutic mAbs are not ionic in nature. The membrane materials applied are 
mainly polysulfone (PS), polyethersulfone (PES) or regenerated cellulose (RC) (Rubin and 
Christy 2002; Van Reis et al. 1999). Especially PES membranes have a wide pH and tem-
perature tolerance (Deanin 1972) which makes them a robust material in terms of cleaning 
and sterilizing in place. Due to their hydrophobicity compared to RC these membranes 
tend to interact strongly with a variety of solutes making them prone to adsorption of pro-
tein which can result in yield loss. Especially, at the pH equal to the IP of the protein, in-
creased deposition of protein has been observed accompanied by reduced permeate flux 
(Fane et al. 1983; Koehler et al. 1997; Palacio et al. 1999; Salgin 2007). 
It was reported that the charge of a membrane can be affected by pH or solutes, 
whether the material is ionic or not (Maenttaeri et al. 2006). As the material itself is not 
ionic it has been suggested that the apparent zeta potential of the membrane is affected by 
specific adsorption of ions on the membrane surface from the circulating solution 
(Nystroem et al. 1989). Streaming potential measurements are commonly used to charac-
terize the interface of the membrane and an electrolyte. The external pressure (∆p) causes 
movement of the liquid and thus ions are stripped off along the shear plane and a stream-
ing current is formed. The resulting electrical field is generated due to accumulation of 
charge on the downstream side (Ariza et al. 2001). The measurable electrical potential dif-
ferences (∆V) between the two ends of the solid/ liquid system gives direct information 
about the electrostatic charge at the shear plane and thus the so-called apparent zeta po-
tential can be calculated (see chapter V and VI). 
Benavente and Johnson showed that the apparent zeta potential of a PS membrane 
varied in the same way as that of the protein. The zeta potential of both, the protein and 
the membrane depends on the prevailing pH and salt concentration of the processed bo-
vine serum albumin (BSA) solution (Benavente and Jonsson 1998). Results revealed that 
membrane permeability decreases strongly when the salt concentration increases or the pH 
decreases, having its minimum at the IP of BSA. Concomitantly, the apparent zeta poten-
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tial values of the membrane decrease with increasing pH and salt concentration showing 
again a minimum when the pH is equal to the IP of BSA. 
In summary, the surface chemistry of the membrane as well as the solution conditions 
have influence on the deposition of a specific protein on the membrane surface and hence 
permeate flux. The presence of salts and the pH alter the effective charge on the protein 
surface and the apparent zeta potential of the membrane. 
Moreover, the growth and the hydraulic permeability of the deposited layers have in-
fluence on permeate flux. Both, surface charge of the protein and the character and con-
centration of the salts used, have impact on the permeability of the deposited layers. The 
permeability of the protein deposits was reported to decrease with increased ionic strength 
of the feed at a pH above and below the protein IP (Fane et al. 1983; Palecek et al. 1993; 
Palecek and Zydney 1994). This reflects the decrease in electrostatic repulsion between the 
proteins due to charge shielding effects of the salt. Permeability was relatively independent 
of ionic strength at the isoelectric point in the < 0.5 M salt concentration range (Palecek et 
al. 1993; Salgin 2007). Generally, at a pH equal to the IP it is suggested that more compact 
packing of the uncharged molecules occurs, resulting in a denser polarized layer than un-
der electrostatic repulsion. This leads to more pronounced permeate flux decline 
(Nakatsuka and Michaels 1992). 
Beside the influence of pH and salts, Kelly and Zydney reported that existing aggre-
gates in the feed solution have an impact on the permeability of the membrane. Enhanced 
deposition of BSA was caused by the attachment of native protein molecules on existing 
aggregates on the membrane resulting in flux decline. After physical deposition of the ag-
gregated species, chemical attachment of native BSA was reported. This chemical addition 
appeared to occur via the formation of an intermolecular disulfide linkage. Permeate flux 
increased when 1 mM dithiothreitol was added to the feed solution or s-cysteinylated BSA 
was applied (Kelly and Zydney 1995). 
3 Stability during processing 
Due to their size, complex structure and the correlation between their structure and func-
tion, proteins have a limited stability and are prone to degradation. In general, proteins are 
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known to be susceptible to chemical and physical instability (Brange 2000; Goolcharran et 
al. 2000; Manning et al. 1989b). 
Chemical instability refers to modifications of covalent bonds, encompassing deami-
dation reactions, oxidation reactions or cleavage of peptide bonds. Physical instability or 
degradation refers to changes in secondary or tertiary structure, adsorption to surfaces, 
aggregation and precipitation. 
Concerning aggregation, there are different types of aggregates previously mentioned 
in the literature, although there is no consistent definition used in general (Cromwell et al. 
2006; Philo 2006). The type of aggregate can be categorized regarding size, type of bond, 
reversibility and protein conformation (Mahler et al. 2009). 
For the purpose of this work, aggregates are divided in different types on the basis of 
their physical properties, as regards solubility and size. Aggregates which are not visible as 
discrete particles and can not be removed by a filter with a pore size of 0.1-0.2 µm are 
referred to as soluble higher molecular weight species (HMWs). Usually these aggregates 
of a size < 0.1 µm are analyzed by size exclusion chromatography. Aggregates which can 
be removed by 0.1-0.2 µm filtration are referred to as insoluble aggregates. Hence, these 
aggregates have a size of > 0.1 µm up to several hundred µm. This category encompasses 
particles which are visible to the unaided eye, as well as those particles which are subvisi-
ble, since it is reported that the human eye is able to resolve objects slightly smaller than 
100 µm at a distance of 25 cm (Blackwell 1946). 
Subvisible aggregates and particles are only partly addressed in the pharmacopeial 
monographs for sub-visible particles present in a pharmaceutical preparation (EDQM 
2001a; EDQM 2001b; USPC 2002), since the document only refers to the species of 
≥ 10 µm and ≥ 25 µm. Hence, particles between 0.1 µm and 10 µm are not addressed here. 
It is currently under discussion that actually these particles have the potential to impact 
safety and efficacy of the protein product. They appear during processing as well as during 
handling, storage and shipment in the final product container (Carpenter et al. 2009). 
Beside this classification regarding size and solubility, aggregates can be characterized 
by their reversibility mentioned above. Aggregates being covalently linked over chemical 
bonds are usually more stable than reversible aggregates. If they are cross linked over di-
sulfide bridges (Andya et al. 2005; Van Buren et al. 2008), reducing conditions are required 
to resolve them. Reversible aggregates can result from electrostatic protein interactions 
leading to self-association affected by solution conditions, e.g. pH (Liu et al. 2005).  
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Several chemical conditions including pH, ionic strength, redox potential and co-
solvents may be used in DSP to separate the mAb from product and process related impu-
rities. Often the used environmental conditions for the protein are far from physiologic in 
vivo and therefore may provoke chemical as well as physical instability. The low pH during 
Protein A elution and subsequent low pH incubation for viral inactivation is known to 
potentially provoke aggregation (Ejima et al. 2006; Shukla et al. 2005). Therefore, during 
process development it is important to find a combination of parameters which ensures 
both, stability and maximum purity at the same time. 
Moreover, throughout manufacturing, the protein is exposed to several physical stress 
principles. The exposure to air-liquid interfaces (Kiese et al. 2008; Sluzky et al. 1991), to 
solid surfaces of different hydrophobic or hydrophilic materials (Mollmann et al. 2005; 
Randolph and Carpenter 2007), to temperature variations during freeze-thawing (Cao et al. 
2003; Kueltzo et al. 2008) or to UV-light sources (Kerwin and Remmele 2007; Qi et al. 
2008; Roy et al. 2009) can provoke aggregation. 
Moreover, mechanical stress during pumping is known to potentially induce aggrega-
tion. Meireles at al. (1991) studied the effect of different pump heads and observed an 
increase in turbidity of an albumin preparation with pumping time at room temperature by 
using a screw pump. Likewise it was observed that the use of a peristaltic pump enhanced 
aggregation (Chandavarkar 1990). Particle formation of an IgG was eliminated by replac-
ing a radial piston pump with a rolling diaphragm pump (Cromwell et al. 2006). A combi-
nation of physical stress principles can be involved in aggregation as well. Cavitations dur-
ing pumping creating and destroying air bubbles and hence increasing the air-water inter-
face is reported to enhance the formation of protein aggregates. Concomitantly, a higher 
shear stress during pumping was observed to contribute to aggregation (Gomme et al. 
2006). 
3.1 Conformational aspects of aggregation 
It is reported that proteins can form aggregates with predominantly native structure as well 
as with predominantly non-native structure. The latter ones can be termed non-native ag-
gregates. The native secondary structure of mAbs mainly consists of anti-parallel β-sheet 
structure as analyzed by Fourier transformed infrared spectroscopy (FT-IR) and small an-
gle X-ray scattering (Cleland et al. 2001; Costantino et al. 1997). 
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Aggregates can be formed in response to thermal, chemical or physical stress or in the 
absence of any stress factors, showing concomitantly conformational changes in secondary 
structure. The formation of an intermolecular hydrogen-bonded anti-parallel β-sheet struc-
ture was observed during heat induced association of several molecules, regardless of the 
initial secondary structure composition of the native protein (Dong et al. 1995; Van Stok-
kum et al. 2002). Moreover, some molecular regions of the protein, like hydrophobic re-
gions or free SH-groups, become accessible to new intermolecular interactions forming 
aggregates through non-covalent or disulfide bonds. Especially during heating the secon-
dary and tertiary structure becomes more flexible and therefore more reactive towards its 
neighbors (Militello et al. 2004). 
Several studies revealed that rather partially unfolded molecules are involved in aggre-
gation than complete unfolded ones (Fink 1995; Fink 1998; Grillo et al. 2001; Kendrick et 
al. 1998a; Kim and Yu 1996). The classic three-stage model describing the denaturation 
process reflects that protein molecules do not solely exist in the native form (N) or com-
pletely unfolded (Dill and Shortle 1991; Dobson 1992). 
A third state is defined where the molecules are not completely unfolded and there-
fore appear more compact. Only a small expansion of the native surface can be observed 
(Fink 1995; Kendrick et al. 1998a). For this, the intermediates are additionally termed mol-
ten globules or compact intermediates (AI). Today it is known that protein molecules can 
pass more than one intermediate state until they are completely unfolded. The stability of 
the intermediates and hence their detectability can depend on the molecular weight of the 
protein (Bam et al. 1998; Clarke and Waltho 1997). The unfolding is described as a con-
tinuous process in which the molecule passes a reversible transition state (TS) after activa-
tion. Hydrophobic patches are identified on the surface of these intermediates which are 
prone to aggregation (AI n+1 and n AI) to minimize thermodynamically unfavorable inter-
actions with water (Cleland et al. 1993; Fink 1998; Sluzky et al. 1991). Lumry and Eyring 
(1954) described the pathway of non-native protein aggregation. Summarized, it involves a 
reversible conformational change of N forming an aggregation-competent species AI. This 
is followed by irreversible assembly of the non-native molecules AI. A schema of this 
process is presented here: 
 
AITSN →↔  (step 1) 
1+→+ nAIAInAI  (step 2) 
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Aggregation considered within the Lumry-Eyring framework shows a rate limitation within 
the unfolding (step 1) explaining the first order kinetics of aggregation reported for re-
combinant human Interferon γ (rhIFN γ) (Kendrick et al. 1998b; Mulkerrin and Wetzel 
2002; Webb et al. 2001). The subsequent aggregation of the non-native species follows a 
second or higher order process. Thus, according to this model, aggregation does not seem 
to be limited by the protein concentration and hence protein-protein collision. 
In contrast, aggregation of recombinant human Granulocyte-Colony Stimulating Fac-
tor (rhGCSF) was reported to follow a second-order reaction, suggesting that the aggre-
gate-competent species is composed of at least two non-native molecules (AI2) (Chi et al. 
2003b; Krishnan et al. 2002). The dimeric aggregation-competent species can afterwards 
undergo irreversible assembly to form larger aggregates (AIn+2). In addition, the transition 
species (TS) can react with an already formed aggregate (AIn) to form larger aggregates. In 
this model the concentration of the non-native species is the rate limiting step of aggrega-
tion. A schema of the described process is presented here: 
 
222 AITSN →↔  (step 1) 
22 +→+ nAInAIAI  (step 2a) 
1+→+ nn AITSAI  (step 2b) 
3.2 Colloidal aspects of aggregation 
As reported above, protein molecules undergo both, conformational changes and an as-
sembly process to form aggregates. The assembly process is a result of attractive intermo-
lecular interactions leading to self-association. The total interaction forces in aqueous col-
loidal systems are mainly described as attractive hydrophobic van der Waals- and repulsive 
Coulombic electrostatic interaction (Scopes 1994). The sum of these forces represents the 
total interaction energy acting on two spherical particles, as described in the Derjaguin-
Landau-Verwey-Overbeck (DLVO) theory on colloidal stability. 
For proteins, the distribution of hydrophobic and hydrophilic residues as well as 
charged residues on the surface of the molecules mainly determines the overall intermo-
lecular interactions in solution. As described above, hydrophobic amino acid residues are 
exposed on the surface of the protein molecules during unfolding. In the native state these 
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residues are usually buried internally (Damodaran and Kinsella 1981). The exposure of 
these residues can accelerate molecular assembly due to more pronounced hydrophobic 
interactions (Fink 1995; Kendrick et al. 1998a). 
But conformational alteration is not a basic prerequisite for the formation of aggre-
gates. An overall charge near zero minimizes electrostatic repulsion whether the protein is 
unfolded or of native conformation. In any case, the molecules are prone to association 
due to pronounced attractive hydrophobic interaction forces or reduced electrostatic re-
pulsion. In the case of an IgG1, aggregates are reported to be mainly of native structure 
after stressing the protein by shaking and stirring (Kiese et al. 2008). Recombinant human 
granulocyte colony stimulating factor (rhGCSF) has been prevented from aggregation even 
in the partially unfolded state. At pH 3.0, no aggregation was observed when 0.9 % benzyl 
alcohol was added which is known to cause partial unfolding of the protein 
(Thirumangalathu et al. 2006). At pH 3 the protein carries an allover positive charge result-
ing in enhanced colloidal stability and inhibited the formation of aggregates (Chi et al. 
2003a). 
Electrostatic interactions are generally affected by pH and ionic strength of the solu-
tion. Electrostatic interactions between isocharged surfaces are always repulsive suppress-
ing the self-association. Non-charged surfaces are present when the pH of the solution is 
equal to the IP of the protein. In addition, at a pH unequal to the IP, the presence of salt 
can reduce charge-charge repulsion by charge shielding. Figure I-7 shows a schema of the 
total overall interaction energy of two isocharged surfaces in accordance to the DLVO 
theory depending on pH and salt concentration (Chi et al. 2003a; Israelachvili and Wen-
nerstrom 1996). 
When the distance between two isocharged surfaces, e.g. two protein particles, is re-
duced, a maximum interaction energy barrier (∆Wmax) has to be overcome to bring them in 
physical contact. Afterwards, attractive forces result in coagulation and thus aggregation. 
The higher ∆Wmax the more kinetically stable is the colloidal system and dispersed particles 
are present in solution. With increasing salt concentration electrostatic repulsion is 
screened and ∆Wmax is lowered. When the ionic strength is high enough, ∆Wmax becomes 
negative which results in coagulation. 
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Figure I-7: Schema of total interaction energy (W) of two isocharged surfaces result-
ing from the sum of attractive and repulsive net forces depending on pH 
and salt concentration (according to Chi et al 2003a and Israelachvili and 
Wennerstrom 1996) 
∆Wmax is the maximum interaction energy barrier of two particles (black arrow). 
A decrease of ∆Wmax (dashed arrow) occurs with increased salt concentration or 
by decreasing the absolute value of the difference between solution pH and IP of 
the protein (∆ [pH-IP]). A ∆Wmax < 0 (dotted arrow) results in coagulation and 
aggregation. 
Concomitantly, the higher the difference between solution pH and IP of the protein 
(∆ [pH-IP]) is, the higher is the value of ∆Wmax. This results in a more kinetically stable 
system having again dispersed particles present in the solution. Coagulation occurs at 
∆Wmax < 0, e.g. when the pH of the system is equal to the IP of the protein. 
For rhGCSF aggregation was induced by the addition of 150 mM sodium chloride at 
pH 3.5 by shielding charge-charge repulsion present at this pH (Chi et al. 2003a). Advant 
and coworkers reported that self association of recombinant human Interleukin-2 (rhIL-2) 
was enhanced at pH 3.6 which is close to the IP of the protein. This resulted in the forma-
tion of differently sized aggregates. At a pH of 6.5 and 8.6 the formation of dimers was 
reduced (Advant et al. 1995). 
In general, protein self-association is linked to environmental conditions regarding 
protein concentration, temperature, pH, and type and amount of added salts (Przybycien 
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and Bailey 1989). The self-associating species can be either of native conformation or 
structurally altered. 
 The added salts can have influence on both, the conformational stability of the pro-
tein and the colloidal stability of the system. According to the Hofmeister-Series salting-in 
electrolytes preferentially bind to the protein and thus increase the net charge of the pro-
tein. The resulting increased electrostatic free energy of the protein causes a decrease in 
stability and the protein tends to denature in the presence of these electrolytes (Von Hip-
pel and Schleich 1969). Concomitantly, electrostatic repulsive forces prevent protein asso-
ciation and aggregation, or in other words increase the solubility of the protein in aqueous 
solutions. 
On the other hand, electrolytes like sodium-, magnesium or ammonium sulfate are 
termed salting-out additives since the solubility of the protein decreases sharply at high 
molar salt concentrations preserving concomitantly the native conformation of the protein 
(Arakawa and Timasheff 1982; Arakawa and Timasheff 1984). These salts increase the 
surface tension of water and are therefore depleted from the surface layer. This preferen-
tial exclusion of the salt from the surface of the protein leads to the observation of a pref-
erentially hydrated protein surface enriched in water as well as an increase in the total free 
energy of the system (Timasheff 1993). Since the preferential exclusion of the salt per sub-
unit protein is reduced in the agglomerated state, precipitation of the protein is thermody-
namically favored over the dispersed protein in solution. This principle has been widely 
used for selective precipitation and crystallization of proteins for purification purposes 
(McDonald et al. 2009). 
3.3 Concentration dependent aggregation 
By looking at aggregation as a simple association of at least two molecules, this bimolecu-
lar process is considered to be concentration dependent. This can be explained by in-
creased encounter frequency and decreased dissociation tendency in crowded systems 
(Minton 2005). Crowded systems contain macromolecules at concentrations occupying a 
large fraction of the total volume of fluid. The formation of aggregates is reported to be 
enhanced even though a second molecular species is added to the system contributing to a 
general increase in macromolecular concentration. Therefore, self-association as well as 
hetero-association can be facilitated in crowded fluids (Zimmerman and Minton 1993). 
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Rivas et al. (1999) showed that the formation of dimers and larger oligomers of fi-
brinogen can be induced in the presence of > 40 g/l BSA without significant hetero-
association of fibrinogen and BSA. The amount of higher ordered aggregates was in-
creased when an IgG was reconstituted from a dried powder to a protein concentration of 
200 mg/ml. Almost no aggregates appeared, when a concentration of 5 mg/ml was pre-
pared (Dani et al. 2007).  
Especially under quiescent shelf-life setting, aggregation was observed to increase with 
higher protein concentration (Alford et al. 2008a; Treuheit et al. 2002). However, agitation 
induced aggregation was observed to decrease with higher protein concentration. This was 
explained by the reduced air-water interface to protein ratio with increased protein concen-
tration. After occupation of the total interface, the protein remaining in solution is protected 
from surface interaction which is known to greatly enhance aggregate formation on the basis 
of conformational changes (Donaldson et al. 1980; Henson et al. 1970). 
In contrast, macromolecular crowding is expected to stabilize the native structure of 
the protein. Especially in concentrated solutions, the molecules are assumed to exclude 
volume to one another on the basis of steric repulsion and thus reducing the systems en-
tropy. As a consequence, the systems free energy is increased and the most favored state 
will be the one excluding the least volume. Therefore, the compact native state is favored 
over the extended unfolded states of the protein. Moreover, macromolecular compaction 
and association is enforced since aggregated molecules exclude less volume to another 
than an equal number of isolated molecules (Minton 1980; Minton 1998). 
Protein aggregation based on increasing collision frequency may further depend on 
the diffusional mobility of the molecules. Crowding is considered to reduce the diffusional 
mobility of the molecules, since viscosity is observed to increase with a higher macromo-
lecular concentration (Liu et al. 2005). Therefore, diffusional limitations can define an up-
per limit of bimolecular reaction rates at a higher total macromolecular concentration 
(Zimmerman and Minton 1993). 
Beside the diffusional mobility of the protein molecules, the diffusional mobility of 
the solutes is affected at a higher protein concentration. This can be important considering 
the concentration methods which are applied to obtain highly concentrated solutions in 
manufacturing scale. As described in section 2.3.1 of this chapter, UF in TFF-mode is the 
method of choice retaining the protein on the retentate side and concomitantly allowing 
the pass through of soluble solutes to the permeate side. It is known that the concentra-
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tion of the diffusible charged solutes on the permeate and the retentate side is theoretically 
equal leading to the same defined composition of soluble solutes in the retentate before 
and after UF. Due to an increasing concentration of a charged protein on the retentate 
side the partitioning of charged solutes across the semipermeable membrane is affected. 
This thermodynamic non-ideality can result from intermolecular charge-charge based in-
teractions between the charged protein molecules and the charged solutes affecting the 
partitioning of the solute. This is termed the Donnan-effect and Stoner and coworkers 
(2004) related these facts to the process development environment of different therapeutic 
proteins. 
In general, a high total concentration of macromolecules in solution is known to af-
fect the equilibria and kinetics of macromolecular reactions. Due to volume exclusion an 
effect on protein stability including protein folding as well as protein aggregation is re-
ported. 
3.4 Nucleation aspects of aggregation 
Aggregation can be considered as a nucleation and growth phenomenon (Chi et al. 2003b). 
It was observed that aggregation in solution can start suddenly. Afterwards, aggregation 
proceeds and the aggregated species increase in number and size. Concomitantly, the 
monomeric protein population is depleted. 
It is assumed that protein molecules assemble and locally accumulate, eventually ex-
ceeding their solubility limit and precipitate. To create such a new solid-liquid interface, 
assembly is allowed after the system has raised the free energy required. To achieve that, a 
stable critical-sized species has to be formed by spontaneous coalescence consisting of n 
molecules (Andrews and Roberts 2007; Li et al. 2009; Rotter et al. 2005). This species is 
called embryo or critical nucleus. The time until the nuclei are build up is described as a lag 
phase in aggregation and is caused an energy barrier to assembly. When the critical size of 
the nucleus is reached where energy barrier is highest then growth of the nucleus occurs 
and a new phase is formed spontaneously (Chi et al. 2003b; Debenedetti 1996). Such 
nucleation which occurs in the interior of a uniform substance is called homogeneous 
nucleation and is reported to increase with increasing concentration or increased 
temperature (Powers and Powers 2006). 
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Nucleation which occurs at nucleation sites on surfaces contacting the liquid is 
termed heterogeneous nucleation. At such preferential sites the effective surface energy is 
lower, thus the free energy barrier is diminished and nucleation is facilitated (Apfel 1970; 
Debenedetti 1996). 
Figure I-8 shows a schema of homogeneous and heterogeneous nucleation leading to 
the further propagation of larger protein aggregates. When a critical nucleus is formed in 
solution (A), on the surface of an existing aggregate (B) or a foreign surface (C), this spe-
cies grows into larger agglomerates. After exceeding a defined size the new aggregated 
species is separated from the nucleation site. The newly formed aggregates are afterwards 
able to serve as a nucleation site by themselves. 
 
Figure I-8: Nucleation schema (based in parts on Mirchev and Ferrone 1997) 
Homogeneous nucleation where the critical nucleus is formed from solution (A), 
heterogeneous nucleation where the critical nucleus is formed on the surface of 
an existing aggregate (B) and heterogeneous nucleation where the critical nucleus 
is formed on the surface of a foreign material (C). 
For proteins it is reported that critical nuclei are often soluble aggregates that rapidly grow 
and form insoluble aggregates (Cleland et al. 1993; Reithel 1964; Wood et al. 1999). For 
α-synuclein the critical nucleus was a dithyrosine cross-linked dimer which was formed due 
to protein oxidation. When the species exceeded a level of 1-2 % the formation of fibril 
shaped aggregates started. Moreover, after spiking the preformed dimer into an aggregate 
free solution the fibril formation started as well. Due to the inhibition of dimer formation 
by adding methionine as an anti-oxidant, fibril formation was prevented (Krishnan et al. 
2003). The formation of the dimer in the aggregate free solution was not detected during 
15 days incubation at accelerated temperature. This lag phase until aggregate growth pro-
critical nucleus
A
B
C
aggregategrowth
critical nucleus aggregategrowth
critical nucleus aggregategrowth
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ceeds was observed for a number of other proteins, as well as the sudden induction of 
aggregation by spiking the proteinaceous nucleus reducing the lag time (Chi et al. 2003b; 
Harper and Lansbury 1997; Nielsen et al. 2001). 
Ferrone and coworkers reported that sickle cell hemoglobin polymerizes as a 
consequence of both types of nucleation. On the one hand, homogeneous nucleation 
creates aggregates followed by a growth reaction forming polymerized molecules. On the 
other hand, heterogeneous nucleation on preexisting polymers via a specific binding site 
on the surface of the polymers was observed, too (Ferrone et al. 2002; Mirchev and 
Ferrone 1997). 
Considering heterogeneous nucleation Chi et al. revealed that recombinant human 
platelet-activating factor acetylhydrolase (rhPAF-AH) did not aggregate after spiking of 
preformed proteinaceous nuclei. In contrast, extensive aggregation was induced rapidly 
when exogenous nano-sized hydrophilic silica particles were added (Chi et al. 2005b). After 
adsorption to the hydrophilic silica surface, aggregation occurred without detectable 
changes in secondary or tertiary structure. Decreasing the extent or affinity of rhPAF-AH 
adsorption to the particles by adding surfactant or increasing the pH, aggregation was re-
pressed.  
Moreover, Tyagi et al. (2008) reported that the formation of IgG particles was ob-
served during vial filling by using a positive displacement piston pump. By performing 
spiking experiments it was shown that the pump shed nano-particles of stainless steel 
which served as heterogeneous nuclei inducing the formation of protein micro-particles. In 
this study a slight perturbation in secondary structure of the proteinaceous particles was 
observed. 
In general, micro- and nano-sized particles of different materials can be shed or 
abraded from almost all bioprocessing equipment with which the protein solution is in 
contact. Pumps, tubing or filters can be considered as sources for these particles (Tyagi et 
al. 2008). In addition, containers or closures of different foreign wetted materials can shed 
particles which can induce aggregation potentially by a heterogeneous nucleation-
controlled mechanism. Particles of glass, rubber or silicone oil droplets are known to cause 
aggregation of several proteins (Chi et al. 2005b; Jones et al. 2005; Thirumangalathu et al. 
2009). Teflon particles were observed to cause aggregation of insulin (Sluzky et al. 1991). 
Tungsten micro-particles are involved in precipitation of an IgG1 solution in acidic buffer 
(below pH 6.0) without affecting secondary structure (Bee et al. 2009b). 
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Bee et al. (2009a) studied adsorption and aggregation by incubating an IgG1 with mi-
cro-particles of different materials. Glass, cellulose, stainless steel and ferric oxide particles 
were used. By applying stainless steel micro-particles irreversible adsorption was observed 
accompanied by the formation of soluble aggregates. Glass, cellulose and ferric oxide were 
shown to adsorb the protein, however protein aggregation was not observed. In all cases 
the secondary structure appeared nearly native. 
Beside these already mentioned particles derived from the bioprocessing equipment, 
containers or closures, proteinaceous species like HCPs are suspected to potentially induce 
heterogeneous nucleation dependent aggregation (Arakawa et al. 2006).  
Almost every study regarding heterogeneous nucleation dependent aggregation de-
scribes the formation of nearly native aggregates in the presence of nano- or micro-sized 
particles apart from the studies concerning silicon droplets. Here, the protein molecules 
being adsorbed to the oil-water interface showed a slight pertubation in tertiary structure 
(Thirumangalathu et al. 2009). 
Adsorption to solid surfaces is in general known to potentially induce protein aggre-
gation. The adsorption process is mostly driven by either hydrophobic interactions or elec-
trostatic interactions between the surfaces and the protein protein (Norde 1995; Norde 
and Lyklema 1978). Due to partial unfolding of the protein on the surface, structurally 
perturbed molecules can potentially form aggregates on the surface or in the bulk solution 
after desorption. An increase in α-helical structures accompanied by a reduction in β-sheet 
and β-turn conformations is reported after adsorption of a mAb to Teflon particles 
(Vermeer et al. 1998). Formulated Interleukin-2 (IL-2) was shown to adsorb to silicone 
rubber tubing undergoing concomitantly conformational changes regarding secondary 
structure. Moreover, a loss in activity was observed (Tzannis et al. 1997). 
 In the case of heterogeneous nucleation partial unfolding is hardly involved in aggre-
gation. Aggregation can be prevented, if the protein is hindered to adsorb to the surface 
and hence to form a critical nucleus. This was shown for hydrophilic glass particles and 
silicon oil droplets by adding surfactant to the protein solutions (Chi et al. 2005b; Thiru-
mangalathu et al. 2009). 
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Chapter II Objectives of the thesis 
This thesis aimed to gain more insight in mainly physical instability of therapeutic mAbs 
occurring during the purification process and especially at its interface to final formulation. 
The evaluation of critical factors leading to aggregation as well as the development of 
strategies to improve the quality of the purified bulks were focused. Particularly, the tan-
gential UF processing of concentrated mAb bulks intended for subcutaneous administra-
tion of highly concentrated therapeutic formulations was examined. Moreover, the role of 
exogenous impurities which may be present in the purification intermediates was investigated 
considering their potential to facilitate aggregation. 
 
The following objectives were predominantly addressed: 
 
(I) Evaluation of operational parameters in UF concentration processes of IgGs affect-
ing aggregation. The development of a method to produce highly concentrated solu-
tions was aimed ensuring a high end-concentration. At first, a technique being appli-
cable in lab scale as well as in manufacturing scale had to be elaborated to achieve a 
protein concentrations exceeding 100-200 mg/ml. Concomitantly, a short processing 
time and a reduced level of aggregates in the final bulk was mandatory during and af-
ter processing. 
(II) Investigation of the storage stability of highly concentrated mAb solutions consider-
ing applied operational parameters during UF processing. The physical stability of an 
IgG bulk had to be investigated regarding aggregation as well as conformational 
changes. The influence of the UF method used and the protein concentration of the 
bulk had to be focused. Moreover, aggregation behavior due to the presence of pre-
formed aggregates and particles induced by different UF strategies was required. 
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(III) Investigation of thermodynamic non-ideality during UF operations of IgGs. Ther-
modynamic non-ideality known to result from intermolecular charge-charge based 
interactions between macromolecular polyions and small charged solutes had to be 
examined during UF of IgGs. Potential correlation of pH and conductivity during 
the UF concentration process and the partitioning characteristics of soluble solutes 
across the semi permeable membrane were arrogated. The impact on chemical and 
physical stability of the highly concentrated protein solutions at the interface of DSP 
and final formulation should be evaluated. 
(IV) MAb aggregation caused by exogenous process related impurities potentially present 
in the purification intermediates. The physical stability of an IgG monitored in the 
presence of nano- and macro-sized chromatographic particles should be evaluated 
regarding potential heterogeneous nucleation dependent aggregation. Aggregate 
formation as well as conformational changes due to the contact to different chroma-
tographic surfaces need to be examined. In addition, the presence of indigenous pro-
teinaceous species derived from a specific host cell system and their role in mAb ag-
gregation was of special interest. 
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Chapter III Highly concentrated mAb 
solutions: Optimized operational parameters 
in UF minimizing aggregation 
Abstract 
For the production of highly concentrated mAb intermediate solutions in the course of 
downstream processing, ultrafiltration is the industry standard. Key challenges are to 
achieve high end concentrations and to reduce both process time and aggregate formation, 
particularly for therapeutic proteins intended for subcutaneous administration. Therefore, 
in this study the effects of operational parameters on permeate flux and aggregation in the 
concentrated solutions were investigated. 
An optimized ultrafiltration concentration method was developed based on syste-
matic screening of retentate flow rate and transmembrane pressure at different protein 
concentrations in the retentate. In this method flow and pressure values are adjusted de-
pending on the prevailing retentate concentration. The resulting three stage protocol re-
duces process time and assures a low aggregate burden compared to concentration proc-
esses operated at constant flow and pressure conditions. Flow and pressure profiles were 
set and recorded in lab scale using an automated tangential flow filtration system which 
has been shown to adequately reflect process conditions at manufacturing scale. 
The formation of IgG aggregates was monitored by turbidity measurement, SE-
HPLC, light obscuration, dynamic light scattering and a microscopic method. These tech-
niques allow the characterization of a wide range of aggregate sizes of soluble and insolu-
ble aggregates that can occur during processing. In addition, FT-IR spectroscopy was per-
formed to investigate the secondary structure of the aggregates, revealing different quanti-
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ties of structurally perturbed protein which depend on applied flow and pressure condi-
tions during UF. 
Finally, the concentrated material derived from the optimized method showed im-
proved processability at sterile filtration which is an important manufacturing step prior to 
storage. 
1 Introduction 
There is an unbroken demand for highly concentrated low volume formulations of mAbs 
for subcutaneous administration, especially in the field of chronic disease therapy, to im-
prove patient convenience and compliance by offering outpatient treatment (Harris et al. 
2004; Shire et al. 2004). Not only these high dose/ low volume dosage formulations, but 
also concentrated intermediate solutions of different purification steps are highly desired in 
the course of downstream processing. Low volume batches allow economic handling and 
storage and increase flexibility of hard-piped GMP manufacturing suites with fixed vessel 
volumes. To produce mAb solutions with a concentration of at least 100 mg/ml in large 
scale, reliable UF processes are required. The challenge is to achieve high end-
concentration, short process time and high quality of the API at the same time (Harris et 
al. 2004; Luo et al. 2006). 
Throughout manufacturing of biopharmaceutics, proteins are prone to chemical and 
physical instability as reported in chapter I. Hence, every step of the manufacturing proc-
ess has to be evaluated regarding the potential formation of protein aggregates and aggre-
gate precursors in order to diminish the risk of adverse effects in patients (Schellekens 
2003) or loss in efficacy (Schellekens 2005) and to increase API stability during storage. 
During UF the protein faces a combination of physical stress principles like pumping, 
flow induced shear stress or extensive contact to membrane surfaces. In addition, the pro-
tein reaches extremely high concentrations in the gel and polarization boundary layer near 
the membrane which is considered to support aggregation as well (Kiefhaber et al. 1991; 
Wang et al. 2007a). 
Moreover, concentrated gel and polarization boundary layers near the membrane are 
leading to decreased permeate flux (Howell and Velicangil 1982; Kim et al. 1992; Pradanos 
et al. 1996; Suki et al. 1984; Suki et al. 1986). Therefore, a lower level of protein aggregates 
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should reduce additional membrane clogging. Especially if the protein concentration ex-
ceeds approximately 50 mg/ml, the viscosity will exponentially increase which affects 
permeate flux in addition adversely (Liu et al. 2005; Turker and Hubble 1987). On the one 
hand, the feed flow going tangentially to the membrane surface helps to remove deposited 
material from the membrane surface if enhanced back diffusion and lift velocity are suffi-
cient to offset opposing sedimentation and permeation drag forces (Belfort et al. 1994; 
Davis and Leighton 1987). On the other hand, high shear rates in the flow channel poten-
tially provoke aggregates which can be transported to the retentate solution and can ad-
versely affect bulk quality. 
In this study, the influence of applied shear stress during the UF concentration proc-
ess on aggregation, permeate flux and concentration time was investigated using the pro-
portional correlation between the pressure drop ∆p (pi – p0) and the shear stress τw in the 
flow channel of the membrane module. This correlation has been presented before by 
using Equation III-1 (Ahrer et al. 2006): 
L
ppd oiH
w 4
)( −
=τ  Equation III-1 
dH is the hydraulic diameter of the flow channel, pi is the inlet pressure, po is the outlet pres-
sure and L is the length of the membrane (Gerhart et al. 1993). The hydraulic diameter dH 
which behaves proportionally to τw was kept constant for all UF experiments by using the 
same cassette module for each experiment. The hydraulic diameter dH can be calculated by 
Equation III-2 where a is the width and b is the height of the flow channel (Cheryan 1998): 
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The second approach in the present study considers additionally that increased concentra-
tion during the UF process is detrimental to permeate flux and hence increase process 
time. In order to reflect this, the optimal values of cross flow rate and transmembrane 
pressure at different protein concentrations in the retentate were systematically deter-
mined. The aim was to develop an UF method offering improved permeate flux during the 
concentration process and thus reducing concentration time. Concomitantly, the forma-
tion of aggregates in the concentrated mAb solutions should be reduced. 
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2 Materials and methods 
2.1 Materials 
A capture pool of a chimeric human Fc (IgG4)/ rat Fab antibody in citrate buffer pH 5.5 
(IgG A) was taken for the concentration experiments. In addition, completely purified 
bulk of two chimeric human Fc (IgG1)/ mouse Fab antibodies (IgG B and IgG C) in his-
tidine buffer pH 6.0 were used. All mAbs were provided by Roche Diagnostics GmbH 
(Penzberg, Germany). Before UF processing the solutions of 5 mg/ml protein concentra-
tion were filtered through a 0.2 µm membrane cartridge (Sartorius, Goettingen, Germany). 
All chemicals and reagents used were at least analytical grade. Citric acid, sodium hydrox-
ide and hydrochloric acid from Merck KG (Darmstadt, Germany) were employed. L-
histidine from Ajinomoto (Raleigh, USA) was used. 
2.2 Methods 
2.2.1 Ultrafiltration concentration procedure 
For the preparation of concentrated mAb solutions the automated TFF system ÄK-
TAcrossflow (GE Healthcare, Uppsala, Sweden) was used (Liten and Cohen 2007). The 
system was operated using the Unicorn software (GE Healthcare, Uppsala, Sweden). A 
Sartocon Slice flat sheet cassette with a Hydrosart membrane of regenerated cellulose, a 
nominal NMWC of 30 kDa and a membrane area of 0.02 m² was provided by Sartorius 
(Goettingen, Germany). Total membrane loading was about 400 g/m² for each experi-
ment. After concentration the membrane module was cleaned with 1 M sodium hydroxide. 
The normalized flux rate for water (NWF) was determined after every cleaning cycle and 
compared to the obtained value before initial use. The cassette was only applied for the 
next experiments, if the NWF decline in (l/m²/h)/ 1 bar at 20 °C was below 10 % of the 
initial value to ensure complete cleaning and comparable membrane properties. 
2.2.2 Concentration determination 
Concentration was determined by using the photometric absorbance at 280 nm and 
320 nm after buffer blank subtraction (UV-Vis spectrophotometer Evolution 500, Thermo 
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Fisher Scientific, Waltham, USA). The absorbance at 320 nm was subtracted from the 
absorbance at 280 nm and this value was used to calculate the protein content according to 
the law of Lambert-Beer. 
2.2.3 Turbidity measurements 
Turbidity was determined as photometric absorbance after buffer-blank subtraction of the 
undiluted concentrate at 350 nm and 550 nm, where no intrinsic chromophores of the 
mAb absorb (UV-Vis spectrophotometer Evolution 500, Thermo Fisher Scientific, 
Waltham, USA) (Capelle et al. 2007). The samples were mixed before measuring in order 
to avoid a decrease in absorbance due to the settlement of large particles. Turbidity was 
used to determine the relative amount of particles encompassing colloidal and subvisible 
protein aggregates (Mahler et al. 2005). 
2.2.4 Size exclusion high pressure liquid chromatography 
Size exclusion high pressure liquid chromatography (SE-HPLC) analysis was conducted 
with a TSK 3000 SWXL column (Tosoh Biosep, Stuttgart, Germany) on a Summit HPLC-
system (Dionex, Idstein, Germany). The elution peaks were monitored at 280 nm by the 
UV diode array detector UVD170U from Dionex (Idstein, Germany). Isocratic chroma-
tography was conducted at room temperature using an aqueous buffer composed of 
200 mM potassium phosphate and 250 mM potassium chloride at pH 7.0 and a flow-rate 
of 0.5 ml/min. Each sample contained 100 µg mAb per injection. The chromatograms 
were integrated manually by using the Chromeleon software (Dionex, Idstein, Germany). 
This is shown exemplarily in Figure III-1. The percentage of higher molecular weight spe-
cies (HMWs) includes dimers and larger soluble oligomers. It was determined as relative 
area (mAU⋅min) of the respective peaks referred to total area of all peaks including the 
monomer peak and the peak of the lower molecular weight species (LMWs). 
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Figure III-1: Integration borders and retention times of the SE-chromatogram 
HMWs elute first between 10 min (oligomers) and 15 min (dimers). Subsequently, 
the monomer elutes after about 16 min followed by LMWs. 
Total recovery was monitored throughout the analysis by comparing the total peak area of 
the respective sample to the total peak area of a control sample. 
2.2.5 Light obscuration particle counting 
Light obscuration (LO) was used to monitor the formation of particles in a range of 1-
200 µm similar to the method <788> Particulate Matter of Injection in the United States 
Pharmacopoeia and the European Pharmacopoeia method 2.9.1. (EDQM 2001a; USPC 
2002). The particle counter SVSS-C (PAMAS Partikelmess- und Analysesysteme, 
Rutesheim, Germany) was equipped with a laser diode and a photodiode detector in order 
to determine the residual photocurrent after particles have passed the course of the beam. 
The HCB-LD-25/25 was applied as particle sensor. Concentrates of a higher content of 
particles than 120 000/ ml where diluted with buffer to match the specified capacity of the 
used sensor. Three measurements of a volume of 0.5 ml for each sample were analyzed 
after an equilibrating flush of 0.3 ml. Results were calculated as mean value of three meas-
urements and referred to a sample volume of 1.0 ml. Before diluting the concentrates the 
buffer was filtered using Stericup Express plus 0.1 µm filter devices (Millipore, Billerica, 
USA) and the particle burden was determined as described before. 
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2.2.6 Fitration/ staining method 
The method was applied according to Li et al. (2007) to investigate the level of insoluble 
aggregates in the concentrated solutions. 2 ml of the concentrated mAb solutions were 
filtered through a buffer-wetted 0.2 µm cellulose acetate membrane (Sartorius, Goettingen, 
Germany) with a diameter of 47 mm under vacuum. Then 10 ml of citrate buffer pH 5.5 
were added three times and vacuumed away. 2 ml Reversible Protein Detection Kit solu-
tion from Sigma-Aldrich (Steinheim, Germany) were added on the membrane and kept in 
contact for 3 minutes and then drained. After that, the membrane was rinsed with 
3 x 10 ml buffer and 3 x 10 ml water and then dried in air. Subsequently, the membranes 
with the retained and stained particles were examined under a stereomicroscope MZ 12 
(Leica, Wetzlar, Germany) equipped with a digital camera DC 100 (Leica, Wetzlar, Ger-
many) under 80-times magnification. 
2.2.7 Dynamic light scattering 
The Zetasizer Nano S dynamic light scattering (DLS) instrument (Malvern Instruments, 
Worcestershire, UK) was used to monitor colloidal species in the size range of a hydrody-
namic diameter between 1 nm and 6 µm. The scattering information is detected at an angle 
of 173 ° operating with a 4 mW He-Ne-laser at 633 nm using the non-invasive back-
scatter technique (NIBS) (Kaszuba and Connah 2006). The samples were analyzed undi-
luted in a temperature controlled precision quartz cuvette (Hellma, Müllheim, Germany) at 
25 °C. The size distribution by intensity was calculated from the time-dependent correla-
tion function using the multiple narrow mode of the DTS software (Version 5.0, Malvern 
Instruments, Worcestershire, UK). The relative light intensity of the detected peaks is pre-
sented as mean values of three measurements. 
2.2.8 FT-IR spectroscopy 
FT-IR spectra were recorded with the Tensor 27 (Bruker Optics, Ettlingen, Germany) 
applying the MIRacle attenuated total reflection (ATR) cell with a Germanium crystal 
(Bruker Optics, Ettlingen, Germany) to investigate the washed insoluble aggregates sepa-
rated from the concentrated retentate by centrifugation. In addition, the protein adsorbed 
to the UF membrane was investigated after the concentration process. For this, the Sarto-
con Slice flat sheet cassette was dismantled and the Hydrosart membranes were cut out, 
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washed with buffer and were applied to the crystal. The transmission cell AquaSpec 
(Bruker Optics, Ettlingen, Germany) was used to investigate the liquid solutions. 
For each spectrum which was recorded from 850-4000 cm-1 a 120-scan interferogram 
was collected at a double sided acquisition mode with a resolution of 4 cm-1. The reference 
spectrum of buffer and wetted membrane respectively was subtracted to obtain the protein 
spectrum. 
The transmission spectra were edited by a vector normalization followed by the gen-
eration of the second derivative smoothed using a 13-point Savitsky-Golay smoothing 
function. To obtain the spectral characteristic of heat induced aggregation a Bio-ATR II 
unit with Silicium crystal (Bruker Optics, Ettlingen, Germany) was applied and a mAb 
solution of 100 mg/ml was heated up to 90 °C. The absorption spectra recorded in ATR 
mode were corrected concerning band intensity and band position to allow the compari-
son to spectra recorded in transmission mode. Therefore the extended ATR-correction of 
the software OPUS 6.0 (Bruker Optics, Ettlingen, Germany) according to Fringeli (1992) 
was used, to overcome wave number dependent anomalous dispersion (Goldberg and 
Chaffotte 2005; Grdadolnik 2002). 
2.2.9 Sterile filtration experiments 
A filtration line composed of a stainless steel in-line filter housing (Sealkleen, Pall, 
Dreieich, Germany) and a Millex VV PVDF filter unit with a pore size of 0.1 µm and a 
filtration area of 4.52 cm² (Millipore, Billerica, USA) were used and operated under con-
stant pressure of 0.75 bar. The filtrate flow rate over time was determined at 90 mg/ml 
protein concentration. Every filtration was carried out at room temperature and the flow-
through was recorded over ten minutes. The results are presented as mean values of three 
runs ± SD. 
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3 Results and discussion 
3.1 The ÄKTAcrossflow: A representative TFF system 
For the development of purification processes, representative scale down models are nec-
essary which adequately reflect manufacturing conditions up to 10 000 liter scale. This 
assures the implementation of reliable chromatographic and filtration procedures. More-
over, online monitoring of process control parameters is desired. For TFF processes the 
monitoring of pH, conductivity, temperature, fill level, introduced air, pressure and flow 
parameters are considered to be highly valuable since theses parameters have impact on 
protein stability and hence quality (Carpenter et al. 1999). Further, an automated system is 
favored to ensure reproducibility of optimized operating conditions. 
In this work the ÄKTAcrossflow, an automated TFF lab-scale system was used which 
meets all the requirements mentioned above. The effects of operational parameters on 
aggregation, end-concentration and process time were investigated. The system is com-
posed of three piston pumps achieving a feed flow rate of 1-600 ml/min. The pump heads 
are made of a borosilicate tube and a piston of PTFE. The maximum system pressure is 
5.2 bar. As reported in chapter I, different studies revealed that pumping can cause aggre-
gation (Chandavarkar 1990; Meireles et al. 1991). Cromwell et al. (2006) described that the 
use of a piston pump during filling operations of a liquid IgG formulation caused an in-
crease in the number of particles and in turbidity. 
Therefore, we examined the effect of the ÄKTAcrossflow piston pumps on aggrega-
tion by recycling an IgG1 solution of 18 mg/ml for one hour at 25 °C. No UF membrane 
cassette was applied and the permeate side was closed. In addition, we performed the same 
experiments by using a diaphragm pump which is usually known to cause no protein ag-
gregation (Cromwell et al. 2006). This type of pump can be applied in pilot or manufactur-
ing scale and has an output of about ten fold compared to the ÄKTAcrossflow. Therefore, 
the feed flow rate was adjusted to 300 ml/min for the piston pumps of the ÄKTAcross-
flow and to 3 000 ml/min for the diaphragm pump QF 1000S (Quattroflow Fluid Sys-
tems, Hardegsen-Hevensen, Germany). Samples were taken every 15 min during pumping 
and were analyzed by turbidity measurement and SE-HPLC in order to monitor insoluble 
larger aggregates and soluble HMWs. Figure III-2 and Figure III-3 show the analytical 
results for both pump types over 60 min total pumping time. 
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Figure III-2: Effect of pump type on turbidity of a cycled IgG solution at 18 mg/ml 
Turbidity at 350 nm (and 550 nm) monitored over 60 min: Values for the ÄK-
TAcrossflow piston pumps are presented in black (black striped) and for the dia-
phragm pump in grey (grey striped). 
With pumping duration a general increase in turbidity at both wave lengths was observed. 
The turbidity values at both wave lengths are slightly but consistently higher when the 
piston pumps of the ÄKTAcrossflow were used. After 45 min no further significant in-
crease in turbidity with pumping time was observed for both pump types. 
The amount of HMWs during pumping was not affected by either using a piston 
pump or a diaphragm pump. For the starting protein material processed by using the dia-
phragm pump a higher content of HMWs was identified which can be ascribed to a stabili-
ty issue since this sample was stored at room temperature before processing (Figure III-3). 
Since the pistons themselves did not induce the formation of HMWs during pumping 
and only a slight increase in the turbidity of the pumped solution was observed compared 
to the diaphragm pump, the ÄKTAcrossflow was chosen as a suitable TFF system to in-
vestigate the effect of system hydrodynamics on aggregation. 
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Figure III-3: Effect of pump type on the level of HMWs in an IgG solution at 18 mg/ml 
determined by SE-HPLC 
HMWs [%] monitored over 60 min: Values for the ÄKTAcrossflow piston pump 
are presented in black and for the diaphragm pump in grey. 
In order to potentially allow the transfer of our applied operational conditions to a larger 
scale system, the Reynolds numbers (Re) in the flow channel of the described lab-scale 
equipment were calculated and compared to the values of a pilot scale system. As pilot 
scale system the automated TFF system Uniflux 10 (GE Healthcare, Uppsala, Sweden) 
was chosen equipped with four diaphragm pumps to drive the feed. 
The pilot-scale system was equipped with a 0.1 m² Sartocon Slice Cassette with 
30 kDa NMWC (Sartorius, Goettingen, Germany). The membrane modules in lab scale 
and pilot scale module have identical flow path geometry ensuring defined fluid dynamics 
in the membrane module independent of scale (Van Reis et al. 1997). 
The Reynolds numbers were calculated according to the commonly used equation 
presented by Cheryan (1998): 
µ
ρ0Re ud h=  Equation III-3 
Where dh is the hydraulic diameter of the flow channel calculated according to Equa-
tion III–2, µ is the dynamic viscosity of the solution, ρ is the density of the solution and u0 
is the mean feed flow velocity calculated as: 
ba
Q
u
⋅
=0  Equation III-4 
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Where Q is the feed flow rate in m³/s, a is the width and b is the height of the flow chan-
nel. In Table III-1 the Reynolds numbers are displayed for both systems, lab- and pilot 
scale, under typical operating conditions. 
It has to be noticed that all Sartocon Slice devices are composed of multiple mem-
brane layers. Therefore, the values given for mean velocities as well as for the Reynolds 
numbers were divided by three for Sartocon Slice 200 and twenty-five respectively for 
Sartocon Slice Cassette, since these devices are composed of three and twenty-five indi-
vidual channels respectively. The dimensional analysis of fluid dynamics by using Reynolds 
numbers was performed to evaluate the quality of the scale-down model. 
 
TFF system Scale Pump type ∆p [bar] Re [ ] Q [m3/s] u0 [m/s] 
ÄKTAcross-
flow 
lab piston 
pump 
1.2, 
0.6 
48.53, 
23.65 
2.66 x 10-6, 
1.30 x 10-6 
0.049, 
0.025 
Uniflux 10 pilot/ 
manufacturing 
diaphragm 
pump 
1.3 72.69 3.33 x 10-5 0.076 
Table III-1: Reynolds numbers for the ÄKTAcrossflow lab scale system equipped with 
0.02 m² Sartocon Slice module and for the Uniflux 10 pilot scale system 
equipped with the 0.1 m² Sartocon Slice Cassette module 
For calculation purposes a 50 mg/ml mAb solution with a dynamic viscosity 
value of 1.14 mPa s and a density of 1.014 g/ml was applied. 
The determined numbers at different scales revealed that operating conditions applied in 
the lab scale system chosen can in general be transferred to a larger scale system. Reynolds 
numbers are used when performing dimensional analysis of e.g. fluid dynamics, and can be 
used to determine dynamic similitude between different experimental cases, where a fluid 
is in relative motion to a surface (Wilkes 2006). Moreover, Reynolds numbers are used to 
indicate the flow regime by evaluating the relative importance of inertial effects to viscous 
effects. Laminar flow occurs at low Reynolds numbers below 2000 (Wilkes 2006) where 
viscous forces dominate. Turbulent flow occurs at higher Reynolds numbers. There, iner-
tial forces dominate which can produce random eddies, vortices and other flow fluctua-
tions known to provoke protein aggregation (Bee et al. 2009c; Gomme et al. 2006). In the 
presented study, the Reynolds numbers are clearly lower than 2000 indicating that the op-
erated lab scale model, as well as the pilot scale model show comparable flow regimes 
which are clearly laminar. 
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3.2 Effects of applied shear stress 
UF concentration runs were conducted from 5 mg/ml up to 140 mg/ml target concentra-
tion. Four different UF methods were applied each of them using a different ∆p value. 
According to Equation III–1, a higher ∆p value is attributed to a higher τw value. Thus a 
∆p of 0.7, 1.2, 1.8 and 3.0 bar was applied resulting in a calculated τw of 126, 216, 325 and 
541 Pa. The TMP, defined in Equation I–4, was kept constant at 0.6 bar for all experi-
ments. Table III-2 shows the operational parameters as well as the calculated τw values for 
the four different methods used at a glance (method: ∆p 0.7 bar, ∆p 1.2 bar, ∆p 1.8 bar 
and ∆p 3.0 bar). 
 
UF method c [mg/ml] ∆p [bar] TMP [bar] τw [Pa] Qr [l/m²/h] Concentration 
time [min] 
∆p 0.7 bar 5-90 0.7 0.6 126 270a 150b 
∆p 1.2 bar 5-140 1.2 0.6 216 310 a 130 
∆p 1.8 bar 5-140 1.8 0.6 325 465a 130 
∆p 3.0 bar 5-90 3.0 0.6 541 845a 120b 
 
a Average calculated from Qr values during the whole process 
b Target concentration of 140 mg/ml was not reached 
Table III-2: Overview of selected operating conditions of the different UF concentra-
tion methods 
The indicated end concentrations (c) that were actually reached by the applied 
concentration method were determined before flushing the membrane with one 
dead volume. 
The influence of shear stress (τw) on permeate flux and concentration time during UF up 
to 140 mg/ml target concentration was evaluated. Permeate flux versus protein concentra-
tion indicates that the permeate flux was improved by increasing the ∆p from 0.7 bar to 
1.2 bar (Figure III-4). Moreover, the target concentration of 140 mg/ml was achieved and 
the concentration time was reduced from 150 min to 130 min (Table III-2). When the ∆p 
exceeded the value of 1.2 bar neither a further improvement in permeate flux nor a reduc-
tion in concentration time was recognized. At a ∆p value of 3.0 bar an end concentration 
of only 90 mg/ml was reached due to high inlet pressure leading to an abortion of the UF 
process. 
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Figure III-4: Permeate flux (J) versus protein concentration operated at a fixed ∆p of 
0.7, 1.2, 1.8 and 3.0 bar (TMP = 0.6 bar for all experiments) 
For the method operating under a ∆p of 3.0 bar the end concentration of 
140 mg/ml was not reached due to high inlet pressure. 
At the same time, a slight but steady increase in soluble higher molecular weight species 
(HMWs) with increasing ∆p was determined by SE-HPLC analysis. It was shown before 
that an increase in HMWs is not introduced by the piston pumps of the used TFF system 
It has to be noted that the increase in the HMW level is moreover pronounced by the in-
creased protein concentration, comparing the levels at 5 mg/ml (before UF concentration) 
and at 90 mg/ml. However, the increase in the HMW level was observed at comparable 
protein concentrations of 90 mg/ml with increasing ∆p (Figure III-5). The concentrates 
obtained from the ∆p 0.7 bar method revealed an increase in HMWs from 0.4 % up to 
0.6 %. By further increasing the ∆p up to 3.0 bar the HMW level only slightly stepped up 
to about 0.8 %.  
Concomitantly, a substantial decrease in total peak area of the monomer and the 
HMWs in the SE-chromatograms was observed. This can be explained by the retention of 
large protein aggregates and precipitated molecules by the SE-column resulting in the in-
ability to detect them. 
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Figure III-5: Aggregates analyzed by SE-HPLC (grey bars, referring to the left scale), 
turbidity at 350 nm (black triangles, referring to the left scale) and relative 
intensity of the peak >1000 nm hydrodynamic diameter determined by 
DLS (black squares, referring to the right scale) 
At 5 mg/ml (before concentration) and at 90 mg/ml protein concentration ob-
tained after UF at ∆p of 0.7, 1.2, 1.8 and 3.0 bar; experimental data is presented 
as mean values of three measurements ± SD. 
However, their presence is accounted for by looking at the decline of total peak area com-
pared to a control sample. The concentrates obtained from the 0.7 bar method showed a 
decrease in total peak area of about 6 % which stepped up to about 15 % when a ∆p of 
3.0 bar was applied. Additionally, the decrease in total peak area with increasing ∆p was 
accompanied by an increase in the turbidity of the concentrated mAb solutions (Figure 
III-5). An increase in turbidity was ascribed before by Mahler et al. (2005) to the presence 
of subvisible particles of probably up to 1 µm and 2 µm in size. This appearance of parti-
cles larger 1 µm was as well observed by looking at the DLS relative intensity of an aggre-
gated species presented by a peak at >1000 nm hydrodynamic diameter which was increas-
ing with higher ∆p values (Figure III-5). 
Moreover, LO measurements were conducted since this technique is accounted for 
the detection of particles of 1 µm to 200 µm in size. LO revealed that an increase in parti-
cles larger 1 µm was observed with increasing ∆p (Figure III-6) underlining the results 
obtained from total peak area evaluation of the SE-chromatograms, turbidity measure-
ments and DLS. 
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Figure III-6: LO data for particles per ml larger 1 µm (black bars, referring to the left 
scale) and 25 µm (grey bars, referring to the right scale) 
At 5 mg/ml (before concentration) and at 90 mg/ml protein concentration ob-
tained from UF at ∆p of 0.7, 1.2, 1.8 and 3.0 bar; experimental data is presented 
as mean values of three measurements ± SD. 
Moreover, the formation of very large particles exceeding 25 µm was observed with in-
creasing ∆p. A higher level of particles is additionally obvious when the protein concentra-
tion increases from 5 mg/ml (before UF concentration) to 90 mg/ml showing again that 
the formation of particles is in general enhanced at a higher protein concentration as re-
ported in chapter I.. 
Summarized, an increased level of HMWs and particles in the retentate during UF 
processing depends on the applied ∆p. These aggregates potentially contribute to mem-
brane clogging resulting in permeate flux decline over time which is generally observed 
during all experiments as shown in Figure III-4. At a ∆p of 3.0 bar, i.e. at highest shear 
stress referring to Equation III-1, the highest burden of aggregates in the retentate is rec-
ognized and accompanied by a sudden flux decline due to membrane clogging. As a con-
sequence, the target concentration of 140 mg/ml was not reached (Table III-2). 
If particles are completely rejected by the membrane their surface accumulation is 
equal to the difference between particles moving back to the retentate and particles con-
vectively transferred to the surface (Youravong et al. 2003). It is reported that particle 
movement away from the membrane is proportional to wall shear stress due to enforced 
diffusion or inertial lift, depending on particle size and hydrodynamic conditions (Gésan-
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Guiziou et al. 1999). In our case, we observed that the wall shear stress should not exceed 
1.2 bar since sufficient back transport and therefore improved permeate flux especially at 
very high retentate concentrations were achieved. For values larger 1.2 bar no improve-
ment of permeate flux was achieved (Figure III-4). This is in accordance with the model of 
Davis and Leighton (1987; Porter 1972), showing that low shear rates or high feed concen-
tration reduce the permeate flow rate. At the same time shear-induced transport has to be 
limited to avoid the generation of aggregates of different sizes and especially their removal 
from the membrane surface adversely affecting bulk quality as shown in Figure III-5 and 
Figure III-6. 
It has to be mentioned that factors like turbulence promoter or entrance/exit design 
of the used membrane cassette are not represented in the simplified calculation concerning 
shear stress (Equation III-1). Hence, the calculations should be considered an estimation. 
3.3 Systematic variation of operational parameters: The 
optimized method 
As reported, UF operations conducted at constant pressure and flow conditions result in 
rapid flux decline due to high permeation drag, aggravated membrane fouling and a rapidly 
increased protein concentration near the membrane. This is accompanied by an rapidly 
increasing protein concentration in the retentate and hence viscosity during the processing 
(Bacchin and Aimar 2005; Vladisavljevic and Rajkovic 1999). 
The results in section 3.2 of this chapter underline that permeate flux decline was 
generally inevitable during the UF concentration process at fixed pressure and flow condi-
tions. Therefore, an adaptation of pressure and flow conditions depending on the protein 
concentration in the retentate was considered successful to modify the system hydrody-
namics and thus improve permeate flux over time. In contrast, one constant ∆p during the 
whole UF process results in a defined feed flow rate Q and retentate flow rate Qr respec-
tively, according to Equation I-7. Moreover, it results in a fixed shear rates τw, according to 
Equation III-1. Hence, the increasing protein concentration and its contribution to permeate 
flux decline during processing is not considered. It assumed e.g. that with higher protein 
concentration and thus membrane polarization a higher retentate flow rate and thus wall 
shear stress is suitable to remove deposited protein from the surface of the membrane. 
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Since the TMP is known to have a large impact on permeation drag and the retentate 
flow rate directly influences the shear rate over the surface as presented above, these pa-
rameters were chosen as key parameters influencing permeate flux during UF concentra-
tion. To improve flux during the concentration process, the optimal flux at a specific re-
tentate flow rate and TMP was systematically screened at defined protein concentrations in 
the retentate. In contrast to common approaches where these experiments are only carried 
out at a single concentration (Luo et al. 2006), the increase in concentration during the UF 
was mimiced. Experiments were conducted at a protein concentration of 5-180 mg/ml. 
The minimal and maximal retentate flow rates were defined according to the preliminary 
experiments revealing that a ∆p of 1-2 bar and a retentate flow rate of about 200-
500 l/m²/h respectively is suitable to provide enough wall shear stress to improve perme-
ate flux without supporting aggregation.  
Figure III-7: Flow and pressure diagram of the ÄKTAcrossflow at 45 mg/ml protein 
concentration under total retentate recycling 
A retentate flow rate (Qr) of 450 l/m²/h was applied in combination with a TMP 
of 0.3-2.0 bar (black arrows); the grey arrows mark the point at which the perme-
ate flux (J) was determined. 
A TMP of 0.3-2.0 bar was applied. Under total retentate recycling (closed permeate) each solu-
tion with a protein concentration of 25, 45, 90 and 180 mg/ml was processed using a TMP of 
of 0.3, 0.5, 0.9 and 2.0 bar at a retentate flow rate of 150, 240, 390 and 450 l/m²/h in series. 
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Figure III-7 shows the flow and pressure diagram recorded with the ÄKTAcrossflow 
for the solution at 45 mg/ml IgG concentration and a retentate flow rate of 450 l/m²/h 
exemplarily. The maximum permeate flux (grey arrows) was determined when the defined 
TMP value was reached and concomitantly stable over 1 min (black arrows). The experi-
ments and the evaluation of maximum permeate flux were repeated at a retentate flow rate 
of 150, 240 and 390 as well as at the other protein concentrations reported above. After-
wards, the determined permeate flux was plotted against TMP for all experiments resulting 
in the curves shown in Figure III-8 and Figure III-9. 
Figure III-8: Transmembrane pressure (TMP) versus permeate flux (J) for a concentra-
tion of 5 mg/ml (solid lines), 25 mg/ml (fine lines) and 45 mg/ml (dotted 
lines) 
Retentate flow rate (Qr) was adjusted consecutively to 150, 240, 360, 390 and 
450 l/m²/h. TMP was adjusted consecutively to 0.3, 0.5, 0.9 and 2.0 bar. The fine 
black line indicates the clean water flux at the same TMP and cross flow values. 
Based on this permeate flux versus TMP plot the values of retentate flow and TMP at each 
concentration were identified from the knee point of the curves where permeate flux is at 
its maximum. In this plot it is obvious that a further increase in TMP and retentate flow 
rate does not result in further permeate flux improvement. The described evaluation plot 
closely follows the hypothesis of critical flux in the weak form in which any deviation of 
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the straight line of clean water flux, without considering the slope, indicates the onset of 
multilayer fouling (Field et al. 1995; Wu et al. 1999). 
No knee point was reached by the applied retentate flow rate and TMP values for the 
starting concentration of 5 mg/ml (Figure III-8). Therefore, the results for 25 mg/ml were 
considered as well. No flux improvement was observed by increasing the TMP beyond 
1.25 bar at a retentate flow rate of 240 and 360 l/m²/h. Considering the previous findings 
that higher shear stress during UF can result in an increased aggregate level of the concen-
trated solutions we identified a retentate flow rate of 240 l/m²/h and a TMP of 1.25 bar as 
the optimal condition at the beginning of the UF process for a concentration of 5 to 
25 mg/ml.  
Figure III-9: Transmembrane pressure (TMP) versus permeate flux (J) for a concentra-
tion of 90 mg/ml (solid lines) and 180 mg/ml (dotted lines) 
Retentate flow rate (Qr) was adjusted consecutively to 150, 240, 360, 390 and 
450 l/m²/h. TMP was adjusted consecutively to 0.3, 0.5, 0.9 and 2.0 bar. The fine 
black line indicates the clean water flux at the same TMP and retentate flow rate. 
From 25 to 50 mg/ml the TMP was lowered to 0.85 bar because the 45 mg/ml experi-
ments did not reveal an improved permeate flux beyond this TMP value. In addition, the 
retentate flow rate was increased to 450 l/m²/h, bringing the permeate flux from 30 up to 
45 l/m²/h at 0.85 bar TMP. 
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For a concentration range from 50 mg/ml up to the target concentration of 
140 mg/ml a TMP of 0.85 bar and an increased retentate flow rate of 390 l/m²/h were 
chosen. No improvement of flux was observed exceeding a TMP of 0.85 bar (Figure 
III-9). However, an increased cross flow velocity was successful to achieve a higher per-
meate flux up to a retentate concentration of 180 mg/ml. 
Table III-3 summarizes the TMP and retentate flow values for an UF concentration 
process from 5-180 mg/ml considered suitable to achieve maximal permeate flux during 
processing. This three stage process was titled optimized method (optMeth). 
 
UF method c [mg/ml] ∆p [bar] TMP [bar] τw [Pa] Qr [l/m²/h] Concentration 
time [min] 
5-25 0.6 1.25 108 240 
25-50 1.2 0.85 216 450 
optMeth 
50-140 1.6 0.85 288 390 
110 
Table III-3: Overview of selected operating conditions of the optimized UF concentra-
tion methods (optMeth) 
 
The set of curves in Figure III-8 and Figure III-9 shows that at a defined concentration a 
further increase in TMP ends in constant permeate flux. This is visualized by a permeate flux 
plateau indicating that a pressure independent region is reached. This is in accordance with 
the concentration polarization model based on the film theory (Porter 1972; Sablani et al. 
2001) presented in chapter I. The data shows improved permeate flux with increased reten-
tate flow rate in the TMP independent region. This clearly varies with protein concentration 
in the retentate, underlining that the model theory does not consider the hydrodynamic in-
teractions in the concentrated boundary layer due to shear flow of the layer during tangential 
flow operations (Davis and Leighton 1987; Fradin and Field 1999; Li et al. 1998a; Madaeni et 
al. 1999). Taking into account that permeate flux at a defined TMP and retentate flow rate is 
decreasing with higher concentration during UF processing the importance of changing op-
erational conditions, depending on the prevailing concentration in the retentate is obvious in 
order to improve permeate flux and to reduce concentration time. 
The optMeth offers an improved permeate flux compared to a method operating 
constantly under a fixed ∆p of 1.2 bar and a fixed TMP of 0.6 bar (method: ∆p 1.2 bar). 
Moreover, the permeate flux curve of the optMeth converges to a method with an in-
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creased TMP of 1.0 bar (method: ∆p 1.2 bar/ TMP 1.0 bar) but the predetermined con-
centration was reached and no membrane clogging was observed leading to an abortion of 
the UF process (Figure III-10). 
Figure III-10: Permeate flux (J) versus protein concentration for different concentration 
methods 
For the method operating under increased TMP of 1.0 bar the end concentration 
of 140 mg/ml was not reached due to high inlet pressure. 
This corresponds to literature dealing with critical flux operations and showing that uncon-
trolled convection of solutes towards the membrane surface due to a permanently in-
creased TMP causes strong concentration polarization and thus rapid flux decline (Aimar 
et al. 1989). By reducing the TMP during the concentration process, following the concept 
of the optMeth, the point at which concentration polarization proceeds is less imminent 
compared to method operating at fixed pressure conditions. At the same time, an increase 
in retentate flow rate accelerates shear-induced back-diffusion. This is considered suitable 
to explain the approximately 20 % reduction in process time when the optMeth is used 
compared to the UF methods operating at constant pressure and flow conditions. 
Table III-4shows the recorded concentration times for the optMeth as well as the dif-
ferent UF method operating under constant flow and pressure conditions at a glance. 
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UF method c [mg/ml] ∆p [bar] TMP [bar] τw [Pa] Qr [l/m²/h] Concentration 
time [min] 
∆p 0.7 bar  5-90 0.7 0.6 126 270 a 150b 
∆p 1.2 bar  5-140 1.2 0.6 216 310 a 130 
∆p 1.8 bar  5-140 1.8 0.6 325 465 a 130 
∆p 3.0 bar  5-90 3.0 0.6 541 845a 120 b 
       
∆p 1.2 bar/ 
TMP 1.0 
 5-90 1.2 1.0 216 480 a 100 b 
       
optMeth  5-25 0.6 1.25 108 240 
 25-50 1.2 0.85 216 450 
 50-140 1.6 0.85 288 390 
110 
 
a Average calculated from Qr values during the whole process 
b Target concentration of 140 mg/ml was not reached 
Table III-4: Overview of the operating conditions of the different UF concentration 
methods used 
The indicated end concentrations (c) that were actually reached by the applied 
concentration method were determined before flushing the membrane with one 
dead volume. 
It is assumed that the systematically defined operational conditions of the optimized con-
centration process (optMeth) avoid aggregation and thus high inlet pressure, leading finally 
to the abortion of the UF process. This contributes to the significantly reduced processing 
time concomitantly reaching the target concentration of 140 mg/ml in the retentate. 
3.4 Effect of defined operational parameters on aggregation 
The amount of aggregated protein was monitored during the concentration process by using 
several analytical methods like LO, turbidity measurement, DLS and SE-HPLC (Hawe and 
Friess 2008) in order to allow the characterization of differently sized aggregates in the proc-
essed protein solutions. 
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Large aggregates may be excluded, resolved or modified during SE-HPLC due to the in-
teraction with the column matrix or changes in the sample buffer matrix during dilution in the 
mobile phase (Stulík et al. 2003). In order to monitor the formation of soluble HMWs in the 
end-concentrated solutions SE-HPLC was applied. Moreover, DLS measurements were con-
ducted using time-dependent fluctuation of a scattered light signal to calculate the hydrody-
namic diameter of aggregates as well as their relative amount (Demeester et al. 2005). This 
method is particularly valuable to detect aggregated species even in small traces. Samples dur-
ing the UF experiments were taken every time the protein concentration doubled and were 
analyzed by LO and turbidity measurement to detect larger aggregates (Figure III-11). 
Figure III-11: Turbidity measurement (triangles, referring to the right scale) and number 
of particles larger than 1 µm (bars, referring to the left scale) during UF 
concentration from 5-90 mg/ml 
Samples were taken every time the retentate concentration doubled. 
LO revealed that by using the optMeth the lowest particle burden is generated over the 
whole process at comparable protein concentrations. The data is supported by turbidity 
measurements at 350 nm since it is known that an increase in particles of up to 1-2 µm in 
size is in good correlation with an increase in turbidity, as reported above (Mahler et al. 
2005). 
During the UF processing not only particles of proteinaceous nature can be generated 
but also particles of non-proteinaceous origin can be leached or abraded from tubing, 
pump heads or fittings (Arakawa et al. 2006; Tyagi et al. 2008). Both types o aggregates 
contribute to higher turbidity values as well as a higher number of particles determined by 
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LO. Tyagi et al. reported that stainless steel particles shed by the piston pump caused the 
formation of protein micro-particles after incubation at room temperature. 
To identify the source and type of particles, a filtration/ staining method was used as 
described by Li et al. (2007). This method distinguishes between proteinaceous and unspe-
cific particulate matter independent on rheological or optical properties of the sample and 
is therefore particularly suitable for high concentrations. Solely the proteinaceous particles 
are stained with the metal chelat stain pyrogallol red-molybdate which is known to be able 
to stain proteins immobilized on solid-phase supports (Shojaee et al. 1996). The aromatic 
functionalities of the dye enhance association with proteins through hydrophobic interac-
tions and the dye contains a domain that reversibly binds to proteins, consisting of one or 
more anionic sulfonate residue for selective electrostatic interaction with amino side chains 
at acidic pH (Patton et al. 1999). 
The filtered buffer solution did not show any retained and stained particles on the 
surface of the 0.2 µm filter (Figure III-12A). 
 
Figure III-12: Optical microscopy images of stained insoluble aggregates separated from 
the solution by 0.2 µm filtration 
Buffer after recirculation (A) and 5 mg/ml protein solution before UF (B). 
The buffer solution was taken from the equilibration run of the ÄKTAcrossflow after 
30 min recirculation in the system. Moreover, the protein solution before UF showed only 
a few retained proteinaceous particles which are visible as stained purple dots on the filter 
surface (Figure III-12B). 
An increased level of insoluble protein aggregates was clearly visible on the filter sur-
face when the concentrated mAb solutions obtained from the different UF methods were 
investigated (Figure III-13). The concentrates of the most stressful ∆p 3.0 bar mode 
showed the highest aggregate burden (Figure A). In comparison, the concentrates derived 
 
A B
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from the optMeth (Figure C) showed a reduced level of stained insoluble proteinaceous 
particles on the filter surface with respect to number and size. This was shown as well in 
comparison to the concentrates derived from the ∆p 1.2 bar method. Hence, this analysis 
underlines the results obtained from LO and turbidity measurements that the optMeth 
shows the lowest level of large proteinaceous aggregates. 
 
Figure III-13: Optical microscopy images of stained insoluble aggregates separated from 
the concentrates by 0.2 µm filtration 
Concentrated solutions of 90 mg/ml after UF using the ∆p 3.0 bar method (A), 
the ∆p 1.2 bar method (B) and the optMeth (C). 
Based on SE-HPLC data, almost no improvement in the quality of the concentrates was 
detected by applying the optMeth compared to the method operating at a constant ∆p of 
1.2 bar (Figure III-14). By referring to the method applying a ∆p of 3.0 bar, a slight im-
provement considering the level of HMWs was detected by SE-HPLC if the optMeth or 
the ∆p = 1.2 bar method were used. 
A decline in total peak area of the SE-chromatograms was recognized when the dif-
ferently concentrated samples were analyzed. Total recovery of the samples derived from 
both UF methods, the optMeth and the ∆p = 1.2 bar method, were quite comparable with 
a value of about 8-10 %. Again, the decrease in total peak area stepped up to about 15 % 
when the ∆p = 3.0 bar method was applied. 
A B C
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Figure III-14: Aggregates monitored by SE-HPLC, turbidity measurement and DLS rela-
tive intensity of the peak > 1000 nm (referring to the right axis) 
For 90 mg/ml mAb solutions received from the optMeth compared to two other 
methods operating under constant ∆p of 1.2 bar and 3.0 bar; experimental data is 
presented as mean values of three measurements ± SD. 
By evaluating the DLS relative intensity, the concentrates of the optMeth show a clearly 
reduced level of aggregates larger than 1000 nm mean diameter. In general, larger aggre-
gates present in trace levels are detectable with high sensitivity by using DLS, because the 
intensity of scattered light increases exponentially with the hydrodynamic radius according 
to the Rayleigh equation considering spherical particles (Ahrer et al. 2003; Demeester et al. 
2005). This analytical method is again suitable to detect aggregates which are retained by 
the SE-column. Thus, aggregates are accessible by this method which are not detectable by 
SE-HPLC and are only reflected by the decline in total peak area of the chromatogram.  
The monomer of an IgG is represented by the first peak at about 10 nm mean hydro-
dynamic diameter. The aggregates in the concentrated solutions appear at a hydrodynamic 
diameter larger than 1000 nm (Figure III-15). 
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Figure III-15: DLS size distribution by intensity for 90 mg/ml mAb solutions derived 
from the optMeth compared to two other methods operating under con-
stant ∆p of 1.2 bar and 3.0 bar 
The first peak refers to the monomer, the second peak to an aggregated species. 
The signal relative intensity of the monomer and the aggregate peak depends on the con-
centration method used. For the concentrates produced under a constant ∆p of 3.0 bar, 
the aggregate peak at > 1000 nm hydrodynamic diameter significantly increased up to 
44.5 % relative intensity while the monomer peak intensity decreased at the same time, 
contributing just 53.5 % of the total scattered light. For the concentrate from the optMeth 
the monomer peak shows a relative intensity of 87.2 % which is quite comparable to the 
value of the solution before concentration. For the aggregate peak the lowest relative in-
tensity of 12.8 % was observed. Although reaching the upper limit of the measurement 
size range of the DLS system the intensity distribution confirms the results of turbidity 
measurements, LO and total peak area evaluation of the SE-chromatograms showing that 
the concentrates of the optMeth provide the most desirable quality with respect to aggre-
gation. 
Table III-5 summarizes the analytical data for turbidity at 350 nm, DLS relative inten-
sity for the monomer and the aggregate peak, and the number of particles larger 1 µm for 
the above mentioned IgG4 (IgG A) in a citrate buffered system. In addition the data was 
collected for two IgG1 mAbs (IgG B and IgG C) in histidine buffer, indicating that the 
presented results are qualitatively transferable to other molecules in a different buffer system. 
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It is shown that the concentrated solutions of three different mAbs using the 
optMeth result in a reduced level of protein aggregates compared to the concentrates from 
the methods operating under constant pressure conditions. The analytical results for the 
concentrated solutions were compared at 90 mg/ml protein concentration to have compa-
rable values, since the ∆p 3.0 bar was not able to exceed this concentration. 
 
DLS relative intensity [%] mAb Method Turbidity at 
350 nm [AU] 
First peak 
[10 nm] 
Second peak 
[> 1000 nm] 
Number of particles 
per ml [> 1 µm] 
IgG A Before 
concentration 0.063 ± 0.010 98.83 ± 1.65 1.17 ± 1.65 3.38 x 10
4 ± 305 
 ∆p 1.2 bar 0.715 ± 0.010 81.30 ± 1.13 18.70 ± 1.13 7.20 x 106 ±   55 x 103 
 ∆p 3.0 bar 0.935 ± 0.010 55.53 ± 3.49 44.47 ± 3.49 7.90 x 106 ±  13 x 103 
 optMeth 0.566 ± 0.030 87.17 ± 2.10 12.83 ± 2.10 3.56 x 106 ±  22 x 102 
      
IgG B Before 
concentration 0.026 ± 0.010 100.00 ± 0.00 0.00 ± 0.00 8.02 x 10
3 ± 100 
 ∆p 1.2 bar 0.520 ± 0.060 75.43 ± 7.79 24.57 ± 7.79 4.38 x 106 ±  20 x 103 
 ∆p 3.0 bar 0.881 51.40 ± 2.64 48.60 ± 2.64 6.17 x 106 ±  40 x 103 
 optMeth 0.409 ± 0.010 77.53 ± 1.75 20.17 ± 2.74 2.09 x 106 ±  21 x 103 
      
IgG C Before 
concentration 0.029 ± 0.010 100.00 ± 0.00 0.00 ± 0.00 9.16 x 10
3 ± 50 
 ∆p 1.2 bar 0.454 ± 0.020 80.18 ± 2.79 19.93 ± 2.81 14.88 x 106 ± 60 x 103 
 ∆p 3.0 bar 1.099 ± 0.050 70.53 ± 0.75 29.47 ± 0.75 23.22 x 106 ± 58 x 103 
 optMeth 0.393 94.53 ± 3.23 5.47 ± 3.23 8.17 x 106  ± 22 x 103 
Table III-5: Analytical data for three different mAbs (IgG A in citrate buffer, IgG B and 
IgG C in histidine buffer) 
At 5 mg/ml (before concentration) and at 90 mg/ml derived from the indicated 
concentration methods; the mean values of three measurements are presented 
± SD. 
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3.5 Secondary structure analysis 
FT-IR spectroscopy was applied to elucidate if the protein exhibits changes in secondary 
structure due to the UF procedure. Therefore, the insoluble aggregates in the retentate 
were investigated, as well as the protein directly deposited on the surface of the mem-
branes after UF concentration. 
IgGs exhibit mainly β-sheet structure revealed by X-ray analysis (Costantino et al. 
1997). MAbs show two characteristic bands in the second derivative FT-IR spectrum at 
around 1639 and 1690 cm-1 reflecting the presence of intramolecular ß-sheet structure 
(Chang et al. 2005; Cleland et al. 2001). Conformational changes are indicated by a shift to 
a strong temperature-induced frequency at 1615-1625 cm-1 and a concomitantly reduced 
intensity of the band at around 1639 cm-1 as well as at 1690 cm-1 (Matheus et al. 2006a; 
Pelton and McLean 2000). Hence, the second derivative spectra were truncated between 
1700 and 1500 cm-1 to prospect for changes in secondary structure (Kendrick et al. 1996). 
Figure III-16: Comparison of the second derivative FT-IR spectra 
The native mAb in solution at 5 mg/ml and 90 mg/ml (black lines, almost per-
fectly overlaid), the protein adsorbed to the membrane (dashed black line), the 
separated insoluble aggregates from the ∆p 3.0 bar-, ∆p 1.2 bar-, and the opti-
mized UF method (grey lines, almost perfectly overlaid) and the heat treated solu-
tion at 90 mg/ml (dotted line). 
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When the spectrum of the protein on the processed and washed hydrophilic cellulose based 
membrane was compared to the spectra of the protein in solution, only slight differences 
were observable (Figure III-16). 
This reveals that the protein directly adsorbed to the membrane after processing al-
most remained in its native secondary conformation. By looking at the spectra of the sepa-
rated insoluble aggregates from the retentate, the diminished bands at 1639 cm-1 and 
1690 cm-1 as well as the shift of the band at 1639 cm-1 to a lower wave number revealed 
perturbation in secondary structure, i.e. loss in the proportion of ß-sheet motifs. This was 
shown to be much more pronounced by heating which is in accordance with current litera-
ture mentioned above.  
The findings correspond to the work of Maruyama and coworkers who found that 
the simple adsorption to hydrophilic UF membranes induced only a slight perturbation in 
secondary structure of BSA (Maruyama et al. 2001b). Moreover, the aggregated protein 
was scratched from the gel layer near the membrane after concentrating the solution in a 
stirring cell. The sample exhibit significantly denatured protein investigated by FT-IR 
(Maruyama et al. 2001a). 
It has to be pointed out that the investigated samples in this study showed no spectral 
differences depending on the applied UF method. The recorded spectra of the protein in 
solution at 5 mg/ml and at 90 mg/ml almost perfectly overlaid. Moreover, the different 
operational parameters applied during UF did not cause any spectral differences between 
the several insoluble aggregates removed from the retentate. All samples of the separated 
aggregates revealed the same spectral differences compared to the native protein in solu-
tion. However, the amount of the aggregates in the retentate during UF strongly depends 
on the applied flow and pressure conditions as shown before. Therefore, the increase of 
structurally altered insoluble aggregates during UF is not attributed to protein-membrane 
interactions but rather to the flow velocity during the tangential flow mode. The protein in 
solution is constantly moved over the membrane during TFF and the generated structur-
ally perturbed aggregates are transported to the retentate adversely affecting the quality of 
the produced bulk. 
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3.6 Effect of bulk quality on the sterile filtration process 
Sterile filtration in normal flow mode is mandatory for the formulated active pharmaceuti-
cal ingredient as well as during DSP to ensure the absence of particles, microorganisms 
and aggregates which can cause detrimental effects including loss of activity, altered half 
life or immunogenic reactions (Cleland et al. 1993). 
Membrane fouling causing rapid filtrate flow decline and increased filtration time in 
microfiltration generally includes concentration polarization, adsorption of particles, pore 
blocking and deposition of particles on the membrane surfaces (Wang et al. 2007b). If 
concentrated solutions are sterile filtered the high viscosity plays an additional role in 
terms of filtrate flow decline (Green and Scheer 1998; Liu et al. 2005). 
For the mAb solutions from the different concentration methods the filtrate flow rate 
was plotted over time (Figure III-17A). It is obvious that the concentrates of the optMeth 
showed an improved filtrate flow rate over time at a comparable protein concentration of 
90 mg/ml and thus comparable viscosity. A linear correlation between filtrate flow rate 
and filtration volume was observed (Figure III-17B). 
Figure III-17: Filtrate flow rate over time for concentrates at 90 mg/ml after UF 
Solutions obtained from the optMeth and two other methods operating at con-
stant ∆p of 1.2 bar and 3.0 bar (A). Data plotted in accordance to the pore block-
age model (B); experimental data is presented as mean values of three measure-
ments ± SD. 
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This linear correlation is in accordance with a traditional pore blockage mechanism assum-
ing that filtration flux decline is mainly related to the aggregate burden of the to be filtered 
solution (Hermia 1982; Ho and Zydney 2000). 
The concentrates derived from constant pressure UF methods are more prone to 
pore blockage since these solutions have a higher level of insoluble protein aggregates. 
This is in agreement with Palacio et al. (2002) who found that pore blockage during micro-
filtration is directly related to the concentration of particles in solution. 
Hence, to improve filtration flow and to reduce process time in sterile filtration op-
erations, it is recommended to consider the optimal operating conditions during previously 
conducted UF. 
4 Summary and conclusion 
The influence of applied shear stress on permeate flux and aggregation during the UF con-
centration process was evaluated using an automated lab scale TFF system. It was demon-
strated that this system equipped with a scalable flat sheet cassette adequately reflects 
process conditions in larger scale. 
 The studies presented in this chapter mainly revealed an increased level of large in-
soluble and structurally perturbed aggregates in the concentrated solutions. This increase is 
directly correlated to the applied shear stress during UF. Permeate flux decline was attrib-
uted to induced aggregates depositing on the membrane surface and causing pore clogging 
of the membrane device used. It was observed that a minimal wall shear stress has to be 
applied to ensure sufficient back transport of deposited solutes to the retentate. At the 
same time the wall shear stress has to be limited to avoid the generation of soluble and 
insoluble aggregates and their removal from the membrane device to the concentrated 
retentate, since these aggregates adversely affect bulk quality. 
It was observed that permeate flux during UF strongly depends on the protein con-
centration in the retentate as well as on the applied pressure and flow conditions. By vary-
ing TMP and cross flow values systematically depending on the concentration in the reten-
tate, an UF concentration method was developed particularly suitable for the production 
of highly concentrated mAb solutions up to 140 mg/ml. This optimized three stage proc-
ess resulted in an improved permeate flux and a significantly reduced concentration time. 
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A 20 % reduction in process time was recognized when the optimized method is used 
compared to two UF methods operating at constant pressure and flow conditions. 
Concomitantly, the concentrates generated by using this optimized UF method 
showed a reduced aggregate level compared to two other methods. This was observed for 
three different mAbs in two different buffer systems. The combination of SE-HPLC, 
DLS, LO and a filtration/ staining method allowed the characterization of a wide range of 
sizes of soluble and insoluble aggregates occurring during the UF concentration process. 
These techniques were used to evaluate the quality of the produced concentrates. 
With regards to sterile filtration the optimized method showed an improved flow rate 
during filtration processing due to improved bulk quality in terms of aggregation. This is 
important because this essential final manufacturing step is already adversely affected by 
the high viscosity of the concentrated protein solution. 
Finally, FT-IR spectroscopy revealed a perturbed secondary structure of the aggre-
gates appearing during UF which was attributed to high flow and pressure values in tan-
gential flow mode rather than to surface related unfolding. The protein adsorbed to the 
UF membrane remained nearly native independent of the applied flow and pressure condi-
tions. 
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Chapter IV Effects of operational 
parameters during UF on the stability of 
highly concentrated mAb solutions 
Abstract 
Protein bulks have to show sufficient physical stability to minimize the risk of aggregation, 
since the opportunities to remove any process related impurity are limited to the final poli-
shing during purification. Directly after UF concentrated IgG solutions of 90 mg/ml were 
stored at several conditions to investigate their physical stability depending on total protein 
concentration as well as on the UF protocol applied during processing. In general, the 
formation of differently sized aggregates was shown to be enhanced at a higher total pro-
tein concentration in the unformulated bulk. After 0.2 µm-filtration of the concentrated 
bulks no benefit was recognized regarding the formation of aggregates when the optimized 
method was used during UF. In general, 0.2 µm-filtration showed a significant influence 
on the level of soluble higher molecular weight species (HMWs) during storage at elevated 
temperatures. A reduced formation of the smaller HMWs was recognized in the presence 
of subvisible aggregates of up to 1-2 µm as well as those being larger than 1 µm in size. 
This was attributed to a repressed nucleation and subsequent growth of aggregated species 
which is a known mechanism of aggregate propagation in protein solutions. Moreover, a 
successive formation of visible precipitated aggregates was observed during storage at 2-
8 °C when subvisible aggregates were already present. In general, the storage of the filtered 
solutions at 2-8 °C was found to be superior to storage in the frozen state regarding the 
level of soluble aggregates in the concentrated bulk. In addition, conformational stability 
was investigated using ATR FT-IR spectroscopy analysis. A consistently higher melting 
temperature (Tm) was found at a higher total protein concentration, however the concen-
trates generated by using the optimized method showed a consistently higher Tm value 
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compared to the concentrates derived from other UF protocols. Since aggregation was in 
general enhanced at a higher total protein concentration independent from the UF proto-
col used, aggregation at higher total protein concentrations seems to be rather based on 
homogeneous nucleation and growth than on aggregation based on perturbation in secon-
dary structure. 
1 Introduction 
Currently, highly concentrated formulations of therapeutic mAbs can be considered as a trend 
in commercial manufacturing. Since the accessible volume for local s.c. application is 1-3 ml, 
mAb solutions at concentrations of at least 100 mg/ml are required (Harris et al. 2004; Shire et 
al. 2004) in order to achieve effective concentration levels in the blood of about 100-400 mg 
protein per administration (Dani et al. 2007). Following s.c. injection, most drugs pass through 
the interstitial matrix, traverse capillaries or lymphatics before they reach the vascular com-
partment (Bookbinder et al. 2006). The interstitial matrix is a complex three-dimensional struc-
ture where aggregated molecules can be retained and may increase the risk of immunogenicity 
(Schellekens 2005). Therefore, aggregation has to be particularly prevented for concentrated 
preparations since these solutions are intended to be subcutaneously administered. This is of 
special importance after the last concentration step of the purification process, since no in-
struments are available to further reduce the aggregate level in the formulated bulk. 
Moreover, the stability of the intermediate pools at different stages of purification has 
to be evaluated considering protein aggregation. Due to high volumetric productivity of 
new cell line generations and optimized fermentation processes high product titer are 
achieved (Graumann and Premstaller 2006). This can result in large eluate volumes when 
high capacity resins are not available or suitable. The large pool volumes have to be han-
dled by using the existing hard-piped manufacturing plants and vessels (Low et al. 2007). 
Therefore, the subsequent UF concentration is necessary to match the limited volume 
capacity of the existing plants by creating low volume units. 
This chapter addresses the influence of applied operational parameters in tangential 
flow UF on the stability of highly concentrated API bulk during storage, since UF is the 
industry standard for concentration and diafiltration procedures in large scale purification 
processes. There are studies describing that large velocity gradients can deform or denature 
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the native structure of globular proteins resulting in a loss of activity or fragmentation of 
the covalent backbone (Charm and Lai 1971; Virkar et al. 1981; Wang et al. 2007a). Anti-
gen-binding activity of a recombinant scFv antibody fragment was reduced in a buffer 
solution at a shear rate of 20 000/s (Harrison et al. 1998). Often, the processed solutions 
appear opalescent or precipitated after processing, although only a small amount of total 
protein loss was observed (Narendranathan and Dunnill 1982; Thomas et al. 1979). In 
contrast Jaspe and Hagen (2006) described more recently that even shear rates of 
200 000/s did not result in any detectable destabilization of the protein regarding espe-
cially protein unfolding. Here, cytochrome C was used whose fluorescence increases 
sharply upon unfolding suitable to monitor conformational changes during the exposure 
to high shear. 
As presented in chapter III, a three step process applying different flow and pressure 
conditions depending on the prevailing protein concentration in the retentate resulted in 
improved quality of the concentrates regarding aggregation. This was compared to two 
other UF methods operating under elevated constant flow and pressure during the con-
centration process. Therefore, the three differently processed concentrates were stored at 
2-8 °C, at -20 °C and at elevated temperature in order to investigate the influence of opera-
tional conditions during UF on physical stability including aggregation and changes in sec-
ondary structure. 
As described in chapter I, it is reported that aggregates already in small traces and 
without showing any conformational alterations can induce ongoing aggregation due to an 
nucleation and growth process (Cleland et al. 1993; Reithel 1964; Wood et al. 1999). 
Therefore, the filtered and unfiltered mAb solutions at 90 mg/ml derived from the differ-
ent UF concentration methods were investigated regarding the effect of preformed aggre-
gates and particles on stability during storage. 
2 Materials and methods 
2.1 Materials 
A therapeutic mAb solution of a chimeric human Fc (IgG4)/ rat Fab antibody in histidine 
buffer at pH 5.5 was taken for the concentration experiments. The mAb was provided by 
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Roche Diagnostics GmbH (Penzberg, Germany). The solution of 5 mg/ml protein con-
centration was filtered through a 0.2 µm membrane filter (Sartorius, Goettingen, Germany) 
before UF processing. All chemicals and reagents used were at least analytical grade. Hy-
drochloric acid was taken from Merck KG (Darmstadt, Germany). L-histidine from Aji-
nomoto (Raleigh, USA) was used. 
2.2 Methods 
2.2.1 Ultrafiltration concentration procedure and storage 
For the preparation of concentrated mAb solutions the automated TFF system ÄK-
TAcrossflow (GE Healthcare, Uppsala, Sweden) was used (Liten and Cohen 2007). The 
experiments were conducted by using the equipment and techniques as described in chap-
ter III. Table IV-1 shows the applied UF concentration methods and the resulting opera-
tional conditions. 
 
Method c [mg/ml] ∆p [bar] TMP [bar] τw [Pa] Qr [l/m²/h] 
∆p 1.2 bar 5-90 1.2 0.60 216 310 a 
∆p 3.0 bar 5-90 3.0 0.60 541 845a 
optMeth 5-25 0.6 1.25 108 240 
 25-50 1.2 0.85 216 450 
 50-90 1.6 0.85 288 390 
 
a Average calculated from the flow rate values (Qr) recorded during the whole process 
Table IV-1: Overview of operating conditions of the different UF concentration me-
thods 
The indicated end concentrations (c) correspond to values before flushing the 
membrane. 
 
The different concentration methods were run until a target concentration of about 
90 mg/ml was reached, since the method applying a ∆p of 3.0 bar is not applicable to exceed 
this concentration. Thus, solutions at comparable protein concentrations were obtained. 
After the UF concentration up to 90 mg/ml, each concentrated pool was divided into 
two aliquots of an equal volume of 45 ml. One portion was filtered at a constant pressure 
of 1.0 bar through a Sartopore 2 XLG Disposable filter unit with a pore size of 0.8 and 
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0.2 µm and a filter area of 58 cm² (Sartorius, Goettingen, Germany). Both, the filtered and 
the unfiltered solutions were stored at 40 °C, 2-8 °C and -20 °C in sterile CRYO.S tubes 
(Greiner Bio-One, Frickenhausen, Germany). The frozen samples were stored over three 
months and were then thawed in a 25 °C tempered water bath. Afterwards, freezing and 
thawing was repeated two times to end up with three freeze and thaw cycles in total. 
2.2.2 Concentration determination 
Concentration was determined in the samples by using the photometric absorbance at 
280 nm and 320 nm after buffer blank subtraction (UV-Vis spectrophotometer Evolution 
500, Thermo Fisher Scientific, Waltham, USA). The absorbance at 320 nm was subtracted 
from the absorbance at 280 nm (UV 280-320) and this value was used to calculate the pro-
tein content according to the law of Lambert-Beer. 
To determine the percent in soluble protein remaining in the filtered and unfiltered 
solutions during storage, the samples were centrifuged for 30 min at 10 000 x g (Heraeus 
Multifuge, Thermo Fisher Scientific, Waltham, USA) and the concentration was deter-
mined in the supernatant using UV 280-320 as described above. The percent soluble pro-
tein remaining was calculated by referring to the protein concentration of the respective 
sample before storage as 100 %. 
2.2.3 Turbidity measurements 
Turbidity was determined as photometric absorbance of the undiluted concentrates at 
350 nm and 550 nm after buffer-blank subtraction (UV-Vis spectrophotometer Evolu-
tion 500, Thermo Fisher Scientific, Waltham, USA). The analysis was conducted as de-
scribed in chapter III. 
2.2.4 Size exclusion high pressure liquid chromatography 
SE-HPLC analysis was conducted using a TSK 3000 SWXL column (Tosoh Biosep, Stutt-
gart, Germany) on a Summit HPLC-system (Dionex, Idstein, Germany). The elution peaks 
were monitored at 280 nm by the UV diode array detector UVD170U from Dionex (Id-
stein, Germany). Isocratic chromatography was conducted as described in chapter III. 
Integration procedure using the Chromeleon software (Dionex, Idstein, Germany) is 
shown exemplarily in Figure III-1 (see page 52). The percentage of higher molecular 
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weight species (HMWs) including dimers and larger soluble oligomers was determined as 
relative area (mAU⋅min) of the respective peaks referred to total area of all peaks including 
the monomer peak and the peak of the lower molecular weight species (LMWs). Total 
recovery was monitored throughout the analysis by comparing the total peak area of the 
respective sample to the total peak area of a control sample. 
2.2.5 Light obscuration particle counting 
LO was used to monitor the formation of particles in a range of 1-200 µm similar to the 
method <788> Particulate Matter of Injection in the United States Pharmacopoeia and the 
European Pharmacopoeia method 2.9.1 (EDQM 2001a; USPC 2002). The measurements 
were conducted using the particle counter SVSS-C (PAMAS Partikelmess- und Analysesys-
teme, Rutesheim, Germany) as described in chapter III. 
2.2.6 Dynamic light scattering 
The Zetasizer Nano S (Malvern Instruments, Worcestershire, UK) was used to monitor 
colloidal species in the size range of a hydrodynamic diameter between 1 nm and 6 µm. The 
scattering information is detected at an angle of 173 ° (Kaszuba and Connah 2006) operating 
with a 4 mW He-Ne-laser at 633 nm using the non-invasive back-scatter technique (NIBS). 
The samples were analyzed undiluted in a temperature controlled precision quartz cuvette 
(Hellma, Müllheim, Germany) at 25 °C. The size distribution by intensity was calculated 
from the time-dependent correlation function using the multiple narrow mode of the DTS 
software (Version 5.0, Malvern Instruments, Worcestershire, UK). 
2.2.7 FT-IR spectroscopy 
FT-IR spectra were recorded with the Tensor 27 (Bruker Optics, Ettlingen, Germany) 
applying the BioATR unit with a Silicium crystal (Bruker Optics, Ettlingen, Germany). 
For each spectrum which was recorded from 850-4000 cm-1 a 120-scan interferogram 
was collected at a double sided acquisition mode with a resolution of 4 cm-1. To monitor 
temperature induced conformational changes in secondary structure of the mAb spectral 
changes were followed from 25-90 °C at 90 mg/ml. 25 µl of the sample solution were ap-
plied into the unit and a temperature ramp from 25-60 °C and from 80-90 °C with a ∆T of 
5 °C and from 60-80 °C with a ∆T of 2 °C were performed. The equilibrium time was 
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120 s at each temperature step. The respective temperature was adjusted by connecting the 
ATR cell to a thermostat (Haake DC30-K20, Thermo Scientific, Waltham, USA). To ob-
tain the reference spectra of the buffer system used, the permeate of the UF concentration 
procedure was taken and the temperature ramps were performed as described before. The 
obtained buffer spectra were than subtracted to obtain the protein spectra. 
The spectra were edited by a vector normalization. Afterwards, a second-derivative 
procedure was done to enhance the resolution, concomitantly preserving the band position 
(Pelton and McLean 2000). The second derivative was smoothed using a 13-point Savit-
sky-Golay smoothing function. For this, the OPUS software version 6.0 was used (Bruker 
Optics, Ettlingen, Germany). 
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3 Results and discussion 
3.1 Aggregation behavior during storage 
All samples were stored under quiescent conditions without shaking or stirring to reflect 
simple storage of the concentrates on-site. The unfiltered as well as the filtered API bulk was 
analyzed over time. Turbidity at 350 nm was measured to monitor especially the presence of 
smaller aggregates of up to 1-2 µm in size as detailed in chapter III. Figure IV-1 shows the 
difference in turbidity between the unfiltered and the filtered concentrates processed at indi-
cated UF conditions (see Table III-1). The turbidity remains quite constant over 4 weeks at 
elevated temperature for all concentrates derived from the different UF methods used. 
Figure IV-1: Turbidity at 350 nm during storage at 40 °C for mAb solutions before con-
centration (5 mg/ml) and after UF (90 mg/ml) by using different concen-
tration methods 
The data referring to the unfiltered solutions is shown on the left side (A) and the 
data referring to the filtered solutions is shown on the right side (B); mean values 
of three measurements are reported ± SD. 
At every time, the unfiltered concentrates referring to the optMeth show the lowest turbid-
ity values after UF processing and during storage (Figure IV-1A). After 6 weeks at 40 °C 
the turbidity of the samples referring to the ∆p 1.2 bar and ∆p 3.0 bar method increases 
sharply to > 2 AU, whereas the samples of the optimized method did not show this in-
crease in turbidity. 
Results from LO show the number of particles larger 1 µm per ml protein solution 
(Figure IV-2A). Again, the samples referring to the ∆p 1.2 bar and ∆p 3.0 bar method 
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showed a higher level of particles before and during storage, compared to the samples 
generated by using the optMeth. As observed for the turbidity measurements, the samples 
referring to the ∆p 1.2 bar and ∆p 3.0 bar method showed an increased level in particles 
larger 1 µm after 6 weeks at 40 °C. Whereas the samples of the optimized method did not. 
In general, the concentrates from the ∆p 3.0 bar method showed the highest particle level 
and the highest turbidity values respectively. 
Figure IV-2: Particles per ml larger than 1 µm during storage at 40 °C for mAb solutions 
before concentration (5 mg/ml) and after UF (90 mg/ml) by using differ-
ent concentration methods 
The data referring to the unfiltered solutions is shown on the left side (A) and the 
data referring to the filtered solutions is shown on the right side (B); mean values 
of three measurements are reported ± SD. 
Moreover, it was recognized that the quality of the produced concentrates considering the 
level of particles after 0.2 µm-filtration is comparable and independent of the applied opera-
tional parameters during UF. The turbidity values and particle numbers did not increase to 
the high levels observed before storage. This became obvious by comparing the turbidity 
data and number of particles during storage after filtration (Figure IV-1B and Figure IV-2B) 
to the respective data before filtration (Figure IV-1A and Figure IV-2A). 
The yield after 0.8/ 0.2 µm-filtration of the concentrated solutions was determined. 
No significant differences were observed depending on the UF method used. The yield 
was calculated referring to the applied protein mass before conducting the filtration 
(m before filtr) as 100 %. For each filtration experiment m before filtr ≈ 4 g was applied. Further, 
the protein mass after filtration was determined (m after filtr). The measured concentration 
after filtration was therefore multiplied with the corresponding volume (c after filtr x V after filtr). 
A B
0.0E+00
5.0E+06
1.0E+07
1.5E+07
2.0E+07
2.5E+07
before
concentration
∆p 1.2 bar ∆p 3.0 bar optMeth
pa
rt
ic
le
s/
 m
l [
>
1µ
m
]
before storage
40°C 1 week
40°C 3 weeks
40°C 4 weeks
40°C 6 weeks
0.0E+00
1.0E+05
2.0E+05
3.0E+05
4.0E+05
before
concentration
∆p 1.2 bar ∆p 3.0 bar optMeth
pa
rt
ic
le
s/
 m
l [
>1
µm
]
before storage
40°C 1 week
40°C 3 weeks
40°C 4 weeks
40°C 6 weeks
pa
rt
ic
le
s/
 m
l [
>
1µ
m
]
pa
rt
ic
le
s/
 m
l [
>1
µm
]
Chapter IV Effects of operational parameters during UF on the stability 
90 
Figure IV-3 shows the yield after filtration of the concentrated solutions, as well as for the 
solutions at 5 mg/ml protein concentration. 
Figure IV-3: Yield after 0.8/ 0.2 µm-filtration 
The 0.2 µm filtration was performed with the solutions at 5 mg/ml (before con-
centration) and at 90 mg/ml after UF applying three different methods (∆p 1.2 
bar, ∆p 3.0 bar and optMeth); mean values of three measurements are reported 
± SD. 
In general, all concentrated samples showed a lower yield of about 85-88 % after 
0.8/ 0.2 µm-filtration, compared to the sample at 5 mg/ml. This is attributed to the higher 
viscosity of the concentrated samples contributing to an increased loss of protein on the 
filter and the filtration equipment. 
Potential quality differences of the concentrated solutions due to different operational 
conditions during UF were further investigated during storage at -20 °C and 2-8 °C. The 
filtered solutions did not show any differences in turbidity during storage (Figure IV-4B). 
Neither an increase in turbidity after freezing and thawing, nor after storage at 2-8 °C was 
recognized. A slight increase in the number of particles larger 1 µm was only observed after 
6 months at 2-8 °C for all filtered concentrates (Figure IV-5B). 
As regards the unfiltered solutions before and after freezing and thawing, the concen-
trates derived from the optimized UF method revealed a slightly reduced turbidity as well as 
a slightly lower number of particles larger 1 µm compared to the solutions obtained from the 
two other UF methods (Figure IV-4A and Figure IV-5A). 
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Figure IV-4: Turbidity at 350 nm during storage at -20 °C and 2-8 °C for mAb solutions 
before concentration (5 mg/ml) and after UF (90 mg/ml) by using dif-
ferent concentration methods 
The data referring to the unfiltered solutions is shown on the left side (A) and the 
data referring to the filtered solutions is shown on the right side (B); mean values 
of three measurements are reported ± SD. 
 
Figure IV-5: Particles per ml larger than 1 µm during storage at -20 °C and 2-8 °C for 
mAb solutions before concentration (5 mg/ml) and after UF (90 mg/ml) 
by using different concentration methods 
The data referring to the unfiltered solutions is shown on the left side (A) and the 
data referring to the filtered solutions is shown on the right side (B); mean values 
of three measurements are reported ± SD. 
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Freezing and thawing did not result in significant differences regarding the turbidity and the 
particle burden of all unfiltered samples compared to the values before storage. 
After storage at 2-8 °C over 3 months, all concentrates were less turbid and contained a 
lower number of particles larger 1 µm than before storage. After 3 months up to 6 months 
this reduction in the number of particles larger 1 µm detected by LO and the reduction of 
smaller particles of up to 1-2 µm in size detected by turbidity measurements continued. A 
significantly reduced total peak area of the SE-chromatograms was not observed which is 
often related to the formation of larger aggregates which are excluded by the SE-matrix and 
are therefore not detectable by this analytical method (see chapter III). However, precipi-
tated protein which was visible by the unaided eye was observed during storage of these 
concentrated solutions at 2-8 °C. 
Therefore, the concentration of the samples was determined by UV 280-320 after cen-
trifugation for 30 min at 10 000 x g in order to determine the loss of soluble protein due to 
precipitation. It was assumed that the loss of differently sized proteinaceous particles de-
tected by turbidity and LO measurements in the unfiltered solutions is caused by the forma-
tion of an insoluble precipitate during storage at 2-8 °C. 
The analysis was done for the filtered as well as for the unfiltered samples, since the fil-
tered solutions obtained from the several concentration methods did not show any differ-
ence during storage at -20 °C or 2-8 °C regarding turbidity and number of particles lar-
ger 1 µm (Figure IV-4B and Figure IV-5B). Moreover, only a marginally sedimented deposit 
was recognized on the bottom of the tubes. 
A decrease in the percent soluble protein remaining with storage time was observed 
in the unfiltered concentrated solutions at 90 mg/ml during storage at 2-8 °C (Figure 
IV-6A). After 6 months, only about 80 % of soluble protein was found in solution. The 
decrease in the percent soluble protein remaining for the filtered concentrates stored at 2-
8°C was only about 10 % after 6 months (Figure IV-6B). 
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Figure IV-6: Percent soluble protein remaining in solution with storage time at 2-8 °C 
(plain symbols), 40 °C (black symbols) and after freezing and thawing in 
3 cycles (grey symbols) 
Analysis was done by UV 280-320 measurements after centrifugation for 10 min 
at 10 000 x g; the concentrates referring to the ∆p 3.0 bar method were exempla-
rily analyzed; the data referring to the unfiltered solutions is shown on the left 
side (A) and the data referring to the filtered solutions is shown on the right 
side (B); only for figure (A) the mean values of three measurements are reported 
± SD. 
In general, a more pronounced decrease in percent soluble protein remaining after storage 
at 2-8 °C was observed at 90 mg/ml compared to solutions at 5 mg/ml. Freezing and 
thawing in three cycles did not result in this pronounced decrease of soluble protein, inde-
pendent of protein concentration or filtration procedure conducted before storage. These 
results underline that the reduction of differently sized particles during storage at 2-8 °C 
over 6 months can be attributed to the formation and precipitation of much larger ones 
which are no longer detectable by turbidity measurements or LO. 
As regards the percentage of soluble higher molecular weight species (HMWs) during 
storage at elevated temperature, the unfiltered solutions show no significant difference 
depending on the UF concentration method used, neither before nor after storage (Figure 
IV-7A). Moreover, the same trend is obvious for the filtered solutions (Figure IV-7B). 
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Figure IV-7: HMWs [%] during storage at 40 °C for mAb solutions before concentration 
(5 mg/ml) and after UF (90 mg/ml) by using different concentration 
methods 
On the left side the unfiltered solutions (A) and on the right side the filtered solu-
tions (B) are shown; mean values of three measurements are reported ± SD. 
Only after 4 and 6 weeks at 40 °C the filtered solutions produced at a ∆p of 3.0 bar re-
vealed a significantly higher level of soluble aggregates than the concentrates derived from 
the optimized method and the ∆p 1.2 bar method. In general, higher HMW levels were 
observed during storage of the filtered samples compared to the unfiltered ones. A possi-
ble explanation for this is discussed in section 3.2 of this chapter. 
During storage at 2-8 °C and after freezing and thawing in three cycles all concen-
trates show a comparable quality regarding the HMW level independent of the UF method 
used (Figure IV-8A and Figure IV-8B). However, a slight increase in HMWs for all sam-
ples was observed over 3 and 6 months, especially in comparison to the samples at 
5 mg/ml. Comparable HMW levels are observed for the filtered and unfiltered samples. 
Generally, it is observed that freezing and thawing at a high protein concentration of 
90 mg/ml lead to much higher HMW level than storage at 2-8 °C. All concentrates show 
an increased level up to about 3 % HMWs after freezing and thawing in three cycles. 
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Figure IV-8: HMWs [%] during storage at -20 °C and 2-8 °C for mAb solutions before 
concentration (5 mg/ml) and after UF (90 mg/ml) by using different con-
centration methods 
On the left side the unfiltered solutions (A) and on the right side the filtered solu-
tions (B) are shown; mean values of three measurements are reported ± SD. 
Freeze-thaw procedures are reported to cause partial unfolding of proteins leading to ag-
gregation. This can be attributed to low temperature causing cold-denaturation (Privalov 
1990), to pH changes due to buffer crystallization (Gomez et al. 2001; Pikal-Cleland and 
Carpenter 2001), to the exposure of protein molecules to the ice-liquid interface 
(Krielgaard et al. 1998; Sluzky et al. 1991), to different freezing and thawing rates (Cao et 
al. 2003) and to the container material, geometry and volume used (Kueltzo et al. 2008). 
Moreover, a higher protein concentration in aqueous solutions is suspected to increase the 
rate of aggregation (Zettlmeissl et al. 2002). During freezing, a local increase in protein 
concentration due to eutectic phase separation is observed which is expected to promote 
aggregation as well (Heller et al. 1997; Heller et al. 1999). However, it has been observed 
that increasing the concentration will reduce aggregation during freeze-thawing, due to the 
reduced fraction of protein molecules which is actually exposed to the ice interface 
(Treuheit et al. 2002; Zippelius 2002). 
In the present study, a higher protein concentration of 90 mg/ml leads to a higher 
percentage of HMWs during storage compared to the 5 mg/ml solution (Figure IV-8). No 
changes in secondary structure determined with FT-IR in transmission mode were ob-
served during storage independent of concentration or storage conditions (data not 
shown). For the storage of unformulated purification intermediates no excipients like sug-
ars (Cleland et al. 2001; Kendrick et al. 1997), polyols, amino acids (Chen et al. 2003) or 
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surfactants (Chang et al. 1996) were applied which are known to protect the API against 
chemical and physical instability. Therefore, the most gentle storage condition has to be 
chosen to prevent especially the formation of soluble HMWs which are hardly removable 
at the end of the purification process. In this study, the storage at 2-8 °C was observed to 
be suitable to circumvent the formation of these aggregates in the concentrated protein 
solutions. However, the formation of larger insoluble aggregates and actually precipitated 
protein was observed under theses conditions. 
3.2 Homogeneous nucleation and growth 
Differences in the aggregation behavior due to the 0.2 µm-filtration procedure became 
obvious by looking concomitantly at the level of small soluble HMWs and the proteina-
ceous particles detectable by turbidity measurements and LO in the unfiltered and filtered 
concentrates during storage. 
Regarding soluble aggregates, the filtered solutions showed a higher level of HMWs 
during storage at elevated temperature than the unfiltered ones (Figure IV-7). After 
4 weeks at 40 °C all concentrated solutions revealed a level of 3.2-3.5 % HMWs in the fil-
tered solutions and of only 2.0-2.2 % HMWs in the unfiltered solutions, analyzed with SE-
HPLC. After 6 weeks at 40 °C, all concentrates generated by different UF methods showed 
5-6.2 % HMWs in the filtered solutions and only 3-3.5 % HMWs in the unfiltered solutions.  
By comparing concomitantly the level of larger aggregates in the unfiltered and filtered 
concentrates, all filtered ones showed a significantly reduced turbidity value at 350 nm over 
6 weeks at 40 °C (Figure IV-1). Moreover, the level of particles larger 1 µm in the filtered 
solutions was inherently lower compared to the unfiltered ones during storage at elevated 
temperature over 6 weeks (Figure IV-2). Only the filtered solutions showed this reduced 
level of particles larger 1 µm as well as the lower turbidity values during storage, however a 
higher level of HMWs was obvious which was not recognized in the unfiltered solutions. 
Figure IV-9 shows the increase of HMWs and the turbidity values with storage time at 40 °C 
exemplarily for the concentrates derived from the ∆p 3 bar method. After 3 weeks, the for-
mation of HMWs is clearly increased when a lower turbidity and thus a lower number of 
particles of up to 1-2 µm is present in solution (Figure IV-9B). 
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Figure IV-9: Percent HMWs and turbidity values with storage time at 40 °C depending 
on the filtration status of the concentrated solutions (90 mg/ml)  
The data for the unfiltered (A) and filtered (B) concentrates derived from the ∆p 3 
bar method were taken; the data is a combination of Figure IV-1 and Figure IV-7. 
After 6 weeks, the unfiltered solutions with a turbidity value of only 0.5 AU on average 
showed a significantly increased level of about 6.2 % HMWs compared to the filtered so-
lutions containing only 3.5 % HMWs after 6 weeks. 
This aggregation behavior during quiescent storage conditions can be explained by 
looking at aggregation as a nucleation and growth phenomenon (chapter I, section 3.4). 
Aggregation is propagated on the basis of the successive formation of larger aggregates 
from already existing smaller ones. These smaller ones which are called homogeneous nu-
clei, are reported to be created by spontaneous coalescence and are known to be therefore 
preferentially formed at a higher total protein concentration or at a higher temperature. 
After the formation of the nuclei and thus a new stable solid-liquid interface, aggregation is 
propagated on the basis of these nuclei which are growing into larger aggregates. Succes-
sively, much larger particles can be build up until their solubility is exceeded and the pro-
tein is precipitating. Conversely, the presence of already existing larger aggregates or parti-
cles should prevent the formation of the smaller ones, since a new solid-liquid interface is 
already build up and a stable species larger than the critical-sized nucleus is already present 
in solution. 
In the here presented study, the formation of soluble aggregates was generally en-
hanced at a higher protein concentration or at a higher temperature which is in accordance 
with the presented theory. A filtered and nearly HMW free solution showed an increased 
level of up to 5-6 % HMWs after 6 weeks stored at elevated temperature as reported 
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above. In the presence of already existing large aggregates the formation of HMWs, the 
smallest aggregate species detected, was inhibited. 
A quite similar level of HMWs was observed by comparing the unfiltered and the fil-
tered concentrates stored at 2-8 °C (Figure IV-8). The HMW level of all concentrates 
stepped up from 0.6 % to only 1.0 % over 6 months. Concomitantly, a decrease in turbid-
ity as well as in the number of particles larger 1 µm was recognized in the unfiltered con-
centrates (Figure IV-4A and Figure IV-5A). Moreover, the formation of visibly precipi-
tated and therefore very large aggregates was recognized by a decrease in percent soluble 
protein remaining (Figure IV-6). This was more pronounced when the turbidity of the 
concentrates was already increased and particles larger 1 µm were already present in solu-
tion (unfiltered concentrates). Figure IV-10 shows the decrease in turbidity at 350 nm and 
the percent precipitated protein with storage time at 2-8 °C exemplarily for the concentrates 
derived from the UF method applying a ∆p of 3 bar. The unfiltered solutions show a clear 
decrease in turbidity and concomitantly a more pronounced increase in precipitated and thus 
very large and visible aggregates compared to the filtered solutions. 
Figure IV-10: Turbidity values and percent precipitated protein with storage time at 2-
8 °C depending on the filtration status of the concentrated solutions 
(90 mg/ml) 
The data for the unfiltered (A) and filtered (B) concentrates derived from the ∆p 3 
bar method were taken; the data is a combination of Figure IV-4 and Figure IV-6. 
Here, the formation of very large aggregates which are precipitating during storage is fa-
vored when smaller aggregates, detected by turbidity measurements and LO, are already 
present in solution. This is again in accordance with the already mentioned theory of ho-
mogeneous nucleation and growth detailing that the formation of a larger species is based 
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on the presence of already existing smaller ones. This process is presumably favored and 
therefore detectable at a lower temperature, since solubility inherently depends on the en-
vironmental temperature. 
The assumed aggregation process in the concentrated solutions is illustrated sche-
matically: 
 
22 NN ↔  (step 1) 
n
Nn NN +
+ →← 22  (step 2a) 
n
Nn NN +
+  →← 22 2  (step 2b) 
m
Nn
n NN
x →++2  (step 3) 
 
Here N refers to a native monomer forming at least a soluble dimer or oligomer N2 pre-
ceding aggregation (step 1). These soluble aggregates detected by SE-HPLC represent the 
stable critical-sized nuclei. The schema suggests an equilibrium between the monomer and 
the soluble aggregates which are then forming larger aggregates. The soluble aggregates 
grow successively into larger ones (N2+n), detected by turbidity measurement and LO, by 
incorporating further monomeric species N (step 2a) or soluble aggregates N2 (step 2b). 
The aggregated species N2+n can further grow into very large visible particles Nm which 
irreversibly precipitate by incorporating potentially all kinds of aggregates or monomeric 
molecules Nx (step 3). 
To verify that larger aggregates are build up on the basis of already existing smaller 
ones, DLS analysis was performed to have an additional analytical method in place which 
is capable to detect aggregates in a size range which was not yet covered by the applied 
methods. LO is capable to detect particles of 1-200 µm whereas turbidity measurements at 
350 nm are mainly suitable to recognize particles of up to 1-2 µm in size (see chapter III). 
The SE-column is capable for the separation of IgG monomers, dimers and oligomers up 
to about two-fold in hydrodynamic diameter which corresponds to about eight-fold in 
molecular weight (Ye 2006). Higher aggregates are usually excluded from the SE-column 
since the used SE-matrices commonly applied for the analysis of IgGs have a mean pore 
size of about 250 Å (Dolman and Thorpe 2002). Therefore, DLS in batch mode was used 
to detect the IgG monomer with a hydrodynamic diameter of about 10 nm (=100 Å) be-
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side various aggregated species up to a hydrodynamic diameter of about 1 to 6 µm. In gen-
eral, DLS is a sensitive method to detect aggregates even in small traces, since the total 
scattered light intensity is proportional to the size of the scattering particles (Kunitani et al. 
1997). 
After 6 weeks at 40 °C the DLS data revealed an additional aggregated species at 
about 100 nm mean hydrodynamic diameter in the unfiltered solutions derived from the 
∆p 1.2 bar and 3.0 bar method (Figure IV-11A and Figure IV-12A). This species is neither 
detectable by LO, nor by SE-HPLC. 
Figure IV-11: DLS size distribution by intensity for the concentrated solutions 
(90 mg/ml) derived from the ∆p 1.2 bar UF method 
Unfiltered solutions (A) and filtered solutions (B). 
Moreover, the unfiltered concentrates derived from the UF method applying a 
∆p of 3.0 bar showed an increase in peak intensity of the aggregated species of about 
1000 nm hydrodynamic diameter (Figure IV-12A). Both, aggregated species appearing at 
about 100 nm and 1000 nm in hydrodynamic diameter indicate that larger aggregates are 
formed over time in the unfiltered solutions at 40 °C. This was recognized by an increase 
in turbidity of these solutions after 6 weeks at elevated temperature (Figure IV-1A). Inter-
estingly, the concentrates generated by using the optimized UF method did not show the 
aggregated species at around 100 nm hydrodynamic diameter (data not shown). Moreover, 
the turbidity of these samples was not increased after 6 weeks (Figure IV-1A). 
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Figure IV-12: DLS size distribution by intensity for the concentrated solutions 
(90 mg/ml) derived from the ∆p 3.0 bar UF method 
Unfiltered solutions (A) and filtered solutions (B). 
An aggregated species was not observed in the filtered solutions (Figure IV-11B and 
Figure IV-12B). No additional peak appeared beside the monomer peak during storage. 
However, the peak referring to the monomer is broadened. This is considered as an indi-
cation of the augmented formation of soluble aggregates smaller than an octamer which 
was already noticed by SE-HPLC (Figure IV-7B). Monomeric molecules and these soluble 
aggregates can not be resolved by DLS, since two species are only separated into two 
peaks if their hydrodynamic diameter differs at least by a factor of two (Demeester et al. 
2005; Philo 2006). 
By looking at the DLS size distribution by intensity of the unfiltered concentrates 
stored at 2-8 °C over 6 months the aggregate peak at about 1000 nm vanished (Figure 
IV-11A and Figure IV-12A). Moreover, the size distribution by intensity of the unfiltered 
concentrates after 6 months at 2-8°C is nearly equal to the filtered ones before storage 
(Figure IV-11B and Figure IV-12B), where the large aggregates were mechanically re-
moved. This is considered therefore a further indication that much larger aggregates were 
build up during storage which are no longer detectable by DLS analysis. This formation of 
much larger visible particles was already recognized due to a decrease in the percent solu-
ble protein remaining as reported before (Figure IV-6). 
The filtered solutions do not show any alteration in the size distribution by intensity 
during storage at 2-8 °C which is consistent with the results obtained from SE-HPLC, since 
only a slight increase in soluble HMWs was recognized during storage (Figure IV-8B). 
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In summary it was shown that the level of existing aggregates has influence on the 
ongoing aggregate formation during quiescent storage of unformulated concentrated IgG 
solutions. In the presence of larger mainly subvisible aggregates, detected by turbidity 
measurements and LO, the formation of soluble HMWs was clearly reduced during stor-
age at elevated temperature compared to a filtered bulk which was cleared from proteina-
ceous particles by 0.2-µm filtration. At 2-8 °C the formation of visible particles precipitat-
ing during storage was enhanced when subvisible aggregates were already present in the 
solution. Concomitantly, no further increase in soluble HMWs was detected, neither for 
the unfiltered, nor for the filtered solutions. Therefore, the highly concentrated purifica-
tion intermediates have to be preferentially stored at 2-8 °C after 0.2 µm filtration, since 
the loss in soluble protein remaining and the formation of soluble HMWs was shown to 
be reduced. 
3.3 Conformational stability 
ATR FT-IR temperature ramps are known to be capable to evaluate the thermal stability 
of proteins. The protein melting temperature (Tm) which is defined as the temperature 
where equal amounts of native and denatured structure exist in equilibrium can be deter-
mined by monitoring the position and intensity of the amide I component frequencies as a 
function of temperature. In this study Tm was used to investigate if changes in conforma-
tional stability occur depending on the operational conditions used in UF, thus influencing 
aggregation during storage. 
MAbs show two characteristic bands in the second derivative spectrum at around 
1639 and 1690 cm-1 reflecting the presence of intramolecular ß-sheet (Chang et al. 2005; 
Cleland et al. 2001). Conformational changes are indicated by a reduced band at around 
1639 cm-1 and a concomitantly arising strong temperature-induced band at 1615-1625 cm-1. 
Moreover, a weak intensity peak at around 1690 cm-1 arises. All these spectral changes are 
assignable to the formation of intermolecular β-sheets which was fund to be mainly pre-
sent in aggregated protein molecules (Pelton and McLean 2000). Figure IV-13A-C shows 
the second derivative spectra of the heated solutions at 90 mg/ml derived from the differ-
ent UF methods. In the case of the used IgG, the band at 1637 cm-1 was found to strongly 
decrease and the band at 1624 cm-1 was found to strongly increase with higher tempera-
ture. 
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Figure IV-13: ATR FT-IR second derivative spectra of mAb solutions concentrated to 
90 mg/ml by using different UF methods 
Arrows mark the direction of spectral changes of the bands at 1637 cm-1 and 
1624 cm-1 with increasing temperature from 25 (bolded black line) to 90 °C 
(bolded grey line); ∆p 1.2 bar (A), ∆p 3.0 bar (B) and optMeth (C). 
Different methods can be in general applied to determine Tm of a protein from the FT-IR 
spectra. Based on direct plots of the relative intensity values of the decreasing native band 
and the increasing temperature induced band from the second derivative spectra, the mid-
point of the thermal transition can be identified. For this, the inflection point of both 
curves can be determined which is described by Dong et al. (1997) for Factor XIII and by 
Kendrick et al. (1998b) for huIFN-γ. In addition, the intersection between the tempera-
ture-induced band and the disappearing frequency of the native state can be determined, as 
reported by Matheus et al. (2006a) for different proteins including an IgG1. 
Figure IV-14 shows the changes in intensity in the second derivative spectra for the 
frequencies at 1637 cm-1 and 1624 cm-1 with increasing temperature up to 90 °C for the 
three concentrates generated by using different UF protocols. With increasing temperature 
a continuous increase in relative intensity of the native amide I band was observed which 
was accompanied by a continuous decrease in relative intensity at 1624 cm-1. Both curves 
show a sigmoid shape with a clearly defined inflection point. The inflection point of the 
curves was calculated by using the Origin software (Origin 7.5 SR5, OriginLab Corpora-
tion, Northampton, USA) applying a sigmoid fit according to the Bolzmann equation 
(Markovic et al. 2007). Table IV-2 summarizes the determined melting temperatures based 
on the three different interpretation approaches described above. 
1580160016201640166016801700
wave number [cm -1]
ar
bi
tra
ry
 u
ni
ts
BA C
1637 cm-1
1624 cm-1
1580160016201640166016801700
wave number [cm -1]
1580160016201640166016801700
wave number [cm -1]
1689 cm-1
ar
bi
tra
ry
 u
ni
ts
Chapter IV Effects of operational parameters during UF on the stability 
104 
Figure IV-14: Changes in intensity in the ATR FT-IR second derivative spectra at 
1637 cm-1 (black squares) and 1624 cm-1 (grey squares) during heating up to 
90 °C of a 90 mg/ml mAb solution concentrated by using different UF 
methods 
∆p 1.2 bar (A), ∆p 3.0 bar (B) and optMeth (C); the respective sigmoid fit accord-
ing to the Bolzmann equation is indicated by the solid line. 
A Tm of around 70 °C was observed which correspond to the values for IgGs that have been 
reported in literature (Matheus et al. 2006a; Matheus et al. 2006b; Vermeer et al. 1998; Ver-
meer and Norde 2000). Considering the different interpretation approaches to determine Tm, 
quite similar values were obtained. In general, the values for Tm identified by using the inflec-
tion point of the decreasing band are always lower than the values based on the intensities of 
the increasing frequency. For both approaches, as well as for the interpretation by using the 
intersection between the denatured and native frequency, consistently higher values for Tm 
were identified for the concentrates generated by using the optimized UF method. 
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Tm (FT-IR) [°C] 
Inflection point using sigmoid fit 
(Boltzmann equation) 
Method Protein 
concentration 
Increasing band 
at 1637 cm-1 
Decreasing band at 
1624 cm-1 
Intersection between 
in- and decreasing 
band 
before UF   5 mg/ml 69.2 ± 0.2 69.6 ± 0.2 69.9 
∆p 1.2 bar 90 mg/ml 70.9 ± 0.2 69.8 ± 0.2 71.2 
∆p 3.0 bar 90 mg/ml 70.2 ± 0.1 69.4 ± 0.2 70.1 
optMeth 90 mg/ml 71.5 ± 0.2 70.5 ± 0.2 71.9  
Table IV-2: Melting temperature (Tm) for mAb solutions at 90 mg/ml determined from 
ATR FT-IR second derivative spectra by using three different interpreta-
tion approaches 
Results of sigmoid fitting are listed with ± 1 standard error of the non-linear re-
gression. 
Concomitantly, a consistently higher Tm was recognized for the concentrated solutions at 
90 mg/ml compared to the Tm values of the solutions at 5 mg/ml. This suggests that con-
formational stability regarding secondary structure is affected by the UF method used, but 
in general, a higher total protein concentration leads to an increase of the melting tempera-
ture as well. This is in accordance with current literature reporting that concentrated protein 
solutions are protected against conformational changes. The rate of denaturation of several 
proteins exposed to heat and ethanol has been found to be reduced in the presence of sig-
nificant concentrations of up to 100 mg/ml of other heat stable proteins (Minton 2000; 
Minton et al. 1982). The addition of dextran at high concentrations stabilizes lysozyme and 
cytochrome C with respect to thermal denaturation (Sasahara et al. 2003). Matheus and co-
workers (2006a) reported that an IgG1 formulation at 100 mg/ml showed nearly no differ-
ence in Tm when the pH was changed from 5 up to 8 although aggregation was clearly fa-
vored at pH 8. 
An explanation is provided by the excluded volume theory arguing that in the pres-
ence of highly concentrated macromolecules the unfolding of proteins should be reduced 
due to facing a crowded or so-called volume-occupied system (Alford et al. 2008a; Hall 
and Minton 2003; Harn et al. 2007). Due to steric- and charge-based repulsion of the mac-
romolecules, the protein molecules exclude volume to another thus resulting in an increase 
in free energy. As volume occupancy increases, compact protein conformations of the 
native state become increasingly energetically favored over extended conformations of 
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equal volume, present in the denatured state (Minton 1980). Therefore, the native confor-
mation of a protein becomes more stable relative to any less compact denatured state. 
It is concluded that the formation of aggregates in highly concentrated solutions is 
rather controlled by a homogeneous nucleation and growth process than by partially un-
folded molecules, since the protein was shown to be in general protected against conforma-
tional changes at a higher total protein concentration. This is in accordance with the litera-
ture, since nucleation and growth phenomena were mainly recognized when the native con-
formation of the protein was preserved (see chapter I). The increase in Tm at a high protein 
concentration of 90 mg/ml did not result in a decreased formation of aggregates during 
storage below the melting temperature. Quite the contrary was recognized, since aggregation 
was enhanced with increasing total protein concentration in the solution. The applied UF 
method seems to significantly affect the conformational stability of the protein, but these 
results did not correspond to the aggregation behavior during performed stability studies. 
No significant differences regarding the level of several types of aggregates in the differently 
processed concentrates were observed during storage below Tm. 
4 Summary and conclusion 
In this chapter, the physical stability of highly concentrated IgG bulks derived from differ-
ent UF methods was investigated. The three stage protocol using the optimized opera-
tional conditions presented in chapter III showed the lowest level of larger aggregates be-
fore and during storage at elevated temperature, at 2-8 °C and after freezing and thawing. 
After 0.2 µm-filtration of the concentrates no differences regarding the level of larger 
subvisible protein aggregates detected by turbidity measurements and LO were observed 
depending on the UF method used. This was recognized during storage at elevated tem-
perature, at 2-8 °C as well as after freezing and thawing in three cycles. Almost all pro-
teinaceous particles were removed by filtration and did not reappear during storage. There-
fore, the improved quality of the bulk derived from the optimized UF method regarding 
the level of proteinaceous particles is no longer relevant after the filtration of the concen-
trated bulk. 
As regards soluble HMWs, no significant differences between the several unfiltered 
concentrates were observed neither before, nor after storage. Only after 6 weeks at 40 °C 
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the filtered concentrates revealed a significantly higher level of HMWs generated by using 
the ∆ 3.0 bar method. In general, during freezing and thawing in three cycles a significantly 
increased level of HMWs was detected. Both, the filtered and unfiltered solutions at 
90 mg/ml showed an increase in HMWs up to three times compared to the solutions at 
5 mg/ml. Since the level of HMWs was quite stable at 1 % when the concentrates were 
stored at 2-8 °C, this is the recommended storage condition for the unformulated highly 
concentrated bulk material. 
The filtered solutions stored at elevated temperature showed a higher level of soluble 
aggregates compared to the concentrates which remained unfiltered during storage. This 
was attributed to the already existing larger subvisible aggregates in the unfiltered solutions 
preventing the formation of the smaller soluble aggregate species in accordance with the 
theory of homogeneous nucleation and growth. 
The secondary structure was found to be affected by the UF methods used. The con-
centrates generated by using the optimized method showed a consistently higher melting 
temperature which was evaluated by using three different interpretation approaches based 
on temperature dependent ATR FT-IR second derivative spectra analysis. Moreover, the 
highly concentrated protein solutions showed consistently higher Tm values compared to 
the solutions with a protein concentration of only 5 mg/ml. In contrast, aggregation dur-
ing storage was in general enhanced at a higher total protein concentration, independent 
from the UF method used. Thus, aggregation during storage at higher total protein con-
centrations seems to be rather based on homogeneous nucleation and growth than on a 
perturbation in secondary structure. The preservation of the native conformation of the 
protein does not seem to be efficient enough to ensure the physical stability of the concen-
trated bulk. Physical stability encompasses in fact conformational and colloidal stability 
and the latter seems to be the more decisive factor regarding the storage stability of the 
highly concentrated solutions. 
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Chapter V Thermodynamic non-ideality 
during UF concentration of mAbs at the 
interface of DSP and final formulation 
Abstract 
The purified mAb bulk is generally obtained in a concentration requiring a subsequent UF 
concentration step prior to formulation especially for the supply of bulk material for highly 
concentrated mAb preparations up to 200 mg/ml. 
It is known for a number of molecules that at high protein concentrations the molar-
ity of the actually free diffusible buffer forming anions and cations changes during diafil-
tration. This thermodynamic non-ideality is based on electrostatic interactions of the solute 
and the protein at non isoelectric pH leading to unequal partitioning of charged solutes 
across the membrane. Due to this so-called Donnan-effect the buffer composition of dif-
ferent IgG solutions was shown to be significantly different before and after the UF con-
centration step having an impact on pH, conductivity and hence stability of the highly 
concentrated mAb bulk. 
It has been found that by using the Donnan-effect theory the change in concentration 
of the buffer forming ions can be calculated prior to the UF filtration step, allowing for a 
“preventive” adjustment of the concentration of the ions in the solution before the UF 
process starts. The studies show that in the case of histidine a systematic and convenient 
add-on of this solute was successful in matching the predefined histidine molarities as well 
as pH of a highly concentrated bulk. Therefore, chemical and physical stability of the con-
centrated mAbs at 200 mg/ml were improved. 
It has further been found that the systematic add-on in the case of histidine provides 
best results considering the formation of aggregates and particles during the UF concentra-
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tion step as well as during storage. In comparison, the level of aggregates was clearly in-
creased when the pH was adjusted closely to the IP of the mAb before starting the UF 
concentration in order to avoid the thermodynamic non-ideality during processing. More-
over, a reduction in concentration time and a higher permeate flux over time were ob-
served for the solutions using the systematic add-on approach. 
Finally, in the case of histidine, an add-on can contribute to a decrease in viscosity of 
the highly concentrated API bulk. 
1 Introduction 
After the final polishing step in a mAb purification process, the protein has usually to be 
diafiltrated into the required formulation buffer. Concomitantly, highly concentrated mAb 
formulations are favored today to provide both, low volume injections and efficient dosing 
for subcutaneous administration (Shire et al. 2004). UF is the industry standard for large-
scale concentration and diafiltration processing. Since the appropriate formulation buffer 
ensures sufficient stability during the storage and shelf-life of the mostly liquid concen-
trates, it needs to be ensured that predefined conditions are present after the UF process. 
The pH, the conductivity and the concentration of the applied buffer components are 
known to have influence on the chemical and physical stability of the therapeutic protein 
(Daugherty and Mrsny 2006; Wang 2005; Wang et al. 2007a). 
Concentration and diafiltration by using UF is based on the principle of a semi per-
meable membrane separating the protein (P) from diffusible water and solutes which can 
be either cationic (Cat + ) or anionic (An - ). In this system diluted solutions have to estab-
lish the same product of ion concentration and ion activity respectively on both sides of 
the membrane, the retentate side (r) and the permeate side (p) (Equation V-1). Moreover, 
electroneutrality is postulated having the same concentration of cations on both sides of 
the membrane (Equation V-2) and concomitantly the same concentration of anionic spe-
cies on both sides (Equation V-3) (Martin et al. 1980): 
[ ] [ ] [ ] [ ]rrpp AnCatAnCat −+−+ =  Equation V-1 
[ ] [ ] pp AnCat −+ =  Equation V-2 
[ ] [ ]rr AnCat −+ =  Equation V-3 
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By introducing a macromolecular polyion into the system which is retained by the mem-
brane, e.g. a positively charged protein (P + ), this species disturbs the charge equilibrium 
on the retentate side shown in Equation V-3 (Martin et al. 1980) resulting in:  
[ ] [ ] [ ]rrr AnPCat −++ =  Equation V-4 
To reestablish the equilibrium of charge, positively charged solutes are displaced to the perme-
ate side while negatively charged solutes are accumulated on the retentate side. This is of spe-
cial importance when the protein concentration increases. This can be underlined when Equa-
tion V-2 and Equation V-3 are inserted in Equation V-1 resulting in Equation V-5: 
[ ]
[ ]
[ ]
[ ]r
r
r
p
Cat
P
Cat
Cat
+
+
+
+
+= 1  Equation V-5 
Equation V-5 shows the ratio of the diffusible cationic solute concentrations on the per-
meate and the retentate side in equilibrium. When the charged protein [P + ] will be con-
centrated on the retentate side exceeding the solute concentration [Cat + ] by far, the con-
centration of the positively charged solute [Cat + ] on the permeate side is approximately 
the [ ]rP + -fold of the concentration of the positively charged solute [Cat + ] on the reten-
tate side. 
 This thermodynamic non-ideality results from intermolecular charge-charge based in-
teractions between the macromolecular polyions and those of other macromolecular ions 
and charged solutes in its vicinity, affecting the partitioning of small solutes across the 
semi permeable membrane. This is termed the Donnan-effect which was first pointed out 
by Frederick G. Donnan in 1911 (Donnan 1911; Tanford 1967). 
Stoner and coworkers related these facts in 2004 to the process development envi-
ronment of therapeutic proteins showing that the Donnan-effect has an impact on the 
outcome of dialysis of Interleukin-1 receptor antagonist (IL-1ra), PEGylated soluble tumor 
necrosis factor receptor (PEG-sTNF-IR) and Fusion conjugate protein (AMG-719). The 
concentration of charged solutes encompassing chloride, histidine and acetate was moni-
tored during dialysis of the different proteins at various protein concentrations (Stoner et 
al. 2004). 
In the present study, thermodynamic non-ideality during UF concentration procedure 
of mAbs was investigated in buffer systems which are frequently applied at the interface of 
DSP and final formulation. The intention was to gain insight in the characteristics and 
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relevance of thermodynamic non-ideality during tangential UF processing of IgGs after 
final purification steps considering especially chemical and physical stability of API bulks. 
An automated TFF lab-scale system was used which has been shown to adequately reflect 
process conditions at manufacturing scale (see chapter III). 
The pH and the conductivity were monitored during concentration experiments up to 
200 mg/ml at a non isoelectric pH of about 5. Further, the concentration of histidine and 
sodium ions as well as of acetate and chloride ions during the UF concentration process of 
an IgG1 and an IgG4 were investigated. The characteristics oft the displacement and the 
accumulation respectively of cationic and anionic solutes during UF experiments was 
compared to different mathematical models based on protein-solute interaction and vol-
ume exclusion. 
Based on this data, the extent of the displacement and accumulation of solutes is ex-
pected to be predictable before and during UF. This is of special importance for the pro-
duction of highly concentrated solutions for sub-cutaneous use since the Donnan-effect is 
per definition pronounced with increasing protein concentrations and a pH further away 
from the IP of the protein. Following the concept of cGMP, predefined buffer conditions 
within defined specifications have to be present after a process step which can not be en-
sured at a high protein concentration as explained above. Thus, compared to processes at 
low protein concentrations, the buffer conditions have to be corrected afterwards to meet 
the specifications. This can be potentially relevant for the stability of the concentrated 
solutions, since it is assumed that the altered buffer composition during UF can affect the 
stability of the concentrated protein. Moreover, the inconvenient readjustment of pH in 
the highly concentrated bulks can result in an extreme high or low respectively local pH 
resulting in chemical or physical instability. Therefore, the stability of the IgG1 during and 
after UF was investigated for histidine as the buffer solute considering the influence of 
protein and solute concentration. 
It is reported that the composition of the buffer potentially influences the viscosity of 
highly concentrated protein solutions, depending on type and amount of salts present 
(Kanai et al. 2008; Liu et al. 2005; Liu and Shire 2002). Thus, the effect of thermodynamic 
non-ideality of histidine during UF on the viscosity of the concentrated solutions was in-
vestigated. 
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2 Materials and methods 
2.1 Materials 
A therapeutic mAb solution of a chimeric human Fc (IgG1)/ mouse Fab antibody in 
20 mM histidine buffer at pH 5.5 and a concentration of 50 mg/ml were taken for the 
concentration experiments in histidine buffer (IgG X). To obtain material containing a 
higher molarity of histidine, histidine base was added to the protein solution and the pH 
was titrated to 5.5 by using 0.1 M hydrochloric acid. To obtain solutions containing 
20 mM and 45 mM acetate pH 5.0 respectively, the 20 mM histidine material was diafil-
trated against the 10-fold volume of sodium acetate puffer pH 5.0 by using TFF. 
A second therapeutic mAb solution of a chimeric human Fc (IgG4)/ mouse Fab an-
tibody in 20 mM histidine buffer at pH 5.0 and a concentration of 20 mg/ml were taken 
for the experiments in histidine buffer (IgG Z). To generate material in different buffer 
system, the protein solution was diafiltrated as described before. Both mAbs were pro-
vided by Roche Diagnostics GmbH (Penzberg, Germany). 
Before UF processing the solutions were diluted to 10 mg/ml protein concentration 
by using the suitable buffer and were filtered through a 0.22 µm membrane cartridge (Sar-
torius, Goettingen, Germany). All chemicals and reagents used were at least analytical 
grade. Hydrochloric acid, sodium hydroxide and sodium chloride were taken from Merck 
KG (Darmstadt, Germany). L-histidine from Ajinomoto (Raleigh, USA) was used. Acetic 
acid was taken from Fluka (Steinheim, Germany). 
2.2 Methods 
2.2.1 Ultrafiltration concentration procedure 
For the preparation of concentrated mAb solutions the automated TFF system ÄK-
TAcrossflow (GE Healthcare, Uppsala, Sweden) was used (Liten and Cohen 2007). The 
optimized UF method (optMeth) as described in chapter III was used for all UF experi-
ments up to 200 mg/ml protein concentration. The experiments were conducted by using 
the equipment and techniques as described in chapter III. After UF the concentrates were 
filtered at a constant pressure of 1.0 bar through a Sartopore 2 XLG Disposable filter unit 
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with a pore size of 0.8 and 0.2 µm and a filter area of 58 cm² (Sartorius, Goettingen, Ger-
many). For stability studies, the filtered solutions were stored at 40 °C, 2-8 °C and -70 °C 
in 5 ml sterile CRYO.S tubes (Greiner Bio-One, Frickenhausen, Germany). The frozen 
samples were thawed in a 25 °C tempered water bath before analysis. 
2.2.2 Concentration determination 
The protein concentration was determined in the solutions by using the photometric ab-
sorbance at 280 nm and 320 nm after buffer blank subtraction (UV-Vis spectrophotome-
ter Evolution 500, Thermo Fisher Scientific, Waltham, USA). The absorbance at 320 nm 
was subtracted from the absorbance at 280 nm and this value was used to calculate the 
protein content according to the law of Lambert-Beer. 
2.2.3 Conductivity and pH monitoring 
The pH was determined in the retentate by using the Microprocessor pH Meter pH 196 
equipped with a pH single-rod measuring cell E50-1.5 from WTW (Weilheim, Germany). 
The conductivity was determined by using the ProfiLine Konduktumeter LF 197 equipped 
with a standard conductivity cell TetraCon 325 from WTW (Weilheim, Germany). All 
samples were tempered in a water bath to 25 °C before measuring pH and conductivity. 
2.2.4 Size exclusion high pressure liquid chromatography 
SE-HPLC analysis was conducted with a TSK 3000 SWXL column (Tosoh Biosep, Stuttgart, 
Germany) on a Summit HPLC-system (Dionex, Idstein, Germany). The elution peaks were 
monitored at 280 nm by the UV diode array detector UVD170U from Dionex (Idstein, Ger-
many). Isocratic chromatography was conducted and evaluated as described in chapter III (see 
page 52). 
2.2.5 Histidine quantification 
The samples were diluted to about 100 µM histidine concentration with purified water 
(Milli-Q, Millipore, Billerica, USA). Afterwards, 500 µl diluted sample was mixed with 
500 µl perchloric acid (5 %) (Fluka, Steinheim, Germany). After 10 min the sample was 
centrifuged at 25 °C with 13 000 rpm for 10 min (miniSpin, Eppendorf, Hamburg, Ger-
many). 100 µl of the supernatant were injected on a MonoS 5/ 50 GL column (GE 
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Healthcare, Uppsala, Sweden). The CEX-chromatography was conducted on a Ulti-
mate 3000 HPLC-system (Dionex, Idstein, Germany) at room temperature using a gradi-
ent elution applying two aqueous buffers composed of 50 mM acetate, pH 3.2 (buffer A) 
and 50 mM acetate, pH 3.2, 1 M sodium chloride (buffer B). A flow-rate of 1.0 ml/min 
was applied. Elution was monitored at 210 nm. At pH 3.2, histidine is greatly retained on 
the CEX resin due to its overall positive charge. Elution is achieved during the sodium 
chloride gradient due to charge shielding. The chromatograms were integrated manually by 
using the Chromeleon software (Dionex, Idstein, Germany). Figure V-1 shows a chroma-
togram exemplarily. To quantify the amount of histidine, the area (mAU ⋅min) of the de-
fined peak was compared to a standard curve (r² = 0.9998). 
Figure V-1: CEX chromatogram of the histidine quantification method 
UV signal at 210 nm (black line, left scale) and percentage of buffer B of the elu-
tion gradient (dotted black line, right scale) during chromatography. 
2.2.6 Acetate quantification 
The samples were diluted to about 25 mM acetate concentration with purified water (Milli-
Q, Millipore, Billerica, USA). Afterwards, 500 µl diluted sample was mixed with 500 µl 
perchloric acid (5 %) (Fluka, Steinheim, Germany). After 10 min the sample was centri-
fuged at 25 °C with 13 000 rpm for 10 min (miniSpin, Eppendorf, Hamburg, Germany). 
100 µl of the supernatant were injected to a LiChrosorb RP C18 4/ 250 column (Merck 
KG, Darmstadt, Germany). Chromatographic runs were conducted on a Ultimate 3000 
% buffer B
50
100
0
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HPLC-system (Dionex, Idstein, Germany) at room temperature using an isocratic elution 
over 15 min applying an aqueous buffer composed of 6 mM phosphoric acid (Fluka, 
Steinheim, Germany), pH 3 (Kordis-Krapez et al. 2001). Acetate as acidic acid is greatly 
retained on the C18 RP resin at the very low pH in the presence of perchloric acid. During 
elution with the aqueous phosphoric acid at pH 3, the acetic acid is partially deprotonated 
and thus removed from the column. After each sample run the column was washed with 
3 ml acetonitrile (Merck KG, Darmstadt, Germany) to avoid sample carryover. A flow-rate 
of 1.0 ml/min was applied. Elution was monitored at 210 nm. The chromatograms were 
integrated manually by using the Chromeleon software (Dionex, Idstein, Germany). Figure 
V-2 shows a chromatogram exemplarily. 
Figure V-2: Reversed phase chromatogram of the acetate quantification method 
UV signal at 210 nm. 
To quantify the amount of acetate the area (mAU⋅min) of the defined peak was compared 
to a standard curve (r² = 0.9999). 
2.2.7 Chloride quantification 
The samples were diluted 1:200 with purified water (Milli-Q, Millipore, Billerica, USA). 
10 µl of the diluted sample was injected on an IonPac AS11-HC 2/250 column (Merck 
KG, Darmstadt, Germany). AEX-chromatography was conducted on an ICS 3000 Re-
agent-Free Ion Chromatography system (Dionex, Idstein, Germany) at room temperature 
using a gradient elution over 30 min applying an aqueous solution up to 100 mM sodium 
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hydroxide. A flow-rate of 0.38 ml/min was applied. Detection was carried out on an ICS 
3000 CD conductivity detector. The chromatograms were integrated manually by using the 
Chromeleon software (Dionex, Idstein, Germany). Figure V-3 shows a chromatogram 
exemplarily. To quantify the amount of chloride the area (mAU⋅min) of the defined peak 
was compared to a standard curve (r² = 0.9963). 
Figure V-3: AEX chromatogram of the chloride quantification method 
Conductivity signal (black line, left scale) and concentration of NaOH [mM] in 
the elution gradient (black dotted line, right scale) during chromatography. 
2.2.8 Sodium quantification 
To quantify the amount of sodium ions, the samples were analyzed with the multi-sensor 
system BioProfile 100 plus (NOVA Biomedical, Waltham, USA). The method is based on 
potentiometry. The activity of the ions determines the voltage of the electrode. Sodium 
ions were quantified using a glass electrode at 25 °C after a two point calibration. Samples 
were diluted 1:1 with purified water (Milli-Q, Millipore, Billerica, USA) before measuring. 
2.2.9 Turbidity measurement 
Turbidity was determined as photometric absorbance of the undiluted concentrates at 
350 nm after buffer-blank subtraction (UV-Vis spectrophotometer Evolution 500, 
Thermo Fisher Scientific, Waltham, USA). The samples were mixed before measuring in 
order to avoid a decrease in absorbance due to the settlement of large particles. 
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2.2.10 Light obscuration 
LO was used to monitor the formation of particles in a range of 1-200 µm similar to the 
method <788> Particulate Matter of Injection in the United States Pharmacopoeia and the 
European Pharmacopoeia method 2.9.1 (EDQM 2001a; USPC 2002). The measurements 
were conducted using the particle counter SVSS-C (PAMAS Partikelmess- und Analysesys-
teme, Rutesheim, Germany) as described in chapter III and IV. 
2.2.11 Isoelectric focusing 
For isoelectric focusing (IEF) Servalyt Blank Precotes (125 mm x 125 mm x 300 µm) from 
Serva (Heidelberg, Germany) were used for horizontal flat bed electrophoresis. The blank 
ready to use gels were incubated for 45 min in Servalyt 3-10 buffer (Serva, Heidelberg, 
Germany) containing 2 % CHAPS and urea. Afterwards, the gels were dried in air for 
20 min. The protein solutions were diluted to 1 mg/ml by using the appropriate bulk 
buffer. The amount of mAb per well was 6 µg per sample. As running buffer Servalyt 3-10 
buffer was used. The IEF-markers 3-10 from Serva (Heidelberg, Germany) were used. 
Electrophoresis was performed at 500-2000 V over 2.5 hours. After fixation in 20 % tri-
chloroacetic acid (Fluka, Steinheim, Germany) the washed gels were stained with Serva 
Blue W Coomassie dye (Serva, Heidelberg, Germany). 
2.2.12 Papain ion exchange high pressure liquid chromatography 
To quantify the extent of deamidated Fab fragments of IgG X analytical IEX chromatog-
raphy after papain digestion was performed (papain IEX-HPLC). The samples were di-
luted to 1.0 mg/ml protein concentration containing 0.01 mg/ml papain (Roche Daignos-
tics, Penzberg, Germany). Samples were incubated at 37 °C for 2 hours. Afterwards, 1 ml 
of the sample was applied to a sephadex G-25M PD-10 column (GE Healthcare, Uppsala, 
Sweden) and the buffer system was changed to 20 mM histidine, pH 5.5. 150 µl of the 
sample were loaded to a MonoS 5/50 GL column (GE Healthcare, Uppsala, Sweden). 
Chromatographic runs were conducted on a Ultimate 3000 HPLC-system (Dionex, Id-
stein, Germany) using a gradient elution over 45 min by applying an aqueous buffer com-
posed of 50 mM 3-(N-morpholino) propanesulfonic acid (AppliChem, Darmstadt, Ger-
many), pH 6.5 (buffer A) and a buffer composed of 50 mM 3-(N-morpholino) propane-
sulfonic acid and 1 M sodium acetate (Riedel-de-Haen, Seelze, Germany), pH 6.8 
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(buffer B). A flow-rate of 1.0 ml/min was applied. UV detection was carried out at 
280 nm. The chromatograms were integrated manually by using the Chromeleon software 
(Dionex, Idstein, Germany). Peak characterization was performed on the basis of ESI-MS. 
This IgG1 is untypically complexly glycosylated in the antigen-binding region. Deamidated 
complex glycosylated Fab fragments with two and one N-acetyl-neuraminic acids 
(gFab_d_2SA and gFab_d_1SA) as well as deamidated non-glycosylated Fab fragments 
(Fab_d) were separated from the Fc-fragment and several glycosylated and non-
glycosylated Fab fragments (gFab_2SA, gFab_1SA, gFab_0SA, gFab_hM, Fab). To quan-
tify the overall extent of deamidated Fab-fragments the relative area (mAU⋅min) of the 
gFab_d_2SA-, the gFab_d_1SA- and the Fab_d peak referred to total area of all detected 
peaks in percent were summarized and presented as ∑Fab fragments_d [%]. Figure V-4 
shows the IEX chromatogram exemplarily. 
Figure V-4: IEX chromatogram of digested IgG X  
UV signal at 280 nm (black line, left scale) and percentage of buffer B of the elu-
tion gradient (dotted black line, right scale) during chromatography. The species 
referring to ∑Fab fragments_d are arrow marked encompassing gFab_d_2SA, 
gFab_d_1SA and d_Fab (from left to right). 
2.2.13 FT-IR spectroscopy 
FT-IR spectra were recorded with the Tensor 27 (Bruker Optics, Ettlingen, Germany) 
applying the BioATR unit with a Silicium crystal. For each spectrum which was recorded 
from 850-4000 cm-1 a 120-scan interferogram was collected at a double sided acquisition 
mode with a resolution of 4 cm-1. To monitor temperature induced conformational 
changes in secondary structure of the mAb, spectral changes were followed from 25-90 °C 
0
50
100% buffer BmAU
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at 90 mg/ml. 25 µl of the sample solution were applied into the unit and a temperature 
ramp from 25-60 °C and from 80-90 °C with a ∆T of 5 °C and from 60-80 °C with a ∆T 
of 2 °C was performed. The equilibrium time was 120 s at each temperature step. The 
respective temperature was adjusted by connecting the ATR cell to a thermostat (Haake 
DC30-K20, Thermo Scientific, Waltham, USA). To obtain the reference spectra of the 
buffer system used, the permeate of the UF concentration procedure was taken and the 
temperature ramps were performed as described before. The obtained buffer spectra were 
then subtracted to obtain the protein spectra. 
The spectra were edited by a vector normalization. Afterwards, a second-derivative 
procedure was done to enhance the resolution, concomitantly preserving the band position 
(Pelton and McLean 2000). The second derivative was smoothed using a 13-point Sa-
vitsky-Golay smoothing function. For this, the OPUS software version 6.0 was used 
(Bruker Optics, Ettlingen, Germany). 
2.2.14 Second derivative UV spectroscopy 
Tertiary structure of the protein was examined by second derivative UV spectroscopy (2D-
UV) using the Uvikon XL (Goebel Elektro, Ludwigshafen, Germany). The samples were 
diluted to a protein concentration of 1.0 mg/ml. Absorbance spectra from the near-UV re-
gion between 250-320 nm were collected at a scanning speed of 50 nm/min, a bandwidth of 
1 nm and a scanning step interval of 0.5 nm. A second-derivative procedure was done to 
enhance the resolution, concomitantly preserving the band position (Pelton and McLean 
2000). Therefore, the OPUS software was used (Bruker Optics, Ettlingen, Germany). The 
second derivative was smoothed applying a 13-point Savitsky-Golay smoothing function. 
2.2.15 Viscosity measurement 
To determine the viscosity of the concentrated mAb solutions the SV-10 vibro viscometer 
(AND, Tokyo, Japan) was used. Two gold-covered thin sensor plates are driven with elec-
tromagnetic force at the same frequency vibrating at constant sine-wave in reverse phase. 
The electromagnetic drive controls the vibration of the sensor plates to keep them in con-
stant amplitude. The driving electric current which is the exciting force, will be detected as 
the magnitude of viscidity produced between the sensor plates and the sample fluid. The 
system was calibrated using water and praffinum liquidum in a two-point calibration. 
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Temperature was kept constant at 20 °C by using the water jacket AX-SV-37 (AND, To-
kyo, Japan) which was connected to a Haake DC10 thermostat (Thermo Scientific, 
Waltham, USA). Measurements were carried out three times over 10 min using 10 ml 
sample solution. Every 30 s the viscosity was measured and results were calculated as mean 
value of three measurements. 
2.2.16 Zeta potential measurement 
To determine the charge of the protein at different pHs, electrophoretic mobility of the 
protein was determined by performing Laser-Doppler-Velocimetry using the Malvern 
Zetasizer Nano S (Malvern Instruments, Worcestershire, UK). The zeta potential ζ was 
calculated from the Henry’s equation (Equation V-6) with assumption of uniform charge 
distribution (Henry 1931) by using the Malvern DTS software (Version 5.0, Malvern In-
struments, Worcestershire, UK): 
η
ξεµ
3
2 k
e =  Equation V-6 
Where µe is the electrophoretic mobility, ε is the dielectric constant of the solution, ks is the 
model based constant with a value of 1.5 for a salt concentration higher than 1 mM (Faude 
et al. 2007), η is the viscosity of the solution and ζ is the zeta potential. For sample prepara-
tion the 5 mg/ml mAb solutions were dialyzed into 10 mM acetate buffer pH 5.0 and ti-
trated to a pH of 2.0 afterwards by using 0.2 M hydrochloric acid. The samples were ti-
trated with a 0.2 M sodium hydroxide solution from pH 2 to pH 12 by applying the titra-
tor MPT2 (Malvern Instruments, Worcestershire, UK). The zeta potential was determined 
in 15 steps between pH 2 and 12 in a temperature controlled folded capillary cell (Malvern 
Instruments, Worcestershire, UK) at 25 °C. 
2.2.17 Density determination 
The density ρ of the protein solutions was determined at every protein concentration. A 
pycnometer (Schott, Mainz, Germany) with a volume of 2.076 ml was filled with the sam-
ple solution previously tempered to 20 °C. The mass of the unfilled and filled pycnometer 
was determined by using an analytical balance (MC 210 S, Sartorius, Goettingen, Ger-
many). The density was calculated according to the commonly known equation ρ = m/V. 
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3 Results and discussion 
3.1 Protein – solute interactions at the interface of mAb 
purification and final formulation 
Mostly, IEX chromatography in product flow-through mode is the last chromatographic 
step in commercial purification processes of mAbs to remove mainly residual host cell 
DNA, endotoxins and retrovirus-like particles (see chapter I). Hence, the purified IEX 
pool is present in a phosphate or tris(hydroxymethyl)-aminomethan based buffer system at 
a concentration of approximately 10-20 mg/ml. Subsequently, the environmental condi-
tions have to be changed to a buffer system ensuring stability during storage of the API 
during storage. Mostly, the pH has to be slightly acidic between 5 and 6 and a conductivity 
< 5 mS/cm is required (Daugherty and Mrsny 2006). Concomitantly, this buffer system is 
the basis buffer for formulation by using usually different stock solutions of excipients like 
surfactants and sugars to ensure a long shelf life. Therefore, the IEX pool is usually con-
centrated and diafiltrated into a suitable formulation buffer composition by applying UF to 
provide a defined composition of protein, buffer solutes, pH and conductivity. 
3.1.1 Conductivity and pH shifts during UF 
An IEX pool of IgG X was diafiltrated against 20 mM histidine buffer (pH 5.5; 
1.6 mS/cm) applying a 1 to 10-fold diafiltration volume (DV) referred to the pool volume. 
Afterwards, the diafiltrated pool was concentrated up to 215 mg/ml. It was recognized 
that even after applying a 10-fold diafiltration volume the predefined conditions for the 
histidine buffer system concerning pH and conductivity were not stable after the concen-
tration process had been started. Figure V-5 shows conductivity and pH during diafiltra-
tion and concentration of the IEX pool. 
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Figure V-5: Conductivity and pH during UF diafiltration and concentration of an IEX 
pool of IgG X 
The IEX pool was diafiltrated applying a 1- to 10-fold diafiltration volume (DV) 
referred to the pool volume and afterwards concentrated up to 215 mg/ml. 
After starting the concentration process the pH increases up to 5.7 and conductivity 
reaches 2.2 mS/cm at a protein concentration of 215 mg/ml in the retentate. Moreover, 
conductivity and pH were monitored solely during the UF concentration process of IgG X 
in 20 mM histidine buffer at pH 5.5 (Figure V-6). 
Figure V-6: Conductivity and pH during UF concentration of IgG X from 10 mg/ml to 
about 200 mg/ml protein concentration 
In 20 mM histidine at pH 5.5; mean values of three measurements are reported ± SD. 
 
IE
X 
po
ol
2x
 D
V
5x
 D
V
8x
 D
V
10
x 
DV
95
 m
g/
m
l
11
5 
m
g/
m
l
14
0 
m
g/
m
l
17
0 
m
g/
m
l
19
0 
m
g/
m
l
21
5 
m
g/
m
l --
0.0
5.2
5.3
5.4
5.5
5.6
5.7
5.8
0
1
2
3
4
5
6
7
 
pH
 [ 
]
 c
on
du
ct
iv
ity
 [m
S
/c
m
]
 pH
 conductivity
diafiltration concentration 
pH
 [ 
]
 c
on
du
ct
iv
ity
 [m
S
/c
m
]
pH
 [ 
]
 c
on
du
ct
iv
ity
 [m
S
/c
m
]
0 20 40 60 80 100 120 140 160 180 200
0.0
5.2
5.3
5.4
5.5
5.6
5.7
5.8
5.9
6.0
0.0
1.6
1.7
1.8
1.9
2.0
pH
 [ 
]
concentration [mg/ml]
 c
on
du
ct
iv
ity
 [m
S
/c
m
]
 pH
 conductivity
pH
 [ 
]
 c
on
du
ct
iv
ity
 [m
S
/c
m
]
Chapter V Thermodynamic non-ideality during UF concentration of mAbs at the interface of DSP and final 
formulation 
124 
With increased protein concentration an increase in conductivity and an increase in pH up 
to 5.8 were observed. Different observations were made considering the conductivity dur-
ing UF concentration processes, if a second buffer system based on 20 mM acetate at 
pH 5 was used (Figure V-7A). 
Figure V-7: Conductivity and pH during UF concentration from 10 mg/ml to about 
200 mg/ml protein concentration 
IgG X in 20 mM acetate at pH 5.5 (A) and in 45 mM acetate at pH 5.0. 
During the UF process of IgG X in 20 mM acetate buffer, the pH increased up to 5.8 but 
the conductivity decreased with increasing protein concentration. At a higher acetate con-
centration of 45 mM at pH 5.0, essentially the same was obvious as for the 20 mM acetate 
solution referring to the trend of pH and conductivity during the concentration procedure 
(Figure V-7B).  
It was actually expected that conductivity increases generally with protein concentra-
tion at a pH unequal to the IP of the protein (Figure V-6) due to higher charge density per 
volume in the concentrated solutions (Atchley and Nichols 1925). Since the presented 
conductivity trends during UF could not be solely attributed to the protein concentration, 
it was concluded that changes in the buffer system play a role in pH and conductivity 
shifts during UF. At the pH of about 5, histidine as a buffering agent is mainly positively 
charged since the imidazole side chain has a pKa of 6.0 (Kuester and Thiel 2002). By com-
parison, acetic acid molecules with a pKa of the carboxylic group of 4.7 (Kuester and Thiel 
2002) exhibit dominantly a negative charge. Considering the Donnan-effect, positively 
charged protonated histidine ions should be displaced during UF since the IgG X is ex-
pected to appear mainly positively charged at a pH of 5. An IP > 9.5 was determined by 
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IEF of the IgG X (Figure V-8). As a consequence, the pH on the retentate side increases 
due to a loss of protons. 
Figure V-8: IEF-gel image of different IgGs by using an immobilized pH gradient 
 
Acetate ions should accumulate during UF at a pH of 5 referring to the Donnan-effect, 
since the cationic protein molecules interact with the anionic buffer species based on 
charge-charge interactions. Concomitantly, hydroxonium ions will be displaced to the 
permeate. Therefore, a decrease in conductivity and an increase in pH on the retentate side 
were observed during UF in an acetate buffered system at pH 5 (Figure V-7). 
Conductivity and pH were expected to remain stable if UF experiments are conducted 
at a pH more closely to the IP of the protein. Figure V-9 shows that the conductivity of 
1.8 mS/cm and the pH of 7.4 were not affected during UF processing up to 200 mg/ml 
protein concentration by using a buffer system containing 20 mM histidine at pH 7.4. At this 
pH the IgG carries positive as well as negative charge to nearly the same extent and the imi-
dazole side chain of the histidine molecule is mainly unprotonated. Therefore, conductivity 
does not increase with a higher protein concentration during UF. Moreover, diffusible buffer 
ions do not accumulate in the retentate or are not displaced to the permeate to ensure elec-
troneutrality on both sides of the membrane (Equation V-1 to V-3). 
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Figure V-9: Conductivity and pH during UF concentration of IgG X from 10 mg/ml to 
about 200 mg/ml protein concentration 
UF was conducted in 20 mM histidine at pH 7.4. 
3.1.2 Solute accumulation and displacement during UF 
Molar concentration of the buffer solutes was determined to gain further insight into the 
root causes of pH and conductivity changes on the retentate side during UF (Figure V-10). 
For a buffer system containing 20 mM histidine at pH 5.5 a steady decrease in his-
tidine concentration was observed with increasing protein concentration. At a protein con-
centration > 200 mg/ml the histidine concentration decreased to < 10 mM. 
If the pH was increased to 7.4, the loss of histidine during UF processing was reduced 
as expected. The mAb exhibits positive charge to a lesser extent than at a lower pH and 
histidine remains as an externally uncharged zwitterion at the pH above 6.0. Therefore, at 
a protein concentration of around 200 mg/ml the histidine concentration was nearly unal-
tered, decreasing only slightly from 19.2 ± 1.6 mM to 17.2 ± 0.21 mM histidine since the 
protein and the histidine molecule exhibit residual positive charge. Compared to the results 
of a histidine buffer system at pH 5 (Figure V-6) and pH 7.4 (Figure V-9) it is obvious that 
the pH increases only if protonated histidine is lost with increasing protein concentration 
during UF. 
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Figure V-10: Molar concentration of the diffusible solutes in the retentate during UF up 
to about 200 mg/ml IgG X concentration 
The buffers were based on 20 mM histidine at pH 5.5 (black diamonds), 20 mM 
histidine at pH 7.4 (plain diamonds), 20 mM acetate at pH 5.5 (black triangles) 
and 45 mM acetate at pH 5.0 (plain triangles); experimental data is presented as 
mean values of three measurements ± SD. 
When a 20 mM acetate based buffer at pH 5.5 was used, acetate was accumulated in the 
retentate during UF operations as expected by the Donnan-effect. Compared to the ace-
tate molarity present in the solution before UF, the concentrated mAb at about 
190 mg/ml showed an about 2-fold higher molarity of acetate. Therefore, conductivity 
decreased with increasing acetate molarity on the retentate side due to the accumulation of 
oppositely charged species which was shown for two different concentrations of acetate 
(Figure V-7). 
The described results fit into the explanations presented above considering the pH 
and the conductivity characteristics during UF concentration processing using an acetate 
or histidine buffered system. During the UF concentration process of the mAb in two 
defined buffer systems ensuring stability of the API, a significant accumulation in the case 
of acetate, and a significant loss in the case of histidine was observed. The concentration 
of acetate nearly doubled and the concentration of histidine was reduced by half at a pro-
tein concentration of about 200 mg/ml. Both induced changes in conductivity and pH 
during the concentration process. Figure V-11 summarizes the effects. 
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Figure V-11: Loss of histidine and accumulation of acetate during UF of IgG X 
Molar concentration of histidine (black bars) and acetate (white bars) at 
15 mg/ml and 200 mg/ml protein concentration (A); pH (squares) and conduc-
tivity (triangles) of solutions containing 20 mM histidine (black symbols) or 
20 mM acetate (plain symbols) before the UF concentration starts (B); experi-
mental data is presented as mean values of three measurements ± SD. 
3.1.3 Protein-solute interactions during UF: The Donnan-model 
The Donnan-equation describes the partitioning of the completely diffusible ion compo-
nent of a totally dissociated electrolyte over the semi permeable membrane (Tanford 
1967). Therefore, the solute concentration in the retentate was determined during UF ex-
periments and compared to the theoretical values calculated by using the following Equa-
tions taken from Tanford (1967): 
2
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 Equation V-7 
Equation V-7 describes the molar concentration in the retentate of positively charged sol-
utes (S + ) being able to pass through the membrane. S+ depends on the charge of the pro-
tein (z), the molar concentration (P) and the molecular weight (Mp ) of the protein as well 
as on the density of the solution in the retentate (ρ) and the permeate (ρ′ ). S′ is the theo-
retical molar concentration of the diffusible solute. Equation V-8 describes the molar con-
centration in the retentate of negatively charged solutes (S - ) being able to pass through 
the membrane. 
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 Equation V-8 
During the UF concentration process of IgG X in different buffer systems at pH 5.5, the 
concentration of positively and negatively charged buffer ions was determined. Since the 
protein is mainly positively charged at this pH, two cationic and two anionic solutes were 
used to characterize the displacement and the accumulation respectively in the retentate. 
Acetate and histidine at 20 mM were chosen as well as a buffer system containing sodium 
chloride. Sodium chloride was used since this salt is fully dissociated in aqueous solutions, 
providing cationic and anionic species independent of pH. 
To test in particular the influence of the specific charge on the residual solute concen-
tration, an alternative form of Equation V-7 and V-8 was used (Tanford 1967): 
)
1000
(
´
´ PMPSS −= ρ
ρ
 Equation V-9 
Here, protein and solute charge (z) were set to zero. The molar concentration of the solute 
(S) in the retentate being able to pass through the membrane depends only on the density 
of the retentate (ρ) and the permeate (ρ′ ) as well as on the molar concentration of the pro-
tein and the solute. 
Moreover, experimental values were compared to a volume exclusion model assum-
ing that the protein molecules occupy a significant volume in solution at high concentra-
tions. During UF concentration the volume being available in the retentate is reduced for 
small solutes and solvents leading to unequal partitioning of small solutes on both sides of 
the semi permeable membrane (Stoner et al. 2004; Tanford 1967): 
)1(' PPSS υ−=  Equation V-10 
In this case the molar concentration of the solute (S) in the retentate is a linear function of 
the protein concentration (P), the molar concentration of the diffusible solute in the perme-
ate (S′ ) and the protein partial specific volume (υP). A value of 0.75 ml/g was used as protein 
partial specific volume, since mostly values between 0.7 and 0.8 ml/g are reported for differ-
ent proteins including IgGs (Kratky et al. 1973; Lee and Timasheff 1974). 
Figure V-12 shows the theoretical and experimental results of the molar concentra-
tion of histidine, sodium, acetate and chloride in the retentate during UF up to 200 mg/ml 
IgG X concentration. 
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Figure V-12: Theoretical and experimental results of the molar concentration of his-
tidine (A), sodium (B), acetate (C) and chloride (D) in the retentate during 
UF up to about 200 mg/ml IgG X concentration at pH 5.5 
Experimental data is presented as mean values of three measurements ± SD. 
For a buffer system containing 20 mM histidine a steady decrease in histidine concentration 
was observed with increasing protein concentration (Figure V-12A). It is obvious that the 
Donnan-equation is the most suitable model to adequately reflect the experimental data 
compared to the two other models. Since the Donnan-equation is the only model consider-
ing the protein charge, charge-charge interactions are considered to be the root cause of 
thermodynamic non-ideality during UF of the IgG in histidine buffer at pH 5.5. 
By adding 150 mM sodium chloride to the mAb solution in a 5 mM histidine based 
buffer system, the molar concentration of sodium as a cation decreases as expected by the 
Donnan-equation (Figure V-12B). It has to be noted that under conditions of higher total 
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diffusible ion concentration, the Donnan-effect is suppressed. Equation V-5 shows that if 
total diffusible cation concentration is higher than the concentration of positively charged 
protein present in the retentate, the ratio between diffusible cationic solutes in the retentate 
and the permeate is 1 and therefore the solute concentration on both sides is equal. In our 
case the molar protein concentration is low compared to the sodium chloride molarity. This 
is due to the high molecular weight of 150 kDa of an IgG. The molar concentration of the 
IgG increased only from 0.1 mM to 1.2 mM during UF compared to a sodium chloride mo-
larity of 150 mM. Thus, the Donnan-effect becomes more significant at low ionic strength 
and at high protein charge and concentration. Therefore, the two models which do not con-
sider the protein charge gain in accuracy when 150 mM sodium chloride are added. 
When a 20 mM acetate based buffer is used, acetate is accumulated in the retentate 
during UF operations as discussed before (Figure V-12C). At a pH of 5.5 acetate is present 
as both the anion and the acetic acid. It was determined that around 18 % of total acetate 
concentration [Ac - ] in the retentate is present as acetic acid [HAc] at a pH at 5.5 by using 
the Henderson-Hasselbalch equation (Harris 1995): 
[ ]
[ ]HAc
Ac
pkpH A
−
+= log  Equation V-11 
At a pH of 5.9 in the retentate which is the pH at 200 mg/ml protein concentration 7 % 
of acetic acid are present. Due to the increasing pH during the UF process the percentage 
of acetate increases and more acetate will actually be lost than calculated by using the 
Donnan-equation without considering the pH. Therefore, the theoretical diffusible solute 
concentration S′ was corrected by using a factor considering the pH. The ratio between 
acetate and acetic acid was calculated at every pH measured in the retentate (see Figure 
V-7A) by using Equation V-11. The relative increase at every pH was used as the correc-
tion factor. Figure V-12C shows that by using the corrected values for S′ (Donnan cor-
rected, grey line) the Donnan-equation adequately reflects the experimentally determined 
values for the molar concentration of acetate in the retentate during UF. 
By adding 20 mM sodium chloride to a 5 mM acetate based solution, chloride was ac-
cumulated during UF (Figure V-12D). The molar solute concentration for histidine, so-
dium and acetate were approximated by inserting the actual charge value of +9 mV of 
IgG X at a pH of 5.5 in Equation V-7 and Equation V-8 respectively. Generally, the over-
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all protein charge was determined by zeta potential measurements. Figure V-13 shows the 
zeta potential characteristics depending on pH for three different IgGs. 
Figure V-13: Zeta potential titration curves of IgG X, IgG A and IgG Z 
Experimental data is presented as mean values of three measurements ± SD. 
In the case of chloride, the Donnan-effect approximation was not able to adequately re-
flect the experimentally determined molar concentrations of chloride during UF (Figure 
V-12D, Donnan, black line). Therefore, the determined charge was replaced in Equa-
tion V-8 by using the best fit charge of +18 mV (Figure V-12D, Donnan corrected, grey 
line), resulting in a representative approximation of the experimental values. Compared to 
the two other calculations neglecting the protein net charge, the corrected Donnan-
equation is the only model to adequately reflect the experimental data. 
Considering the results of histidine, sodium and acetate it is shown that a special em-
phasis is on the protein net charge since in all cases the volume exclusion model as well as 
the Donnan-model without considering protein charge (z = 0) are always inferior to display 
the experimental values. There are several possibilities to determine the protein valence de-
pending on pH. Beside a calculation based on protein sequence, by combining the average 
pkA values of all acidic and basic amino acid side chains, the experimental determination 
based on electrophoretic mobility is well known. Zeta potential measurement (Faude et al. 
2007; Salinas et al. 2009) or isoelectric gel- and capillary electrophoresis (Winzor et al. 2004) 
are used. Since the protein valence depends not solely upon pH but also on the composition 
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of the buffer electrolytes, there is no reasonable alternative available to determine the actual 
charge of the protein. Due to that, the discrepancy between the actual values and the deter-
mined values of the molar solute concentration by using the Donnan-equation is particularly 
caused by the low precision in actual protein valence determination. 
The importance of protein valence considering the Donnan-effect is underlined when 
the pH of the solution is adjusted more closely to the IP of the IgG. The Donnan-effect is 
then reduced and therefore the two other models which do not consider the charge gain in 
accuracy. This is shown in Figure V-14A for IgG Z in a histidine based buffer system at a 
pH of 7.4. In general, a pH more closely to the IP of the protein can be attributed to a sup-
pression of the Donnan-effect (Figure V-14B). The z-values were taken from Figure V-13 
(+3 mV at a pH of 7.4, +9 mV at pH 5.0 and +20 mV at pH 3.0 for IgG Z). 
Figure V-14: Experimental and theoretical results of the molar concentration of his-
tidine in the retentate during UF up to 200 mg/ml protein concentration 
IgG Z at pH 7.4, figure description is equal to Figure IV-12 (A), IgG Z at pH 7.4 
(black symbols), pH 5.0 (plain symbols) and pH 3.5 (grey symbols), symbols refer 
to the experimental data and the lines to the approximation using the Donnan-
equation (Equation V-7). 
Summarized, the experimentally determined quantities of two displaced cationic and two 
accumulated anionic diffusible solutes during the UF concentration process of two mAbs 
were compared to the calculated values using different model equations. During the UF of 
the two mAbs the Donnan-equation adequately reflects the experimental observations. 
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3.2 Prediction of the solute concentration during UF  
It was shown that unequal partitioning of small solutes during mAb diafiltration and concen-
tration operations can result in solute concentrations, pH- and conductivity values which are 
significantly different from those of the diafiltration buffer. Since this can potentially influence 
stability of the mAb and may result in deviations during DSP and final formulation, the accu-
rate solute concentration should be present in the concentrated bulk material. 
3.2.1 Application of the Donnan-equation 
The Donnan-equation adequately reflects the displacement of histidine during UF concentra-
tion up to 200 mg/ml. Therefore, Equation V-7 was considered suitable to calculate the molar 
concentration of the diffusible solut (S′ ) which has to be present before starting the UF.  
Figure V-15: Histidine molarities required before UF of IgG X to achieve 20 mM (dia-
monds) or 46 mM (triangles) histidine at a defined protein concentration 
At pH 3.0 z = +17.8 mV (black), pH 5.5 z = +9 mV (grey), pH 7.0 z = +4 mV 
(white) and pH 9.0 z = 0 mV (light grey). 
Figure V-15 pictures the required histidine molarity exemplarily which has to be available 
before starting the UF of the IgG X solution to end up with 20 mM or 46 mM histidine at 
different protein concentrations and pHs. The z-values at a given pH were taken from the 
zeta potential titration curves (Figure V-13). The required solute molarity to achieve 
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20 mM and 46 mM histidine at a protein concentration of 200 g/ml (pH of 5.5) was de-
termined to 29 mM and 60 mM.  
This was controlled experimentally by comparing UF runs conducted at 20 mM and 
46 mM histidine, as well as at 29 mM and 60 mM histidine initially present. The histidine 
concentration was monitored during the UF concentration up to 200 mg/ml. 
Moreover, the solute molarity required to achieve 20 mM histidine at 200 mg/ml pro-
tein concentration was calculated for IgG Z at pH 5.0. Here, a bulk having initially 31 mM 
histidine present is theoretically required (z = +11 mV). 
The histidine concentration is quantitatively reflected by the Donnan-equation at any 
time during UF which was expected and reported before (Figure V-16). 
Figure V-16: Molar concentration of histidine during UF concentration operations 
For IgG Z at pH 5.0 having 20 mM histidine (black diamonds) and 31 mM his-
tidine initially present before UF (plain diamonds) (A) and for IgG X at pH 5.5 
having 20 mM histidine (black diamonds), 29 mM histidine (unfilled diamonds) 
and 60 mM histidine (grey diamonds) initially present before UF (B); 
mean values of three measurements are presented with error bars ± SD; 
the lines represent the values theoretically predicted by using the Donnan-
equation (Equation V-7). 
The IgG Z solution at 200 mg/ml protein concentration showed only 11.6 ± 0.5 mM his-
tidine when 20.4 ± 0.4 mM histidine were present before starting the UF. In comparison, 
18.6 ± 0.5 mM histidine at 200 mg/ml protein concentration were found in the concen-
trates when 30.3 ± 0.7 mM histidine were initially present (Figure V-17A). The same was 
obvious for IgG X. By using the buffer system with the calculated higher solute concentra-
tion of 29 mM a concentration of 19 mM after UF was achieved (Figure V-17B). 47 mM 
histidine were found when 60 mM histidine were applied before starting the UF. 
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Figure V-17: Molar concentration of histidine before (at 15 mg/ml protein concentra-
tion) and after UF (at 200 mg/ml protein concentration) 
For IgG Z pH 5.0 (A) and IgG X pH 5.5 (B); mean values of three measurements 
are presented with error bars ± SD. 
In summary, the calculated higher histidine molarity before starting the UF concentration 
process can be predicted using the Donnan-equation resulting in the intended molarities of 
histidine in the concentrated bulks. 
3.2.2 Consequences for pH and deamidation 
The pH was stable during and after the UF when the predicted higher histidine molarity 
was applied before starting the UF concentration process. 
Figure V-18 shows the pH during UF concentration of IgG X containing 20 mM and 
29 mM histidine before processing. At a protein concentration of 200 mg/ml the pH was 
shifted from pH 5.4 to pH 5.8, if the histidine concentration was not increased to 29 mM 
histidine before starting the UF experiments. If the histidine concentration was increased 
to 29 mM, the pH was more stable during UF processing. The stable pH values can be 
potentially attributed to a lower buffer capacity at a lower buffer solute concentration. The 
buffer capacity describes the amount of acid or base needed to change the pH ± 1 (Harris 
1995). At a higher concentration of the buffer component the capacity increases making 
the solution more resistant against pH changes. 
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Figure V-18: pH during UF concentration of IgG X from 15 to 200 mg/ml 
Solutions containing 20 mM histidine at pH 5.5 (black squares) and solutions 
containing 29 mM histidine at pH 5.5 (unfilled squares) before UF; mean values 
of three measurements are presented with error bars ± SD. 
The pH of the solution is known to be important for protein stability. The side chain am-
ide linkage in a glutamine or asparagine residue can be hydrolyzed to form a free carbox-
ylic acid (Manning et al. 1989b). This deamidation is accelerated at more neutral or alkaline 
conditions and at increased temperature (Robinson and Rudd 1974; Robinson et al. 1973; 
Zheng and Janis 2006). 
The introduced unfavorable negative charge in the deamidated molecule can cause 
structurally and biologically alterations encompassing a decrease in bioactivity, as well as 
alterations in pharmacokinetics (Huang et al. 2005). Particularly, the deamidation within 
the heavy or light chain of the Fab is of importance since the variable binding region can 
be affected (Tsai et al. 1993). Therefore, the effect of the histidine concentration and thus 
pH during UF on the deamidation of the Fabs was investigated by using analytical CEX 
chromatography after papain digestion. Papain is a thiol protease that cleaves IgG mole-
cules at the heavy chain hinge region into one Fc and two identical Fab fragments (Smyth 
and Utsumi 1967). The digestion is useful to resolve inherent charge heterogeneity associ-
ated either with the Fab or the Fc fragment (Moorhouse et al. 1997). Figure V-19 shows 
the sum of deamidated Fab fragments for IgG X at 50 mg/ml and 200 mg/ml during stor-
age at 40 °C. 
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Figure V-19: Sum of deamidated Fab fragments of IgG X at 50 mg/ml (striped bars) 
and 200 mg/ml (solid bars) after UF and storage at 40 °C for 8 weeks 
Samples containing 20 mM histidine (grey) and samples containing about 10 mM his-
tidine (black) after UF; samples containing 15 mg/ml protein and 20 mM histidine 
are displayed as white bars; mean values of two measurements are presented ± SD. 
In general, an increase in deamidated Fab fragments was observed for all samples during 
storage. Samples containing 20 mM histidine showed comparable values, independent of 
their protein concentration. At 50 and 200 mg/ml protein concentration, deamidation 
increased during storage over 8 weeks when only 10 mM histidine were present. During 
storage, an increase in deamidated Fab fragments of about 10 % was observed in relation 
to solutions having a higher amount of histidine present.  
Since it was shown that the pH of the concentrated samples was increased when only 
10 mM histidine were present in the solutions, it was assumed that the increased pH con-
tributes to deamidation as well. Therefore, the pH of the samples at 50 mg/ml and 
200 mg/ml protein concentration containing only 10 mM histidine were adjusted to 
pH 5.5 by using hydrochloric acid. Deamidation of the Fab fragments was monitored 
again over four weeks and the results at pH 5.5 were compared to those obtained before 
(Figure V-20). Again, an increase in deamidated Fab fragments of all samples was observed 
during storage. After two weeks a reduction of deamidated Fabs in the concentrated solu-
tions containing 10 mM histidine at the lower pH was observed. After four weeks, all 
samples showed comparable results independent of pH. Therefore, it was concluded that 
both the pH and the histidine concentration have influence on the deamidation level of 
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the IgG. In summary, both concentrates at 50 mg/ml as well as at 200 mg/ml showed a 
higher level of deamidated Fab fragments during storage when the histidine concentration 
was not increased in the Donnan-manner before UF. 
Figure V-20: Sum of deamidated Fab fragments of IgG X at 50 mg/ml (grey) and 
200 mg/ml (black) after UF and storage at 40 °C for 4 weeks 
All samples contain 10 mM histidine after UF; the samples had a pH of 5.8 
(striped bars) and 5.5 (dotted bars); mean values of two measurements are pre-
sented ± SD. 
3.2.3 Robustness of the Donnan-model 
In order to confirm that the Donnan-model adequately reflects the experimental values 
concerning the loss of histidine during UF concentration, different membrane materials, 
UF systems and operational parameters were tested (Table V-1). 
 
Histidine concentration 
[mM] 
pH UF membrane 
material - pore size 
UF system ∆p 
[bar] 
20 5.0 RC  - 30 kDa stirred cell 2.0 
20 5.0 RC  - 30 kDa ÄKTAcrossflow TFF 0.8 
20 5.0 RC  - 30 kDa ÄKTAcrossflow TFF 1.5 
20 5.0 PES  - 30 kDa ÄKTAcrossflow TFF 1.5 
Table V-1: Process conditions in confirmative experiments 
Different UF systems, membranes and operational conditions were tested. 
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Different membrane materials are known to adsorb protein and solutes on the surface. 
Especially PES is known to adsorb protein to a higher extent than RC, due to enhanced 
hydrophobicity as reported in chapter I. Solutes can interplay with the membrane surface 
based on charge-charge interactions (Nystroem et al. 1989). As a consequence, the out-
come of the Donnan-effect concerning the solute molarity in the concentrates can be po-
tentially influenced by the choice of the membrane material. 
Moreover, the UF system used as well as the operational parameters can influence the 
flow characteristics. Therefore, the solute molarity in the retentate during UF processes 
can be potentially affected. For lab-scale experiments, NFF as an orthogonal principle to 
TFF is used by applying stirred cells, operated under inert gas atmosphere. Here, the solute 
is forced to pass through the membrane by using pressurized gas up to 4 bar and a stirring 
procedure. The latter helps in addition to remove the deposited protein from the mem-
brane surface. This can cause aggregation due to enlarged liquid-gas interface, resulting in 
pore narrowing, blockage and enhanced deposition of protein which can potentially influ-
ence the properties of the membrane. 
Figure V-21: Confirmation of the Donnan-model during UF concentration of IgG Z in 
20 mM histidine buffer at pH 5.0 by applying different UF systems, mem-
branes and operational conditions as described in Table V-1 
Donnan fit (black line), experimental data from stirred cell experiment (grey tri-
angles) and TFF experiments applying a RC membrane (unfilled triangles), a PES 
membrane (black triangles), a ∆p of 0.8 bar (unfilled squares). 
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Figure V-21 shows the molar solute concentration of histidine during the UF experiments 
as described in Table V-1. Independent of the applied UF system, membrane material or 
operational conditions applied, the experimental data concerning the histidine molarity 
during UF is adequately reflected by using the Donnan-equation as described before. 
3.3 Evaluation of different approaches to achieve predefined 
solute concentrations in highly concentrated mAb solutions 
In general, different approaches are possible to end up with the predefined solute concentra-
tion and thus pH in the highly concentrated end product. On the one hand the Donnan-
equation can be used to predict the solute molarity needed, as shown before. On the other 
hand the UF process can be conducted at a pH more closely to the IP of the protein, since 
the Donnan-effect is suppressed as shown in Figure V-14B. In this case, the pH has to be 
readjusted after UF processing. In addition, the histidine molarity and the pH can generally 
be adjusted in the concentrated solutions after UF. All three approaches were tested con-
cerning the physical stability of the mAb. Aggregation was examined during the UF concen-
tration process and after readjustment of the pH by using different analytical techniques. 
Moreover, the stability of the concentrated API during storage was evaluated depending on 
the molar concentration of histidine and the protein concentration in the bulk. 
3.3.1 Effect on stability during UF processing 
IgG Z at a concentration of 20 mg/ml was ultrafiltrated up to 200 mg/ml. Buffer systems 
based on histidine were applied. On the one hand, experiments were conducted in a 
31 mM histidine buffer pH 5.0. On the other hand UF was performed in a 20 mM his-
tidine buffer at pH 7.4. Results were compared to experiments conducted in a buffer sys-
tem containing 20 mM histidine at pH 5.0. 
Figure V-22 shows the results for LO (A) and turbidity measurements at 350 nm (B). 
It was observed that the particle formation during UF was enhanced at pH 7.4. In the 
course of UF particles larger 1 µm were formed up to a number of 8x106 and the turbidity 
increased from 0.1 to 1.6 AU. The formation of particles and the turbidity were clearly 
reduced at pH 5.0. The higher turbidity and the higher number of particles at pH 7.4 can 
be attributed to the reduced electrostatic repulsion between the protein molecules enhanc-
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ing self-association, since the pH is closer to the IP of the IgG Z which was determined to 
be around 8 (Figure V-8 and Figure V-13). 
Figure V-22: Particles per ml larger 1 µm (A) and turbidity at 350 nm (B) during UF 
concentration of IgG Z 
In 20 mM histidine pH 5.0 (black), in 20 mM histidine pH 7.4 (light grey) and in 
31 mM histidine pH 5.0 (dark grey); results are presented as mean values of three 
measurements ± SD. 
The massive formation of proteinaceous particles in the retentate at pH 7.4 was clearly 
visible during and after UF processing. Figure V-23 shows a picture of the concentrated 
solutions at 200 mg/ml directly after processing. 
 
Figure V-23: Visual inspection of the concentrated IgG Z after UF (200 mg/ml) 
In 20 mM histidine pH 5.0 (left), in 31 mM histidine pH 5.0 (middle) and in 
20 mM histidine pH 7.4 (right). 
At a pH equal to the IP of the protein, the overall charge of the protein is nearly zero re-
sulting in a more compact packing of the molecules on the UF membrane than under elec-
trostatic repulsion (Nakatsuka and Michaels 1992). Therefore, the permeate flux at pH 7.4 
was significantly reduced during processing compared to the experiments conducted at 
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pH 5.0. Figure V-24 visualizes the permeate flux during UF experiments at pH 7.4 and 
pH 5.0. Moreover, the process time was more than doubled, increasing from 120 min to 
300 min when a pH of 7.4 was adjusted before the UF started. It was observed that the addi-
tion of histidine up to 31 mM did not result in any changes concerning permeate flux or 
process time compared to experiments conducted in 20 mM histidine at pH 5.0. 
Figure V-24: Permeate flux (J) versus concentration of IgG Z during UF 
In 20 mM histidine pH 5.0 (black), in 31 mM histidine pH 5.0 (dark grey) and in 
20 mM histidine pH 7.4 (light grey); results are presented as mean values of three 
UF runs ± SD. 
After UF, the concentrates were readjusted to a pH of 5.0 by adding 0.5 M hydrochloric acid 
(HCl). This was only necessary for the solutions which were concentrated at pH 7.4 as well as 
for the solutions processed at 20 mM histidine pH 5.0 due to the pH shift. 
 
Starting conditions pH before UF pH after UF pH end product 
20 mM histidine pH 5.0 4.97 ± 0.04 5.40 ± 0.06 4.90 ± 0.14 
31 mM histidine pH 5.0 5.07 ± 0.04  5.20 ± 0.05 5.20 ± 0.05* 
20 mM histidine pH 7.4 7.37 ± 0.06 7.47 ± 0.05 4.81 ± 0.22 
 
* No pH adjustment was done (pH after UF = pH end product) 
Table V-2: pH before UF, after UF and for the end-product after readjustment 
0.5 M hydrochloric acid was taken to readjust the end product to pH 5; mean 
values of three measurements are presented ± SD. 
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The experiments conducted at 31 mM histidine pH 5.0 did not show a pH shift as re-
ported before. Table V-2 summarizes the pH values before UF, after UF and after read-
justment to pH 5.0. 
Particle measurements, turbidity at 350 nm and SE-HPLC were performed to moni-
tor the induction of aggregates due to the addition of hydrochloric acid.  
Figure V-25 shows the results for the IgG solutions before UF, after UF and for the 
pH adjusted end products by using 0.5 M hydrochloric acid. 
Figure V-25: Aggregation of IgG Z before UF, after UF and in the final end product 
after pH readjustment using 0.5 M hydrochloric acid: 20 mM histidine 
pH 5.0 (black), 31 mM histidine pH 5.0 (dark grey) and 20 mM histidine 
pH 7.4 (light grey) 
Particles per ml larger 1 µm (bars), turbidity at 350 nm (triangles) (A) and percent-
age of HMWs (B); mean values of three measurements are presented ± SD. 
For the pH adjusted end product an induction of particles larger 1 µm and an increase in 
turbidity were observed for the solutions concentrated in 20 mM histidine at pH 5.0 (Figure 
V-25A). A slight induction of HMWs from 2.23 % to 2.71 % was recognized (Figure 
V-25B). For the solution containing 31 mM histidine at pH 5.0 before UF, the number of 
particles per ml larger than 1 µm, the turbidity values and the percentage of HMWs re-
mained constant since no hydrochloric acid was needed due to an unaltered pH during UF. 
The solutions concentrated at a pH more closely to the IP of the protein showed a highly 
increased number of particles directly after UF, since colloidal stability is compromized un-
der these conditions as explained before. In addition, a decreased level of HMWs directly 
after UF processing was recognized. However, after readjusting the pH from 7.4 to pH 5.0 
the percentage in HMWs stepped up from 0.74 % to 17.15 % by using 0.5 M HCl. Con-
comitantly, the number of particles larger 1 µm and the turbidity values decreased. Due to 
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the lower pH the electrostatic repulsion between the protein molecules increases resulting in 
a dissociation of the reversible large aggregate particles. Nevertheless, the number of parti-
cles and the turbidity values remained much higher compared to the two other end products. 
Due to the massive induction of HMWs by adding 0.5 M HCl to the concentrates after 
UF at pH 7.4, the pH readjustment was conducted using 0.02 M and 0.1 M HCl. It was ex-
pected that the addition of a lower molar acid concentration results in reduced aggregation, 
since the local concentration of acid is much lower. Figure V-26 shows the results referring 
to the induction of oligomers and dimers as well as the sum of HMWs induced by adding 
HCl of different molar concentrations. 
Figure V-26: Percentage of aggregated species of IgG Z and the dilution factor resulting 
from the addition of 0.02-0.5 M hydrochloric acid (HCl) 
IgG Z at 200 mg/ml in 20 mM histidine pH 7.4 after pH correction to pH 5.0 
with 0.02-0.5 M HCl; mean values of three measurements are presented ± SD. 
It was observed that the percentage of dimers as well as of oligomers increases with the 
molar concentration of the hydrochloric acid added. This was prevented by using the 
0.02 M HCl. However, the addition of a diluted HCl resulted in a massive dilution of the 
concentrated protein bulk ending up with about a third in protein concentration after pH 
readjustment. This is in direct opposite to the intention of the UF process to provide 
highly concentrated immunoglobulin solutions. 
Summarized, the add-on of histidine to 31 mM is the approach of choice to circumvent 
the induction of aggregates since no addition of acid is necessary after UF due to stable pH 
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conditions during the concentration process. Further, this strategy is the only way to provide 
the predefined histidine concentration and pH values in the concentrated bulk without a 
readjusting procedure which is accompanied by a dilution of the concentrates. 
3.3.2 Effect on stability during storage 
With the systematic add-on to 29 mM histidine before UF the desired 20 mM histidine at 
200 mg/ml protein concentration was achieved in the case of IgG X. If the Donnan-effect 
is not considered during UF operations the concentrated solutions at 200 mg/ml had only 
7.4 ± 1.6 mM histidine remaining as reported before (Figure V-16B). 
To evaluate the impact of histidine concentration on storage stability of concentrated 
solutions after UF, stability was investigated at 10 and 20 mM histidine concentration. 
Protein concentrations of 15, 50 and 200 mg/ml were applied. Accelerated storage at 
40 °C over 8 weeks and real time studies were conducted at 2-8 °C (4 °C) and -70 °C over 
6 months. Table V-3 provides an overview of the experiments including the analytical 
methods used to investigate the stability of IgG X.  
  
IgG X [mg/ml] Histidine [mM] Sample description Analytical methods 
15 20   15/20 mM 
50 20   50/20 mM 
200 20 200/20 mM 
50 10   50/10 mM 
200 10 200/10 mM 
SE-HPLC, LO, UV 350 nm, DLS 
 
 
2D UV, ATR FT-IR 
Table V-3: Overview of experiments addressing the storage stability at 40 °C over 
8 weeks and at 2-8 °C and -70 °C over 6 months 
 
The formation of soluble HMWs during accelerated stability studies depends on both, 
protein concentration and histidine molarity (Figure V-27A). A slight increase in HMWs at 
50 mg/ml protein concentration was recognized compared to the 15 mg/ml samples at 
comparable histidine concentrations (20 mM). At 200 mg/ml the samples showed a sig-
nificant increase in soluble aggregates during storage compared to the 15 mg/ml and 
50 mg/ml samples at comparable histidine concentrations (20 mM). 
The addition of histidine revealed no effect concerning the formation of aggregates at 
50 mg/ml protein concentration. At a protein concentration of 200 mg/ml the solutions 
3 Results and discussion 
147 
containing 20 mM showed a significantly lower level of HMWs compared to the solutions 
containing only 10 mM histidine. A difference in the HMW level of 1.8 % after 8 weeks 
was recognized. During real time storage a slight increase in soluble aggregates was recog-
nized depending on the protein concentration (Figure V-27B). 
Figure V-27: Formation of soluble aggregates during storage of IgG X solutions deter-
mined by SE-HPLC 
At 40 °C over 8 weeks (A) and at 2-8 °C and -70 °C over 6 months (B). 
Again, at 200 mg/ml a higher level of HMWs was observed compared to the solutions at 
15 mg/ml and 50 mg/ml protein concentration. The increase in histidine from 10 mM to 
20 mM reduces the formation of HMWs only slightly. After 6 months at -70 °C the samples 
containing a higher molarity of histidine showed 1.8 % HMWs compared to the samples con-
taining only 10 mM, having 2.6 % HMWs. After 6 months at 4 °C, the samples containing 
20 mM histidine showed 1.8 % HMWs compared to the samples containing only 10 mM, 
having 2.2 % HMWs. 
Regarding the formation of particles, it was observed that a higher protein concentra-
tion leads to a higher number of particles during storage at 40 °C and 4 °C (Figure V-28A 
and B). The addition of histidine leads to a reduction in the number of particles larger 
1 µm only at a protein concentration of 200 mg/ml during accelerated as well as real time 
stability studies. 
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Figure V-28: Formation of particles per ml larger than 1 µm during storage of IgG X 
solutions determined by SE-HPLC 
At 40 °C over 8 weeks (A) and at 4 °C and -70 °C over 6 months (B); mean val-
ues of three measurements are presented ± SD. 
As regards turbidity, measured at 350 nm it was observed that a higher protein concentration 
leads to higher turbidity values (Figure V-29). 
Figure V-29: Turbidity at 350 nm during storage of IgG X solutions 
At 40 °C over 8 weeks (A) and at 4 °C and -70 °C over 6 months (B); mean val-
ues of three measurements are presented ± SD. 
In general, a higher molecular density and higher number of particles result in an increase in 
UV absorbance at all wave lengths due to scattering effects (Eberlein et al. 1994). The addi-
tion of histidine at 50 mg/ml and 200 mg/ml protein concentration did not result in a de-
crease in turbidity. The samples at 200 mg/ml protein concentration showed only a neglect-
able decrease in turbidity at 350 nm when the histidine concentration was increased from 
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10 mM to 20 mM. This was found during accelerated stability as well as during real time 
studies. 
Proteins are known to be more susceptible to aggregation in the more extensively un-
folded intermediate state or the completely unfolded state, since hydrophobic residues are 
presented to the aqueous environment as reported in chapter I. Since it was recognized 
that IgG X was more prone to aggregation depending on protein concentration and his-
tidine molarity at pH 5.5, conformational stability was investigated. Therefore, FT-IR and 
2D-UV analysis were performed to examine secondary and tertiary structure respectively. 
ATR FT-IR was used to determine the melting temperature (Tm) at 5, 50 or 
200 mg/ml protein concentration and 10 mM or 20 mM histidine molarity according to 
Table V-3. Conformational changes in secondary structure were recognized by a tempera-
ture induced band at 1621 cm-1 and a concomitantly diminished band at 1637 cm-1. A weak 
intensity peak at and 1690 cm-1 was detected as well with increased temperature. Figure 
V-30A shows the second derivative spectra of the tempered solution containing 50 mg/ml 
protein and 10 mM histidine exemplarily. 
Figure V-30: The 50g/ml IgG X solution containing 10 mM histidine was heated from 
25 to 90 °C 
Arrows mark the direction of the spectral changes of the bands at 1637 cm-1, 
1621 cm-1 and 1690 cm-1 in the ATR FT-IR second derivative spectra during heating 
from 25 (black) to 90 °C (grey) (A) and changes in the intensity in the second deriva-
tive spectra at 1637 cm-1 (black) and 1621 cm-1 (grey) during heating (B). 
Tm was determined based on direct plots of the intensity values of the decreasing native band 
at 1637 cm-1 and the increasing temperature induced band at 1621 cm-1 as the midpoint of 
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the thermal transition. Figure V-30B shows the changes in intensity of the two bands for the 
sample at 50 mg/ml protein concentration containing 10 mM histidine exemplarily.  
Table V-4 summarizes the values for Tm. As described in chapter IV, three different 
approaches were applied to identify Tm using the inflection point as well as the intersection 
of the intensity curves of the second derivative ATR spectra. No significant differences for 
Tm were observed depending on protein concentration or histidine molarity. A value of 
about 80 °C was determined for IgG X at pH 5.5 up to a protein concentration of 
200 mg/ml in the presence of 10 and 20 mM histidine. 
 
Tm (FT-IR) [°C] 
Inflection point using sigmoid fit 
(Bolzmann equation) 
Protein 
concentration 
[mg/ml] 
Histidine 
molarity 
[mM] 
Sample 
Increasing band 
at 1637 cm-1 
Decreasing band 
at 1621 cm-1 
Intersection 
of in- and 
decreasing 
band  
  15 mg/ml 20 mM   15/ 20 mM 80.3 ± 0.1 80.2 ± 0.2 80.0 
  50 mg/ml 20 mM   50/ 20 mM 79.9 ± 0.2 79.6 ± 0.2 78.8 
200 mg/ml 20 mM 200/ 20 mM 80.2 ± 0.2 80.1 ± 0.2 79.5 
  50 mg/ml 10 mM   50/ 10 mM 80.3 ± 0.1 80.3 ± 0.1 79.0 
200 mg/ml 10 mM 200/ 10 mM 80.1 ± 0.2 80.1 ± 0.1 79.0  
Table V-4: Denaturation temperature (Tm) for IgG X solutions at 200 mg/ml deter-
mined from ATR FT-IR second derivative spectra by using three different 
interpretation approaches as described in chapter IV 
Results of sigmoid fitting are listed with ± standard error of the non-linear re-
gression.  
Information about tertiary structure was collected by using 2D-UV analysis. The broad 
protein absorbance peak between 240 and 300 nm is composed of overlapping spectra 
arising from the absorbance of phenylalanine (245-270 nm), tyrosine (265-285 nm) and 
tryptophan (265-295 nm) residues (Ichikawa and Terada 1979). Calculating the derivative 
of the absorbance spectrum enhances the resolution and is useful to deconvolute the 
complex multi-spectrum of zero order (Grum et al. 1972; Ichikawa and Terada 1977; 
Lange and Balny 2002). In the second derivative of the spectrum, the absorbance referring 
to the residues is resolved as minima in the region of 245-270 nm for phenylalanine, 265-
285 nm for tyrosine and 265-295 nm for tryptophan. 
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Shifts in the derivative peak positions were shown to arise from changes in the polar-
ity of the local environment of the chromophores with a shift to shorter wave lengths in-
dicating an increase in environment polarity (Mach and Middaugh 1994). This is the case 
when the residues are no longer buried in an apolar region within the protein but located 
on the surface of the more or less unfolded molecule. Moreover, total spectral shifts have 
been observed due to transition from the folded state to the unfolded state (Kueltzo 2005; 
Kueltzo et al. 2003). The peak intensity also provides useful information about protein 
conformation (Ragone et al. 1984). In this study, the second derivative spectrum of the 
IgG X showed a blue shift between 280 and 300 nm when a solution at 15 mg/ml was 
incubated in 4 M guanidine hydrochloride or heated to 80 °C for 10 min. Concomitantly, 
the intensity of the band at 285 nm, 289 nm and 292 nm was decreased compared to un-
treated samples (Figure V-31). 
Figure V-31: 2D-UV spectrum of IgG X at pH 5.5. 
Native solution (black lines), incubated at 80 °C for 10 min (grey dotted lines) 
and incubated in 4 M guanidine hydrochloride for 10 min (grey lines). 
Therefore, the second derivative spectra of the samples at different protein and histidine 
concentrations were monitored at 270-300 nm. Figure V-32 visualizes the 2D-UV spectra 
of the samples directly recorded after UF and stored for 2 and 8 weeks at 40 °C. Under 
accelerated storage conditions no spectral differences were recognized in the 2D-UV spec-
tra, neither after 2 weeks, nor after 8 weeks. Tertiary structure seems to be unaffected at 
pH 5.5 independent from the protein or histidine concentration in the samples. 
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Figure V-32: 2D-UV spectra of IgG X at different protein and histidine concentrations 
(in accordance with Table V-3) during storage 
After UF (A), after 2 weeks at 40 °C (B), after 8 weeks at 40 °C (C); all spectra of 
the different samples almost perfectly overlaid. 
Amino acids as cosolvents are known to increase the conformational stability of the pro-
tein. Therefore, it was actually assumed that the conformational stability should increase 
with increased histidine concentration, since amino acids as cosolvents are known to be 
excluded from the surface of the protein, leading to preferential hydration of the protein 
(Cleland et al. 1993; Timasheff 1993). An increase in surface tension of water is assumed 
to be the root cause of the exclusion mechanism (Arakawa and Timasheff 1983; Timasheff 
1992). As a consequence of the increased surface tension per molecule in the unfolded 
state, the compact native state is thermodynamically favored due to a reduced free energy 
of the system at minimized protein surface. 
Since neither a decrease in Tm, nor changes in tertiary structure were observed with 
decreased histidine concentration, it is assumed that the protein is more prone to native 
self-association at a lower concentration of histidine rather than to aggregation based on 
conformational changes. 
At high protein concentrations the molecules exclude volume to another, based on 
steric- and charge-charge repulsion, resulting in an increase of the total free energy of the 
system (Minton 2000). Since the formed aggregates exclude less volume compared to the 
monomeric molecules, the aggregated species is thermodynamically favored due to a re-
duced surface. This provides a non-specific force for macromolecular compaction and 
association in crowded solutions (Minton 1980; Zimmerman and Minton 1993). 
The tendency to form native aggregates minimizing the protein surface of the system 
was shown to be reduced when the histidine concentration is increased in a concentrated 
protein solution. Due to shielding of attractive charge-charge interactions the volume ex-
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clusion between the IgG molecules is potentially reduced resulting in a decrease of the 
total free energy of the system. Therefore, association is no longer that pronounced in 
order to minimize accessible surface. Alford et al. (2008b) reported an enhanced aggrega-
tion in concentrated rhIL-1ra solutions (200 mg/ml) at low ionic strength presumably due 
to a reduced screening of the attractive interactions. In our study the IgG solutions con-
taining 20 mM histidine showed a two fold higher conductivity than the samples with only 
10 mM histidine (Figure V-33). 
Figure V-33: Conductivity of IgG X solutions at pH 5.5 
Solutions contain 20 mM histidine (black squares) and 10 mM histidine (plain 
squares). 
Alford et al. (2008b) refer to cation-π interactions between monomers as a possible origin 
of attractive interactions that can contribute to aggregate formation (Raibekas et al. 2005; 
Woods 2004). Cation-π interactions can be qualitatively described by an electrostatic 
model, although dispersion forces and polarizability are additionally involved (Dougherty 
1996). The aromatic side chains of the amino acid residues of phenylalanine, tryptophan 
and tyrosine are able to attract cations due to their significant quadrupole moment 
(Bohorquez et al. 2003). While phenylalanine is mostly completely buried in the interior of 
the protein, indolyl and hydroxyphenyl moieties of tryptophan and tyrosine are possibly 
displayed on the surface (Lucas et al. 2006). Thus, these residues are able to interact with a 
cationic solute like histidine reducing attractive interactions between the protein molecules 
and therefore aggregation. It is reported that an IgG was protected against aggregation at a 
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concentration of 100 mg/ml when histidine as a buffering component was applied. Both 
liquid and lyophilized formulations in the presence of mannitol, glycine, glutamic acid and 
polysorbate showed a reduced formation of soluble aggregates when histidine was added 
(Chen et al. 2003). When the concentration of histidine was nearly doubled from 10 to 
25 mM the formation of aggregates was reduced by 50 %. 
In contrast, there are several cases in literature, where aggregation formation was in-
creased with increasing ionic strength. Especially at non isoelectric pH it is reported that 
electrostatic repulsion is reduced due to increasing salt concentration leading to aggrega-
tion. This was shown to be the root cause for aggregation of an IgG revealing an enhanced 
self-association at high ionic strength (Moore et al. 1999). 
3.4 Effect of solute concentration on the viscosity of 
concentrated mAb solutions 
It is known that the viscosity of a macromolecular system depends on the concentration, 
shape, and molecular weight of the dispersed molecules and the viscosity of the dispersion 
medium. The viscosity of an aqueous protein solution is reported to increases with increas-
ing protein concentration (Ross and Minton 1977; Shire et al. 2004). Both mAbs, IgG X and 
IgG Z, showed an increase in viscosity during UF concentration up to 200 mg/ml (Figure 
V-34). The IgG X solutions revealed an increase in viscosity up to 13.8 mPas when the pro-
tein was concentrated to 200 mg/ml. For IgG Z an increase in viscosity was recognized up 
to 27.4 mPas at a protein concentration of 200 mg/ml. 
This increased viscosity can introduce several challenges during manufacturing, filling 
and administration to the patient. Filtration and pumping operations can become infeasible 
with increasing protein concentration and the time required for filtration operations in-
creases due to pore blocking of the filtration device. In the case of pumping, an introduc-
tion of heat to the product bulk due to increased resistance of the viscous solution can 
compromize product quality (Harris et al. 2004). 
Beside the protein concentration, the viscosity of the solution depends on the extent 
of molecular interactions. Ionic strength influences protein solution viscosities by modulat-
ing the electrostatic contribution to the intermolecular potential. Shire and coworkers de-
tail an analysis of a mAb at 100 mg/ml that reversibly self-associates leading to solutions 
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of higher viscosity in comparison to two non-associating molecules (Harris et al. 2004; Liu 
et al. 2005). 
Figure V-34: Viscosity of the two mAbs as a function of protein concentration 
IgG X (diamonds) and IgG Z (triangles) concentrated in 20 mM histidine buffer 
at pH 5.5 and 5.0; mean values of three measurements are presented ± SD. 
It was observed that the highest viscosity appeared near the IP at low ionic strength. 
Moreover, the addition of sodium chloride at this pH led to a decrease in self-association 
and viscosity. Kanai et al. (2008) showed that in this case the Fab part of the molecule was 
the primary site mediating self-association. Since the addition of salts is reported to reduce 
the viscosity of the concentrated solutions it was expected that the use of a higher molarity 
of histidine respectively histidine hydrochloride should end up in a reduced viscosity as 
well (Figure V-35). 
It was found that an increase in concentration of the buffer solute at a pH of around 
5 was effective in reducing the viscosity of both mAb solutions at 130 and 180 mg/ml. At 
a protein concentration of 180 mg/ml of IgG Z the viscosity was reduced by about 33 % 
from 27.4 mPas to 18.4 mPas when the histidine concentration was increased from 10 mM 
to 30 mM. For IgG X a reduction in viscosity from 13.8 mM to 7.4 mPas was recognized 
when the histidine molarity was increased to 40 mM. In general, no further significant de-
crease in viscosity was detected when a concentration of about 40 mM histidine was 
reached. 
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Figure V-35: Viscosity of two mAbs as a function of histidine/ histidine HCl molarity 
IgG X at a concentration of 180 mg/ml, pH 5.5 (black diamonds), IgG X at a 
concentration of 130 mg/ml, pH 5.5 (white diamonds), IgG Z at a concentration 
of 180 mg/ml, pH 5.0 (black triangles) and IgG Z at a concentration of 
130 mg/ml, pH 5.0 (white triangles); mean values of three measurements are pre-
sented ± SD. 
Salinas at al. (2009) described that the addition of only 2 mM NaCl resulted in an ap-
proximately three fold decrease in the viscosity of a mAb at 80 mg/ml. Therefore, the 
effect of added sodium chloride on viscosity was compared to the effect of added his-
tidine/ histidine hydrochloride. Moreover, the actual viscosity of the concentrated solu-
tions after UF was determined containing 10 mM and 20 mM histidine. (Figure V-36). 
A decrease in viscosity of the concentrated solutions was observable with increased 
molarity of both, sodium chloride and histidine. In comparison, the addition of sodium 
chloride results in slightly higher viscosity values when more than 20 mM salt were added. 
Chen et al. (2003) observed as well that an increase in histidine molarity was able to de-
crease the viscosity of an IgG. In our case increasing the histidine molarity from 10 to 
20 mM was successful in decreasing the viscosity from 20 to about 15 mPas. The addition 
of 60 mM histidine resulted in a viscosity of < 10 mPas. The concentrates having 20 mM 
histidine present after UF revealed a decrease in viscosity from 27.4 mPas to 24.9 mPas 
compared to the solution having only 10 mM histidine present after UF. 
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Figure V-36: Viscosity of IgG Z at 180 mg/ml, pH 5.0 as a function of buffer solute mo-
larity 
Addition of sodium chloride (white triangles) and addition of histidine/ histidine hy-
drochloride (black triangles); mean values of three measurements are presented ± SD. 
4 Summary and conclusion 
At the interface of downstream processing and final formulation of highly concentrated 
mAbs up to 200 mg/ml a significant deviation in solute concentration, pH and conductiv-
ity was observed with increased protein concentration during UF. During the concentra-
tion process of two IgGs the loss of histidine and the accumulation of acetate respectively 
were monitored and attributed to thermodynamic non-ideality. Electrostatic interaction 
between the protein and the buffer solutes at the non-isoelectric pH were identified to be 
the root cause of this phenomenon which is especially pronounced at high protein concen-
trations. The Donnan-equation was shown to be a feasible model to adequately reflect the 
experimentally determined molarities of cationic and anionic buffer solutes during UF 
processing of mAbs. 
Therefore, the Donnan-equation was successfully used to predict the histidine molar-
ity required before UF in order to achieve the desired concentration of 20 mM after UF 
and to avoid concomitantly an increase in pH during UF. It was shown that this approach 
was able to circumvent pH corrections in the final concentrated solutions and contributed 
thus to a reduced level of aggregates in the bulk solutions at 200 mg/ml. In addition, a 
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higher protein concentration was achieved, since the dilution of the bulk by the pH-
corrective solution was avoided. Moreover, an improved chemical stability considering Fab 
deamidation at high protein concentrations was observed which was again related to stable 
pH conditions and an increased histidine molarity during UF processing. 
In the case of histidine, it was shown that the loss of this buffer solute during UF can 
affect the physical stability of an IgG1 in solution. The add-on of histidine contributed to a 
reduced level of HMWs and proteinaceous particles especially at an IgG concentration of 
200 mg/ml. 
In addition, the add-on of histidine can contribute to a decrease in viscosity which is 
strongly increased at high protein concentrations. 
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Chapter VI Investigation of heterogeneous 
nucleation dependent aggregation of mAbs 
during purification 
Abstract 
The downstream process of biotechnologically produced proteins comprises in general at 
least one chromatographic step to ensure the removal of aggregated species. However, rate 
and onset of aggregation are usually not predictable and aggregation occurs also after the 
aggregate competent step. This is reported to depend on environmental conditions en-
compassing the contact to different surfaces and the presence of exogenous particles of 
divers materials which are currently under discussion to induce protein aggregation via a 
heterogeneous nucleation controlled mechanism. 
In this study protein aggregation was examined in the course of the purification pro-
cess, since the protein is exposed here to numerous surfaces which are moreover a poten-
tial source of shed and abraded particles. Thus, IgG aggregation was investigated in the 
presence of three different chromatographic matrices based on glass, agarose and polyme-
thacrylate. Adsorption of the IgG and its aggregates to the micro- and nano-sized particles 
was evaluated at different pH values and the formation of differently sized aggregates was 
monitored over time. Conformational stability of the IgG was investigated by (ATR) FT-
IR and UV spectroscopy. 
Moreover, a typical process related impurity, indigenous proteins expressed by the 
applied host cell, was investigated considering the potential to induce aggregation of an 
IgG. Therefore, purified host cell proteins (HCPs) from a CHO master cell, usually ap-
plied to produce IgGs, were characterized considering their molecular weight and IP and 
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IgG aggregation was monitored in the presence of these HCP species under different envi-
ronmental conditions. 
1 Introduction 
Aggregation of therapeutic proteins can potentially occur during all stages of the lifetime 
of a protein, including refolding, purification, storage, shipping and delivery to the patient. 
The purification process offers various capabilities to decrease the level of proteina-
ceous aggregates. Usually, the intermediate purification steps are dedicated to remove 
higher molecular weight species (HMWs) beside other undesired product variants (Kelley 
et al. 2008b). CEX, HIC, reversed phase chromatography and hydroxyl apatite have been 
shown to offer sufficient capability concerning the removal of mAb aggregates (see chap-
ter I). Mostly, CEX in binding mode is used in cGMP purification processes and soluble 
aggregates are separated from the desired product species during washing or gradient elu-
tion using sodium chloride (Fahrner et al. 2001; Kelley et al. 2008a). The removal perform-
ance is highly governed by pH and counter ion concentration of the load, wash and elution 
solutions used. In general, the removal of HMWs, encompassing soluble dimers and oli-
gomers, can be challenging if their level exceed a few percent in product mass (Karlsson et 
al. 1998; Williams and Frasca 2001). 
The capability to remove aggregates after the dedicated chromatographic steps is lim-
ited to larger insoluble aggregates and particles which can be usually addressed by micro 
filtration (Chi et al. 2005b; Sifton 2002). This constraint is relevant for purification inter-
mediates as well as for fully purified material or formulated bulks, since aggregation behav-
ior including onset, rate and morphology of the aggregated state is usually not predictable. 
Hence, the environmental conditions as well as the mechanisms leading to aggregation 
phenomena need to be elucidated to prevent the protein from aggregation. Protein aggre-
gation is known to depend on environmental conditions such as temperature, storage pe-
riod, pH and the presence or absence of solutes and stabilizing excipients (Carpenter et al. 
1999; Chi et al. 2003b; Manning et al. 1995; Manning et al. 1989b; Wang 1999; Wang 
2005). Moreover, the induction of protein aggregates was observed in the presence of ex-
ogenous micro- and nano-sized particles of different materials. Nano-sized silica particles 
(Chi et al. 2005b), silicone oil droplets (Jones et al. 2005; Thirumangalathu et al. 2009), 
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teflon beads (Sluzky et al. 1991), as well as micro-particles out of stainless steel (Bee et al. 
2009a) or tungsten (Bee et al. 2009b; Jiang et al. 2009) are reported to cause protein aggre-
gation. 
In general, the adsorption of protein molecules to interfaces and solid surfaces is 
known to potentially induce aggregation. The adsorption process is mostly driven by either 
hydrophobic interactions or electrostatic interactions between the surface and the protein 
(Norde 1995; Norde and Lyklema 1978). As a consequence of the surface contact, partial 
unfolding of the protein molecules may occur, and these structurally perturbed molecules 
are reported to be precursors for aggregation (Dong et al. 1995; Fink 1998; Fink et al. 
1994; Kendrick et al. 1998a).  
In the presence of the nano- and micro-sized solid particles, as reported above, partial 
unfolding of the protein molecules was hardly recognized, although the formation of ag-
gregates was clearly enhanced and the monomer population was depleted. It is discussed in 
current literature that aggregation is inherently a nucleation and growth phenomenon, 
where molecules have to accumulate, eventually exceed their solubility and can actually 
precipitate (Chi et al. 2005a). Stable assembly of the molecules into a so-called critical-sized 
nucleus and further its growth into larger aggregates is not possible until an energy barrier 
is overcome which results from the free energy required to build a new solid-liquid inter-
face (Debenedetti 1996). Existing particles in solution can serve as so-called heterogeneous 
nuclei facilitating the accumulation of the protein molecules and thus their aggregation. 
Heterogeneous nucleation dependent aggregation can be potentially prevented, if the pro-
tein is hindered to adsorb to the particle surface. This was shown for hydrophilic glass 
particles and silicon oil droplets by adding surfactant to the protein solutions (Chi et al. 
2005b; Thirumangalathu et al. 2009). 
In general, the protein is exposed to numerous surfaces during all stages of the manu-
facturing process, as well as during storage, and particles can be shed or abraded from all 
of them and thus potentially enter the protein bulk solutions. As regards the purification 
process, the protein is exposed to large surfaces during preparative chromatography and 
various filtration steps. Moreover, particles from the packed chromatographic bed may be 
introduced into the eluate serving as heterogeneous nuclei. Usually, the micro-sized chro-
matographic beads are retained in the packed column by a frit out of metal, glass of plastic. 
However, grinding of the beads can potentially occur due to high pressure caused by the 
compression via drag forces exerted by fluid flow through the bed especially at large scale 
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(Tran et al. 2007). Thus, small fragments of different matrix materials can potentially pass 
through the frit and may enter the purified protein bulk. Mostly, matrices based on glass, 
polysaccharides or the synthetic polymer polymethacrylate are usually applied in cGMP 
purification processes of therapeutic mAbs (Fahrner et al. 2001; Fahrner et al. 1999; Hahn 
et al. 2003). 
Beside these already mentioned particles which can be shed or abraded from the bio-
processing equipment, containers or closures, foreign proteinaceous species are suspected 
to induce heterogeneous nucleation dependent aggregation of the therapeutic protein 
(Arakawa et al. 2006). The coding gen-sequence of mAbs is usually expressed in mammal-
ian host cells, e.g. CHO cells (Prouty et al. 1975). Therefore, process related impurities 
such as indigenous proteins expressed by the host cell (called host cell proteins: HCPs), 
DNA or cellular components are present in the harvested cell culture fluid as well as in the 
purification intermediates and can potentially facilitate aggregation of the therapeutic pro-
tein. 
In this study, aggregation of an IgG was investigated in the course of protein purifica-
tion. Interaction of the protein with various marketed chromatographic resins which are 
commonly applied in cGMP purification processes of mAbs, were investigated. The po-
tential induction of aggregates was monitored by SE-HPLC and turbidity measurements. 
Potential heterogeneous nucleation dependent aggregation was studied in the presence of 
nano- and micro-sized chromatographic particles as well as HCPs from CHO cells. 
2 Materials and methods 
2.1 Materials 
A completely purified bulk of a chimeric human Fc (IgG4)/ rat Fab antibody in histidine 
buffer pH 6.0 was taken for the experiments. The mAb was provided by Roche Diagnos-
tics GmbH (Penzberg, Germany). Aliquots were dialyzed into 100 mM acetate pH 3.0, 
100 mM acetate pH 5.0 and 200 mM tris(hydroxymethyl)-aminomethan pH 7.5. After-
wards, the solutions were filtered by using a Sterivex-GV 0.22 µm filter (Millipore, Biller-
ica, USA). 
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Porous chromatographic beads of different matrix materials were applied. Controlled 
pored glass (CPG 700) particles from Millipore (Billerica, USA), sepharose (cross-linked 
agarose) beads from GE Healthcare (Uppsala, Sweden) and polymethacrylate based media 
(Toyopearl HW-65M, Tosoh Bioscience, Stuttgart, Germany) were used. Moreover, the 
corresponding functionalized Protein A affinity and IEX resins were obtained from Milli-
pore (ProSep vA ultra), GE Healthcare (MabSelect) and Tosoh (Toyo CM 65M and 
Toyo Q 65M). 
A CHO master cell usually applied to produce IgG and identical to the CHO master 
cell (Roche Diagnostics GmbH, Penzberg, Germany), except the gene encoding the thera-
peutic protein (“null” CHO cell), was fermented under typical expression conditions 
(Rathore et al. 2003) to obtain host cell proteins (HCPs). The HCPs were purified from 
the filtered harvested cell culture fluid by using ammonium sulfate precipitation. There-
fore, 2.6 mol ammonium sulfate per liter culture fluid were added and the precipitate was 
collected by filtration (Sartopure PP2 20, Sartorius, Goettingen, Germany). The precipitate 
was then removed from the filter by washing with phosphate buffer pH 7.2 containing 
20 mM sodium phosphate and 150 mM sodium chloride. The solution was afterwards 
concentrated and diafiltrated in this phosphate buffer to get rid of the ammonium sulfate 
applying a 5 kDa UF membrane (Hydrosart, Sartorius, Goettingen, Germany). This HCP 
standard solution was then stored at -70 °C. Before performing the seeding experiments, 
the thawed HCP standard solution (HCP concentration about 10 mg/ml) was diluted 1:10 
with acetate buffer pH 5.0 and was filtered by using a 0.2 µm Sterivex-GV filter (Millipore, 
Billerica, USA). The concentration of CHO HCP in solution was determined by an in-
house enzyme-linked immunosorbent assay (ELISA) (Roche Diagnostics GmbH, 
Penzberg, Germany) as required by the ICH guideline Q6B (ICH 1999a) and is in general 
described elsewhere (Champion et al. 2005; Eaton 1995). 
All chemicals and reagents used were at least analytical grade. Acetic acid was taken 
from Fluka (Steinheim, Germany), citric acid, hydrochloric acid, sodium hydroxide, am-
monium sulfate and sodium chloride were taken from Merck KG (Darmstadt, Germany), 
tris(hydroxymethyl)-aminomethan was taken from Angus (Ibbenbueren, Germany). L-
histidine from Ajinomoto (Raleigh, USA) was used. 
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2.2 Adsorption experiments 
Adsorption of the mAb to the different chromatographic surfaces was investigated at dif-
ferent pH by incubating a defined surface of the beads with a defined protein mass. There-
fore, the bead slurry was suspended and mixed with purified and 0.2 µm filtered water 
(Milli-Q, Millipore, Billerica, USA). The beads were collected by vacuum filtration 
(0.22 µm cellulose filter discs, Sartorius, Goettingen, Germany) and were afterwards rinsed 
with purified and 0.2 µm filtered water (Milli-Q, Millipore, Billerica, USA). Subsequently, 
the beads were dried at 40 °C and a defined mass was weighed representing a defined sur-
face as determined by BET gas adsorption experiments. Therefore, about 0.2 g of each 
bead matrix were mixed in sterile 5 ml CRYO.S tubes (Greiner Bio-One, Frickenhausen, 
Germany) with about 5 ml of an IgG solution (5 mg/ml) at pH 3.0, pH 5.0 and pH 7.5. 
The samples were incubated without head space on the rotary mixer RM5 (Froebel, Lin-
dau, Germany) at 35 rpm for 12 hours at room temperature. The samples were then cen-
trifuged for 10 min at 10 000 x g to separate the beads from the protein solution. The 
amount of IgG adsorbed to the respective surface was determined by subtracting the 
amount of the protein determined in the supernatant from the amount of protein initially 
present before incubation. Adsorption to the tubes used was found to be neglectable, since 
< 1 % of total protein were adsorbed to the tubes after incubation for 12 hours at pH 3.0, 
pH 5.0 and pH 7.5. 
Adsorption isotherms were determined by preparing samples containing 5 m² CPG 
surface and various concentrations of the IgG between 0.2 and 6.0 mg/ml at pH 5.0 and 
pH 7.5. Again the bead matrix was mixed in sterile 5 ml CRYO.S tubes (Greiner Bio-One, 
Frickenhausen, Germany) with about 5 ml of the respective IgG solution (5 mg/ml). The 
samples were incubated over 12 hours as described before and were centrifuged for 
10 min at 10 000 x g to separate the beads from the protein solution and to determine the 
protein concentration in the supernatant. The amount of protein adsorbed was determined 
by subtracting the amount of the protein determined in the supernatant from the amount 
of protein initially present before incubation. 
To look at preferential adsorption of HMWs on the CPG surface, IgG solutions at 
pH 5.0 containing 3.2 %, 5.7 % and 6.8 % HMWs were incubated with 0.1-10 m² CPG 
surface. The bead matrix was mixed in sterile 4 ml CRYO.S tubes (Greiner Bio-One, 
Frickenhausen, Germany) with about 4 ml of the respective IgG solution (about 
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5 mg/ml). The samples were incubated over 12 hours as described before and were centri-
fuged for 10 min at 10 000 x g to separate the beads from the protein solution and to de-
termine the protein concentration in the supernatant. In addition, the supernatant was 
analyzed by SE-HPLC. The amount of adsorbed HMWs and monomers in percent was 
determined by subtracting the amount of HMWs determined in the supernatant from the 
amount of HMWs initially present before incubation. 
2.3 Seeding experiments 
Chromatographic beads were suspended in water and were sonicated to obtain nano-sized 
seeds. Therefore, the Sonoplus Ultrasonic Homogenizer (Bandelin Electronic, Berlin, 
Germany) at a processing frequency of 20 kHz over 3x10 min using the 3 mm microtip 
sonotrode was applied. After 20 min hold time the very large particles remaining in solu-
tion sedimented and the size distribution by intensity of the sonicated particles in the su-
pernatant was recorded by using laser diffraction. The fragmented suspended particles 
after 10 min and 30 min sonication time were washed with purified and 0.2 µm filtered 
water (Milli-Q, Millipore, Billerica, USA) and dried in air at 35 °C. 50, 100, 150 and 200 m² 
bead surface per gram protein were seeded into IgG solutions at pH 5.0, at pH 5.0 with 
150 mM sodium chloride and at pH 7.5 with an initial protein concentration of 6 mg/ml 
(total protein: about 30 mg) and 6 % HMWs. The samples were incubated over one week 
without head space on the rotary mixer RM5 (Froebel, Lindau, Germany) at 35 rpm at 
room temperature. At each time point, the samples were centrifuged for 10 min at 
10 000 x g to separate the beads from the protein solution. Protein concentration determi-
nation, turbidity measurements and SE-HPLC analysis were performed with the super-
natant of the centrifuged samples. 
To investigate the effect of HCP on aggregation, IgG solutions at pH 3.0, at pH 5.0, 
at pH 5.0 with 10, 100, 150 and 250 mM sodium chloride and at pH 7.5 with an initial 
protein concentration of about 5 mg/ml (about 20 mg total protein) were spiked with 
0 ng, 500 ng and 1000 ng HCP per mg IgG by using the diluted HCP standard solution. 
The samples were incubated at room temperature and at 40 °C in sterile 4 ml CRYO.S 
tubes (Greiner Bio-One, Frickenhausen, Germany) without head space on the rotary mixer 
RM5 (Froebel, Lindau, Germany) at 35 rpm. Aggregate formation was monitored by SE-
HPLC and turbidity measurements in the HCP-spiked and unspiked solutions. 
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2.4 Concentration determination 
Concentration was determined by using the photometric absorbance at 280 nm and 
320 nm after buffer blank subtraction (UV-Vis spectrophotometer Evolution 500, Thermo 
Fisher Scientific, Waltham, USA). The absorbance at 320 nm was subtracted from the 
absorbance at 280 nm (UV 280-320) and this value was used to calculate the protein con-
tent according to the law of Lambert-Beer. 
2.5 Turbidity measurements 
The turbidity of the seeded solutions was determined after centrifugation as the photomet-
ric absorbance at 350 nm after buffer-blank subtraction (UV-Vis spectrophotometer Evo-
lution 500, Thermo Fisher Scientific, Waltham, USA). 
2.6 Size exclusion high pressure liquid chromatography 
SE-HPLC analysis was conducted with a TSK 3000 SWXL column (Tosoh Biosep, Stutt-
gart, Germany) on a Summit HPLC-system (Dionex, Idstein, Germany). The elution peaks 
were monitored at 280 nm by the UV diode array detector UVD170U from Dionex (Idstein, 
Germany). Isocratic chromatography was conducted as described in chapter III. The chro-
matograms were integrated manually by using the Chromeleon software (Dionex, Idstein, 
Germany). This is shown exemplarily in Figure III-1 (see page 52). The percentage of higher 
molecular weight species (HMWs) including dimers and larger soluble oligomers was deter-
mined as relative area (mAU⋅min) of the respective peaks referred to total area of all peaks 
including the monomer peak and the peak of the lower molecular weight species (LMWs). 
2.7 FT-IR spectroscopy 
Both, the CPG and the ProSep vA ultra particles were incubated at room temperature for 
12 hours with a 6 mg/ml solution of IgG in acetate buffer at pH 5.0. The solutions 
showed a level of 1.5 % HMWs determined by SE-HPLC before incubation. Incubation 
was conducted in saturation mode. After centrifugation for 10 min at 10 000 x g, the parti-
cles were washed two times with 2 ml acetate buffer pH 5 since nearly no protein was de-
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tectable in the washing solution by using UV 280-320. FT-IR spectra of the adsorbed pro-
tein were recorded with the Tensor 27 (Bruker Optics, Ettlingen, Germany) by applying 
the slurry directly on the Germanium crystal of the MIRacle attenuated total reflection 
(ATR) cell to investigate the secondary structure of the protein on the chromatographic 
particles. The AquaSpec transmission cell was used to investigate the protein secondary 
structure after desorption from the particles. Therefore, the particles were incubated in 
200 mM tris buffer pH 9.0 to remove the protein from CPG and in 100 mM acetate buffer 
pH 3.0 to remove the protein from ProSep vA ultra. Incubation time was 12 hours. 
For each spectrum which was recorded from 850-4000 cm-1 a 120-scan interferogram 
was collected at a double sided acquisition mode with a resolution of 4 cm-1. The reference 
spectrum of the respective buffer and the respective wetted particles was subtracted to ob-
tain the protein spectrum. The spectra were edited by a vector normalization followed by the 
generation of the second derivative smoothed using a 13-point Savitsky-Golay smoothing 
function applying the OPUS 6.0 software (Bruker Optics, Ettlingen, Germany). Moreover, 
the absorption spectra recorded in ATR mode were corrected concerning band intensity and 
band position to allow the comparison to spectra recorded in transmission mode. Therefore, 
the extended ATR-correction of the software OPUS 6.0 (Bruker Optics, Ettlingen, Ger-
many) according to Fringeli (1992) was used to overcome wave number dependent anoma-
lous dispersion (Goldberg and Chaffotte 2005; Grdadolnik 2002). 
2.8 Second derivative UV spectroscopy 
Tertiary structure of the protein in solution was examined by 2D-UV spectroscopy using 
the Uvikon XL (Goebel Elektro, Ludwigshafen, Germany). The protein was desorbed 
from the chromatographic surfaces by using a buffer at pH 9.0 to desorb the protein from 
the CPG particles and by using a buffer at pH 3.0 to remove the protein from ProSep vA 
ultra. Afterwards, the samples were diluted to a protein concentration of 1.0 mg/ml. Ab-
sorbance spectra from the near-UV region between 250-320 nm were collected at a scan-
ning speed of 50 nm/min, a bandwidth of 1 nm and a scanning step interval of 0.5 nm. 
The OPUS software (Bruker Optics, Ettlingen, Germany) was used to enhance the resolu-
tion, concomitantly preserving the band position. The second derivative was smoothed 
applying a 13-point Savitsky-Golay smoothing function. 
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2.9 Laser diffraction 
Particle size distribution by intensity of the chromatographic particles was determined by 
using the Horiba LA-950 (Retsch, Haan, Germany) equipped with two laser light sources 
at 650 and 405 nm and 23 wide angle detectors. The particles were suspended in purified 
and 0.2 µm filtered water (Milli-Q, Millipore, Billerica, USA) using the low volume cuvette 
LA-950. A sample refractive index of 1.51 for the glass particles, of 1.54 for the sepharose 
beads and of 1.49 for the polymethacrylate beads were applied. A refractive index of 1.33 
for water was used. Based on the Mie-Scattering theory a particle size over a range of 0.01-
3000 µm can be determined from the recorded intensity and angle of the scattered light 
using the LA-950 software (Retsch, Haan, Germany). 
2.10 BET gas adsorption 
Multipoint (10 measurement points) Brunauer-Emmett-Teller (BET) specific surface area 
of the chromatographic beads was determined at 77 K with the TriStar II 3020 (Micromer-
itics, Mönchengladbach, Germany). Nitrogen was used as an adsorbate. For each meas-
urement at least 0.2 g of the chromatographic beads were applied. Before measuring, the 
samples were stored under vacuum at 45 °C for 24 hours. A relative gas pressure (p/p0) of 
0.06-0.30 was applied. 
2.11 Scanning electron microscopy 
Scanning electron microscopy (SEM) was carried out using the JSM-6500F (Joel, Eching, 
Germany). The beads were dried in a VO 200 vacuum chamber (Memmert, Schwabach, 
Germany) and coated with a fine carbon layer before starting the surface morphology 
analysis. 
2.12 Zeta potential measurements 
To determine the charge of the protein, the HCP and the sonicated nano-sized CPG 700 
at different pH, electrophoretic mobility of the proteins and the CPG 700 particles were 
determined by performing Laser-Doppler-Velocimetry using the Malvern Zetasizer 
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Nano S (Malvern Instruments, Worcestershire, UK). The zeta potential ζ was calculated 
from the Henry’s equation (Henry 1931) with assumption of uniform charge distribution 
by using the Malvern DTS software (Version 5.0, Malvern Instruments, Worcestershire, 
UK) (see Equation V-6). For sample preparation a 5 mg/ml mAb solution and a 5 mg/ml 
HCP standard solution were dialyzed into 10 mM acetate buffer pH 5.0 and were titrated 
to a pH of 2.0 afterwards by using 0.2 M hydrochloric acid. The CPG 700 particles were 
suspended in the same buffer system and the pH was adjusted to 2.0. All samples were 
titrated with a 0.2 M sodium hydroxide solution from pH 2 to pH 12 by applying the titra-
tor MPT2 (Malvern Instruments, Worcestershire, UK). The zeta potential was determined 
in 15 steps between pH 2 and pH 12 in a temperature controlled folded capillary cell (Mal-
vern Instruments, Worcestershire, UK) at 25 °C. 
2.13 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Non-reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed by using the Novex mini-Cell system (Invitrogen, Karlsruhe, Germany) 
equipped with 4-20 % tris-glycine gels. The protein solutions were diluted to 1 mg/ml by 
using the appropriate bulk buffer. Subsequently, the samples were diluted 1:1 with tris-
glycine SDS sample buffer containing 2 % SDS (Invitrogen, Karlsruhe, Germany) and 
denatured at 70 °C for 10 minutes. The amount of IgG per well was 2 µg per sample. As 
running buffer tris-glycine SDS running buffer (Invitrogen, Karlsruhe, Germany) was 
used. Electrophoresis was performed at 200 V. As molecular weight standard the Mark12 
from Invitrogen (Karlsruhe, Germany) was applied. The gels were stained with silver by 
using the Silver Xpress Staining Kit according to the Kit manual (Invitrogen, Karlsruhe, 
Germany).  
2.14 Two-dimensional-gel electrophoresis 
Two-dimensional-gel electrophoresis (2D-gel electrophoresis) of the HCP standard solu-
tion was performed after sample preparation with the Perfect-FOCUS Kit (Calbiochem, 
San Diego, USA). The precipitated protein pellet was resolved in 200 µl buffer (containing 
8 M urea, 2% CHAPS, 0.002% bromphenol blue, 20 mM DTT and 0.5 % IPG buffer). 
Both, isoelectric focusing (IEF) and SDS-PAGE were performed by using the ZOOM 
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Benchtop System (Invitrogen, Karlsruhe, Germany). For IEF, 7 cm buffer hydrated IPG 
strips with a non-linear pH gradient from 3-10 were applied. Focusing was carried out at 
175-2000 V for 2 hours. Afterwards, the proteins in the IPG strips were denatured and 
reduced for 15 min by incubating the strips in equilibration buffer containing 2 % SDS 
and 1 % DTT. Afterwards, the strips were incubated in equilibration buffer containing 
2.5 % iodoacetamide for 15 min to alkylate the proteins. 
The IPG strips were than placed on top of the SDS gel (4-12% tris-glycine gels) and 
sealed onto the gel. SDS-PAGE was performed by using the MES SDS running buffer. 
The gels were run at 100-200 V for about 2 hours. As molecular weight standard the 
Mark12 from Invitrogen (Karlsruhe, Germany) was applied. The gels were stained with 
silver by using the Silver Xpress Staining Kit according to the Kit manual (Invitrogen, 
Karlsruhe, Germany). 
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3 Results and discussion 
3.1 Characterization of chromatographic surfaces 
In general, the matrix material of the chromatographic solid phase, the particle- and the 
pore diameter have impact on the mechanical and physical stability of the beads, the reso-
lution and selectivity and the accessible surface and hence binding capacity (Boschetti 
1994; Jungbauer 2005). 
On the one hand, one is usually interested in applying a high flow velocity of the mo-
bile phase to decrease cycle time during chromatography. Therefore, the bead matrix has 
to be rigid enough to circumvent sorbent shrinkage and high back-pressure. On the other 
hand, a high binding capacity is desired which is usually achieved by applying highly po-
rous materials (LeVan et al. 1997; Yao and Lenhoff 2006). Moreover, these porous materi-
als also show a good mass transfer characteristic reducing, among other parameters, peak 
dispersion and band spreading (Van Deemter et al. 1956). 
The features of the matrices are mutually exclusive to some extent, since porous ma-
terials like sepharose can have good mass transfer characteristics but low equilibrium ca-
pacity due to limited surface area and can not be operated at very high flow velocities due 
to their porosity and hence softness. Rigid and hence less porous materials like glass are 
more mechanically stable but concomitantly they can show increased mass transfer resis-
tance and a reduced accessible surface (Hahn et al. 2003). Moreover, smaller beads are 
applied to increase the number of plates and hence the separation capacity. Concomitantly, 
this requires more rigid matrices since smaller beads lead to increased back-pressure which 
can be easily overcome by using a more rigid material. 
The matrices out of CPG, sepharose and polymethacrylate were investigated by SEM 
at 400-10 000 times magnification (Figure VI-1A-C). The shape of the sepharose and po-
lymethacrylate beads is perfectly spherical whereas the CPG particles are fragmented 
pieces which are irregularly shaped with sharp edges. The surface of all matrix materials is 
highly porous. The pore-size estimated from the SEM pictures at 10 000 times magnifica-
tion is around 1000 Å, as pictured in A2 which refers to the CPG surface. 
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Figure VI-1: SEM pictures of chromatographic surfaces at 400-1000x (left) and at 
10 000x (right) magnification 
Pictures of CPG (A), sepharose (B) and polymethacrylate (C) beads. 
The CPG surface shows a very uniform porous structure which can be explained by the 
production procedure. Porous glass is obtained by polycondensation of sodium silicate 
usually under mild acidic conditions (Tarutani 1984). After the formation of an aqueous 
silica gel the surface area, porous volume and pore size of the final solid particles can be 
precisely controlled by time, temperature, pH and added electrolytes (Iler 1979; Von Van-
sant et al. 1995). Therefore, CPG was initially applied in liquid chromatography and here 
A1
B1
C1
A2
B2
C2
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especially in gel permeation chromatography due to extremely sharp pore-size distributions 
(Haller 1965). 
Polysaccharide networks as present in agarose gels are often cross-linked with divinyl 
sulphone to improve the mechanical stability of the material (Andersson et al. 1998; Po-
rath et al. 1975). Thus, the surface pore-structure is more irregularly formed as observed in 
picture B2 compared to the CPG surface. 
A quite similar irregular sponge-like surface structure as recognized for the agarose 
beads was observed for the polyacrylamide beads at 10 000 times magnification (picture 
C2). Polyacrylamide cross-linked with methylene-bisacrylamide is well known to result in 
low and defined exclusion limits and thus in a fine pored and dense material (Boschetti 
1994; Gressel and Robards 1975). Therefore, this material is essentially used for gel filtra-
tion chromatography. 
The pore size values of the different matrices determined by mercury porosimetry 
were collected from the literature provided by the respective manufacturers. Table VI-1 
shows the reported values. All matrices show a pore diameter between 560 and 1000 Å. 
Therefore, the structure can be described as macro-porous according to the IUPAC classi-
fication of pores (Everett 1972). Since IgG monomers have a hydrodynamic diameter of 
about 100 Å (see chapter III) their diffusion into the pores of the beads is not limited by 
the size and therefore the inner surface is in all cases accessible for the adsorption of an 
IgG. Moreover, most soluble aggregates separated by SE-HPLC are expected to enter the 
inner surface as well, since an octamer shows only a doubled hydrodynamic diameter of 
about 200 Å referred to the hydrodynamic diameter of the monomer (see chapter IV). 
This is expected to be still small enough to enter the inner surface of all three chroma-
tographic matrices. 
Regarding the size of the chromatographic particles, the CPG fragments show a mean 
particle diameter of about 125 µm, whereas the sepharose and the polymethacrylate beads 
are smaller. These particles show a mean particle diameter of 85 µm and 72 µm respec-
tively determined by laser diffraction (Table VI-1). 
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Matrix material Mean particle 
diameter [µm] 
Multipoint BET specific surface area ± SD 
[m²/g] 
Pore diameter* 
[Å] 
Controlled 
pored glass 
(CPG) 
125 ± 60 35.99 ± 3.52   700 
Sepharose   85 ± 37 89.41 ± 2.34   560 
Polymethacrylate   72 ± 19 12.33 ± 0.26 1000  
 
* Determined by mercury porosimetry. Values were taken from the material description of CPG 700 
(www.millipore.com), MabSelect (www.gehealthcare.com) and Toyopearl HW-65M (www.tosoh.com). 
Table VI-1: Mean particle diameter determined by laser diffraction and BET specific 
surface area of the chromatographic beads 
Results are presented as mean values of three measurements ± SD. 
The specific surface area of the CPG particles was determined to 36 m²/g while the value 
for the sepharose beads was much higher showing a specific area of 89 m²/g. The polyme-
thacrylate beads exhibit the lowest specific surface area of 12 m²/g as a consequence of 
their large pore size. These beads are more porous compared to the other two matrices, 
since their accessible surface is much lower and their pore size is much larger. The sepha-
rose beads can be considered as the densest ones, since their accessible surface is much 
higher and their pore size is smaller compared to the other matrices. 
3.2 Adsorption to porous chromatographic matrices 
About 0.2 g of the unfunctionalized chromatographic matrices based on CPG, sepharose 
and polymethacrylate were incubated with the IgG solutions at pH 3.0, pH 5.0 and pH 7.5. 
The mass of protein adsorbed to the chromatographic surface was referred to the mass of 
protein initially present as 100 %. Moreover, this value was divided by the surface area 
which was incubated with the protein solution, to compare the efficacy of the different 
matrices (per m²) in adsorbing the IgG. In addition, the commonly applied functionalized 
beads of the different matrices were incubated as well and adsorption efficacy was com-
pared to the unfunctionalized surfaces. This was done to evaluate unspecific adsorption to 
the bead matrix. 
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3.2.1 MAb adsorption 
The CPG matrix shows the highest adsorption at pH 5.0, while the adsorption of the IgG 
is reduced at a lower pH of 3.0 and at a higher pH of 7.5 (Figure VI-2). 
Figure VI-2: Adsorption of IgG to CPG based matrices at pH 3.0, pH 5.0, pH 7.5 
Percent protein mass adsorbed per square meter matrix; protein mass initially 
present in solution was about 25 mg (initial concentration = 5 mg/ml, vol-
ume = 5 ml); adsorption at pH 3.0 (light grey), at pH 5.0 (dark grey) and at 
pH 7.5 (black); results are presented as mean values of three measurements ± SD. 
In comparison, the ProSep vA ultra medium shows the highest adsorption of the IgG at 
pH 7.5. ProSep vA ultra is a functionalized CPG material having a Protein A affinity ligand 
coupled to its surface. The adsorption of mAbs to the Protein A ligand usually increases 
with pH and shows a maximum at a pH > 5 (see chapter I). At a pH of 5.0 adsorption of 
the IgG to CPG was observed to be comparable to the functionalized Protein A gel. Thus, 
the IgG is considered to be mainly unspecifically adsorbed to the glass matrix at this pH. 
Adsorption to sepharose beads was found to be negligible. Almost no IgG adsorbs to 
the sepharose surface at a pH between 3.0 and 7.5 (Figure VI-3). In comparison, MabSe-
lect which is a Protein A affinity resin as well, but based on sepharose, shows again a pH 
dependent adsorption as expected. The higher the pH, the more IgG is bound to the resin. 
At a pH of 7.5 the highest amount of IgG was adsorbed per square meter gel. In general, 
the overall capacity to adsorb the mAb on the surface is reduced compared to the CPG 
based MabSelect and the unfunctionalized CPG. 
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Figure VI-3: Adsorption of IgG to sepharose matrices at pH 3.0, pH 5.0, pH 7.5 
Percent protein mass adsorbed per square meter matrix; protein mass initially 
present in solution was about 25 mg (initial concentration = 5 mg/ml, vol-
ume = 5 ml); adsorption at pH 3.0 (light grey), at pH 5.0 (dark grey) and at 
pH 7.5 (black); results are presented as mean values of three measurements ± SD. 
Adsorption of the IgG to the unfunctionalized polymethacrylate beads was observed to be 
negligible as well. Almost no protein was lost on the surface during incubation at pH 3.0, 
5.0 and 7.5 (Figure VI-4). 
Moreover, the weak CEX resin having a carboxy-methyl (CM) functionalization on 
the surface adsorbs the IgG at pH 3.0 and 5.0 as expected, since the protein is predomi-
nantly positively charged at these pH values. Adsorption capacity is in general clearly re-
duced compared to the affinity matrices based on CPG and sepharose presented above. At 
pH 7.5 almost no protein adsorbs to the resin, since the net charge of the protein is 
strongly reduced at a pH closely to the IP of the protein. The strong IEX resin based on 
sepharose, exhibiting a quaternary ammonium function (Q) on the surface, shows no ad-
sorption of the IgG at a pH between 3.0 and 7.5, since the protein is here predominantly 
positively charged. 
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Figure VI-4: Adsorption of IgG to polymethacrylate matrices at pH 3.0, pH 5.0, pH 7.5 
Percent protein mass adsorbed per square meter matrix; protein mass initially 
present in solution was about 25 mg (initial concentration = 5 mg/ml, vol-
ume = 5 ml); adsorption at pH 3.0 (light grey), at pH 5.0 (dark grey) and at 
pH 7.5 (black); results are presented as mean values of three measurements ± SD. 
In summary, the unfunctionalized CPG matrix shows the highest adsorption capacity of 
the IgG. This is especially pronounced at pH 5.0 while unfunctionalized sepharose and 
polymethacrylate beads did not show any noteworthy adsorption capacity, neither at acidic 
pH, nor at a more neutral pH. 
3.2.2 Aggregate adsorption 
Before and after incubation of the IgG solution with the different chromatographic sur-
faces at pH 3.0, pH 5.0 and pH 7.5, the solutions were analyzed by SE-HPLC. It was ob-
served that after incubation with the unfunctionalized CPG surface at pH 5.0 and 7.5 the 
solution was almost fully cleared from soluble aggregates (Figure VI-5A). At pH 3.0 a re-
duction from 3 % to about 2 % HMWs in solution was recognized after incubation with 
the CPG matrix. 
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Figure VI-5: Percent HMWs in solution with and without contact to the CPG sur-
face (A) and the functionalized Prosep vA ultra surface (B) 
Percent HMWs in solution determined by SE-HPLC before incubation (light 
grey), after incubation without contact to the chromatographic surface (dark grey) 
and after incubation with the chromatographic surface (black); for each sample 
about 25 mg IgG were incubated with about 10 m² of the respective chroma-
tographic surface; results are presented as mean values of three measurements 
± SD. 
The reduction of HMWs was not observed after incubation with the functionalized 
ProSep vA ultra resin (Figure VI-5B). Only at pH 5.0 the HMW level dropped from about 
2 % to 1.5 %. At pH 7.5 no significant removal of HMWs was detected. At pH 3.0 an 
increase in HMWs was observed after incubation if the functionalized surface was present. 
When sepharose beads were incubated with the IgG solution at the three different 
pH conditions almost no adsorption of HMWs was detectable (Figure VI-6A). Again, at 
pH 3.0 an increase in HMWs was observed after incubation with the unfunctionalized 
beads. At pH 3.0 and pH 5.0 almost no decrease in the level of HMWs was detected when 
the solution was incubated with the functionalized MabSelect resin (Figure VI-6B). Only at 
pH 7.5 a decrease in HMWs was detected. 
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Figure VI-6: Percent HMWs in solution with and without contact to the sepharose sur-
face (A) and the MabSelect surface (B) 
Percent HMWs in solution determined by SE-HPLC before incubation (light grey), 
after incubation without contact to the chromatographic surface (dark grey) and after 
incubation with the chromatographic surface (black); for each sample about 25 mg 
IgG were incubated with about 25 m² of the respective chromatographic surface; re-
sults are presented as mean values of three measurements ± SD. 
3.2.3 Characteristics of mAb adsorption to CPG 
 The incubation studies clearly showed that unfunctionalized porous CPG surfaces are 
capable to adsorb IgG molecules as well as their soluble aggregates. Figure VI-7 shows the 
amount of IgG adsorbed to the CPG particles after 12 h incubation at pH 5.0 versus the 
concentration of protein remaining in the solution. This adsorption isotherm shows a 
sharp initial slope which was attributed to a strong binding affinity of the protein to the 
porous surface at this pH (Figure VI-7B). Complete saturation of the surface was reached 
at a relatively low protein concentration. Maximum adsorption was reached at about 
2.0 mg IgG per square meter CPG. 
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Figure VI-7: Adsorption and desorption isotherm of IgG on CPG particles 
Adsorption studies were done at pH 5.0 (black diamonds), desorption studies at 
pH 3.0 (white diamonds); (B) is a zoom of (A); results are presented as mean val-
ues of three measurements ± SD. 
Figure VI-8 shows the adsorption isotherm at pH 7.5. At this pH the binding affinity of 
the mAb to the CPG surface was found to be reduced since the adsorption isotherm was 
much flatter (Figure VI-8B) compared to the one determined at pH 5.0. Maximum adsorp-
tion was already reached at about 1.0 mg IgG per square meter CPG.  
Figure VI-8: Adsorption and desorption isotherm of IgG on CPG particles 
Adsorption studies were done at pH 7.5 (black diamonds), desorption studies at 
pH 3.0 (white diamonds); (B) is a zoom of (A); results are presented as mean val-
ues of three measurements ± SD. 
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Quantitative desorption was only possible, when the protein loaded CPG particles were 
incubated in a buffer solution at pH 3.0 (Figure VI-7 and Figure VI-8). Adsorption of pro-
tein to silica surfaces is in general reported to be reversible under defined conditions. On 
the one hand, harsh chemical solvents like chloroform, methanol or isopropanol are capa-
ble to desorb the protein from the glass surface (Manning et al. 1989a; Stankovic et al. 
1990). On the other hand, chaotropic salts are reported to be suitable for protein desorp-
tion (Mecs et al. 1984), beside the option of changing the pH (Edy et al. 1976). 
Adsorption of the IgG to the CPG particles was in general found to be pH depend-
ent. Maximum adsorption was observed at pH 5.0 (Figure VI-9). In the presence of 
150 mM sodium chloride (NaCl) at pH 5.0 a slight decrease in IgG adsorption was ob-
served. 
Figure VI-9: Adsorption of IgG on CPG particles at different pHs 
Experiments were carried out in the saturation regime at a soluble protein con-
centration of 2 mg/ml or higher; results are presented as mean values of three 
measurements ± SD. 
A significant decrease in IgG adsorption to the CPG surface was observed when the pH 
was raised above the IP of the protein which was determined to 8.0 by using zeta potential 
measurements (Figure VI-10). At a pH of 9.0 only 0.05 mg protein were found to adsorb 
per square meter CPG. 
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Figure VI-10: Zeta potential titration curves of the IgG (black) and the nano-sized CPG 
particles (grey) 
Experimental data is presented as mean values of three measurements ± SD. 
Beside the zeta potential of the IgG, the zeta potential of the nano-sized CPG particles 
was determined at different pH values (Figure VI-10). The surface charge of the nano-
sized CPG was found to depend on pH. The IP of these glass particles was determined to 
be 4.0. At a pH above 4 the surface charge of the CPG changes from positive to negative 
whereas the overall charge of the IgG remains positive at a pH below 8.0. Therefore, the 
adsorption of IgG to the CPG surfaces is considered to be strongly driven by electrostatic 
interactions, reaching the maximum at pH 5 when the protein and the CPG particles have 
an oppositely charged surface. 
Above pH 4 the residual unreacted surface hydroxyl groups left over from polymeri-
zation (called silanols) exist in ionized form (SiO-) (Behrens and Grier 2001; Tarutani 
1984) attracting any positively charged species by electrostatic forces (Nawrocki 1997; 
Rezwan et al. 2005). 
Moreover, hydrophobic siloxane sites are located on the glass surface (Ghose et al. 
2004) ready for interaction with other hydrophobic surfaces. In aqueous solutions of pro-
teins the various non-polar amino acid residues will tend to be buried in the interior of the 
molecule, thus shielded from water (Norde 1986). However, apolar parts of the protein 
may become exposed to the sorbent surface which are therefore shielded from water as 
well. Moreover, a fraction of the hydrophobic residues can be exposed to the aqueous 
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environment due to geometrical restrictions as reported for albumin (Riddiford and 
Jennings 1966). Therefore, the more lipophilic isopropanol is more effective in the re-
moval of residual protein from an underivatized silica surface compared to methanol or 
ethanol (Reifsnyder et al. 1996) showing that hydrophobic interactions are involved in the 
adsorption of protein on glass surfaces. 
A third mode of interaction with silica is hydrogen bonding. However, in an aqueous 
mobile phase hydrogen bonding between an amino group and the silanol group is consid-
ered to be unlikely, since both moieties will be hydrated with water molecules (Nawrocki 
1997). 
Sulkowski et al. (1987) showed that the simultaneous suppression of both electrostatic 
and hydrophobic interactions are necessary to prevent binding between a protein and a 
glass based surface. Figure VI-9 shows that at the isolelectric pH of 8.0 of the IgG, the 
amount of protein adsorbed was still approximately half of that at optimal binding pH of 
5.0. This suggests that the adsorption of the IgG to the CPG surface is based on both, 
electrostatic and hydrophobic interaction. 
3.2.4 Preferential adsorption of aggregates to CPG 
Soluble mAb aggregates were shown to adsorb to the CPG surface. Especially at pH 5.0 
the addition of 10 m² CPG resulted in a drop of HMWs from about 2.0 % to 0.1 % 
(Figure VI-5A). To further investigate the capability of the undrivatized CPG surface to 
adsorb HMWs and to evaluate the concomitant loss of the monomer on the added sur-
face, protein solutions containing different levels of HMWs (6.8 %, 5.7 % and 3.2 %) were 
incubated with different surface areas of CPG (0.1 m² to 10 m²) at pH 5.0. The percentage 
of monomer and HMWs in solution was determined in the supernatant after incubation 
with the CPG particles by using SE-HPLC. Figure VI-11 shows that the addition of about 
3 m² CPG surface (about 150 m² per gram protein) results in a nearly HMW free solution. 
After incubation, a monomer level of about 99 % was achieved independently of the initial 
level of HMWs present before incubation. 
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Figure VI-11: Percent monomer (A) and percent HMWs (B) in solution after contact to a 
defined CPG surface area at pH 5.0 
About 20 mg IgG (c = 5 mg/ml) with an initial level of 3.2 % (white diamonds), 
5.7 % (grey diamonds) and 6.8 % (black diamonds) of HMWs were incubated 
with up to 10 m² of CPG. 
To evaluate the loss of the IgG monomer and the HMWs on the CPG particles the 
amount of the respective protein species being adsorbed to the CPG surface was calcu-
lated. Therefore, the amount of monomer and HMWs remaining in solution after incuba-
tion with the CPG particles were subtracted from the amount of monomer and HMWs 
initially present in solution. The amount of total protein (encompassing monomer, HMWs 
and LMWs) initially present in solution was about 20 mg. Figure VI-12 shows that the 
amount of adsorbed monomer increases linearly with increased CPG surface area present 
in solution. By adding 10 m² of CPG nearly 100 % (20 mg) of the IgG initially present in 
solution are bound to the CPG particles. This was already identified as the maximum ad-
sorption of 2.0 mg IgG per m² CPG (Figure VI-7). However, about 95 % of the HMWs 
initially present in solution were found to adsorb to the CPG surface when only 3 m² are 
present in solution. Concomitantly, 4 mg of the monomer (about 20 % initially present in 
solution) are lost on the CPG surface. Thus, it is concluded that soluble aggregates are 
preferentially adsorbed to the CPG particles since nearly total HMW adsorption was al-
ready recognized at a significant smaller surface area compared to total monomer adsorp-
tion. 
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Figure VI-12: Milligram of protein adsorbed to a defined CPG surface area at pH 5.0 
About 20 mg IgG (c = 5 mg/ml) with an initial level of 6.8 % HMWs were incu-
bated with up to 10 m² of CPG; the protein concentration was determined by us-
ing UV 280-320 measurements and the percentage of the monomer and the 
HMWs was determined by using SE-HPLC. 
Figure VI-13 shows the percent of monomer and HMWs adsorbed to the CPG surface 
area per gram protein which was initially present before incubation. 
Figure VI-13:  Percent of IgG monomer (white) and HMWs (black) adsorbed to CPG 
20 mg IgG containing 6.8 % HMWs were initially present before incubation with 
0.1-10 m² CPG; experimental data is presented as mean values of three measure-
ments ± SD. 
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Here, the adsorption of HMWs is again clearly favored over the adsorption of the mono-
mer, since the slope of the corresponding curve is much steeper for the HMWs than for 
the monomer. Figure VI-14 shows the corresponding SE-chromatograms of the analyzed 
supernatants after incubation with the CPG surface. 
 
Figure VI-14: SE-chromatograms of the IgG solutions after incubation with up to 350 m² 
surface area of CPG per gram protein 
20 mg IgG containing 6.8 % HMWs were initially present before incubation with 
CPG (black profile); decreasing UV-signal with increasing CPG surface is indi-
cated by changing the colour from black to light grey. 
It is observed that the signal of both, HMW species represented as HMW peak 1 and 
HMW peak 2 is decreasing with increasing CPG surface area present during incubation. In 
first line, the amount of the HMW peak 1 which is considered to be the oligomeric species 
decreases with increasing CPG surface area. Between 40 and 150 m² CPG per gram pro-
tein, the oligomers are completely removed. Only a reduced amount of the HMW peak 2 
species which is considered to be the dimer with a retention time of 13.73 min, was found 
in the solution after incubation. The CPG surface area present during incubation has no 
effect on the amount of the LMWs remaining in solution. Thus, it can be concluded that 
larger soluble aggregates are preferentially adsorbed to the CPG particles. Moreover, 
dimers are prone to adsorb to this surface. The monomeric species is in addition able to 
adsorb to CPG but to a much lesser extent. The surface area of CPG available per gram 
protein can be used to control the amount of aggregated and monomeric species remain-
ing after simple batch incubation. A surface area of 100-150 m² per gram protein is suit-
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able to remove nearly 80-90 % of soluble aggregates from an IgG solution at pH 5.0, hav-
ing concomitantly 80-85 % monomeric IgG remaining in solution. For a solution contain-
ing 20 mg IgG and 6.8 % HMWs the addition of 0.1 g CPG (3 m²) is sufficient to obtain a 
solution of 99 % monomer determined by SE-HPLC by loosing concomitantly about 
20 % of total monmeric protein. 
3.3 Effect of contact to chromatographic surfaces on mAb 
aggregation 
Interfacial adsorption can result in physical instability potentially encompassing the forma-
tion of structural altered molecules (Mollmann et al. 2005; Sluzky et al. 1991; Tzannis et al. 
1997) which are considered as precursors for aggregation (Kendrick et al. 1998a). Moreover, 
a rapid loss of active soluble protein in solution is reported in the presence of nano- and 
micro-sized seeds potentially serving as heterogeneous nuclei facilitating protein aggregation 
as reported before (see chapter I, section 3.4). In this case, the protein adsorbs to the sur-
face, but unfolding does not seem to be involved in this aggregation phenomenon, since 
alterations in secondary or tertiary structure were hardly ever detectable (Bee et al. 2009a; 
Bee et al. 2009b; Chi et al. 2005b; Sluzky et al. 1991; Tyagi et al. 2008). 
Therefore, in this study the IgG solutions were incubated with different surface areas 
of nano- and micro-sized CPG particles over one week to investigate the effect of added 
CPG particles on IgG aggregation. Solutions at pH 5 were applied where the IgG showed 
the most pronounced adsorption to CPG. In addition, the experiments were conducted at 
pH 5 with 150 mM sodium chloride (NaCl) and at pH 7.5, since the protein was shown to 
adsorb to a lesser extent under these conditions. Protein concentration and aggregation in 
the supernatant were monitored over incubation time. Finally, the conformation of the 
protein was investigated before, during and after adsorption to the surface. 
3.3.1 Seeding and aggregation 
To obtain nano-sized particles, the commercially available CPG particles were sonicated in 
water. After sedimentation of the residual large particles, the size distribution in the super-
natant was investigated by laser diffraction. Figure VI-15 shows the size distribution by 
intensity before and after sonication. Before sonication the CPG particles showed a mean 
particle diameter of about 125 µm. A decrease in particle size was observed with 
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sonication time. After 10 min sonication, particles of about 10 µm and smaller were gener-
ated. 
Figure VI-15: Size distribution by intensity [q] of the CPG particles 
CPG particles before sonication (left), after 10 min sonication (middle) and after 
30 min sonication (right). 
After 30 min a mean particle diameter of about 290 ± 88 nm (n = 3) was determined. The 
particles after 10 min and 30 min sonication were used for the seeding experiments. IgG 
solutions (about 6 mg/ml) were incubated with 0-200 m² CPG surface per gram protein 
over one week without headspace on a rotary mixer. The protein was shown to strongly 
adsorb to the CPG surface at pH 5.0 as reported before (Figure VI-16A). 
Figure VI-16: Incubation of IgG at pH 5.0 over 6 days after seeding with CPG particles 
Concentration of soluble IgG remaining in solution (A) and percentage of 
HMWs remaining in solution (B); a defined surface area per gram protein was 
seeded: 0 m²/g (black squares), 50 m²/g (white squares), 100 m²/g (black trian-
gles), 150 m²/g (plain triangles), 200 m²/g (black diamonds); experimental data is 
presented as mean values of three measurements ± SD. 
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The extent of adsorption clearly depends on the surface area of CPG seeded into the solu-
tions. An initial decrease in protein concentration was observed in the supernatant after 
one day incubation. This initial protein loss was proportional to the present surface in so-
lution. The higher the surface area added, the more protein was lost on the CPG particles. 
After this initial adsorption the protein concentration remains constant during incubation 
independent of the initially added surface. No protein loss due to further adsorption or the 
formation of insoluble aggregates was observed during 6 days. 
Moreover, the level of HMWs determined by SE-HPLC decreased with increasing 
CPG surface area as reported before (Figure VI-16B). After one day incubation, no further 
decrease in the level of soluble aggregates was detectable over 6 days. Moreover, no in-
crease of HMWs in the supernatant was recognized. Thus, it can be concluded that neither 
desorption of initially bound aggregates, nor an additional formation of aggregates during 
incubation took place. 
The same experiments were conducted at pH 5.0 using a buffer which contains 
150 mM NaCl (Figure VI-17). 
Figure VI-17: Incubation of IgG at pH 5.0 and 150 mM NaCl over 6 days after seeding 
with CPG particles 
Concentration of soluble IgG remaining in solution (A) and percentage of 
HMWs remaining in solution (B); a defined surface area per gram protein was 
seeded: 0 m²/g (black squares), 50 m²/g (white squares), 100 m²/g (black trian-
gles), 150 m²/g (plain triangles), 200 m²/g (black diamonds); experimental data is 
presented as mean values of three measurements ± SD. 
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Initially, the protein loss was again proportional to the surface area present (Figure 
VI-17A). Beyond one day incubation, no further adsorption of protein was observed over 
5 days. 
In addition, the HMW level was observed to decrease again with provided CPG area 
during one day incubation (Figure VI-17B). Further incubation showed no effect on the 
HMW level in the solutions. Compared to the experiments conducted without adding 
150 mM NaCl, the adsorption of the IgG was in general slightly reduced, as reported be-
fore. Moreover, the adsorption of HMWs under these conditions can be considered as 
similar compared to the values obtained at pH 5.0 without using salt. 
Furthermore, the seeding experiments were conducted at pH 7.5 (Figure VI-18). 
Figure VI-18: Incubation of IgG at pH 7.5 over 6 days after seeding with CPG particles 
Concentration of soluble IgG remaining in solution (A) and percentage of 
HMWs remaining in solution (B); a defined surface area per gram protein was 
seeded: 0 m²/g (black squares), 50 m²/g (white squares), 100 m²/g (black trian-
gles), 150 m²/g (plain triangles), 200 m²/g (black diamonds); experimental data is 
presented as mean values of three measurements ± SD. 
The adsorption of soluble IgG is reduced at this pH as expected and explained above. 
Once more, an increase in the CPG surface area results in a decrease in soluble protein 
remaining in solution. After one day incubation, maximal adsorption was observed and no 
further loss of protein was recognized during the following days (Figure VI-18A). A de-
crease in HMWs was detected with increasing surface area seeded into the solutions 
(Figure VI-18B). The adsorption of the soluble aggregates is complete after one day and 
remains constant over the following 5 days. 
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In general, the adsorption of the soluble aggregates was enhanced at this pH com-
pared to the incubation experiments at pH 5. After one day, the level of HMWs was de-
creased from 6.5 % to 2.0 % by adding 50 m² CPG per gram protein at pH 7.5. In com-
parison, a reduction in HMWs from 5.6 % to 2.5 % was recognized having again 50 m² 
CPG per gram IgG at pH 5.0. 
This can be potentially attributed to a reduction in the electrostatic interactions be-
tween the protein and the CPG surface at pH 7.5 leading to a generally reduced adsorption 
of the monomeric IgG. Concomitantly, hydrophobic interactions between the protein and 
the CPG surface are more pronounced. Since aggregated species are assumed to be more 
hydrophobic than the monomers, this can result in facilitated adsorption of the aggregates 
at this pH, since CPG possesses both, hydrophobic as well as charged functions as re-
ported before. It is reported that both, hydrophobic and charged regions, are present on 
the surface of a protein, potentially mediating the assembly of the molecules to form ag-
gregates (Chiti et al. 2002; Valerio et al. 2005). Differences between the monomeric species 
and the aggregated form of a protein regarding surface charge and hydrophobicity are con-
sidered to be the principle of separation on a charged chromatographic surface. The selec-
tivity of an ion exchange media to separate aggregates is augmented with elevated hydro-
phobicity. It was shown that aggregate removal was facilitated on charged-hydrophobic 
mixed mode surfaces (Gagnon 2009a), better than on exclusively hydrophobic (Lu et al. 
2009) or exclusively charged surfaces (Yigzaw et al. 2009). These mixed mode media ex-
ploit the relatively constant hydrophobicity of a phenyl group in combination with a posi-
tively charged quaternary amine or a pyridyl nitrogen ligand (Huse et al. 2002). 
Under all presented conditions, the adsorption of the IgG and the adsorption of the 
soluble aggregates increased with increasing CPG surface area. The molecules seem to be 
strongly and irreversibly adsorbed to the CPG material under these conditions. Neither the 
protein concentration, nor the level of HMWs in the supernatant changed during further 
incubation. Hence, the seeding of different surface areas did not result in an increase in 
soluble aggregates. Moreover, no precipitation of protein over time was recognized, since 
the concentration of the soluble IgG in the supernatant did not decrease after initial ad-
sorption to the CPG particles during incubation over 5 days (Figure VI-16A, Figure 
VI-17A and Figure VI-18A). Turbidity at 350 nm was found to decrease with increasing 
CPG surface area present in solution and did not change significantly during further incu-
bation over 5 days, too (Figure VI-19). 
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Figure VI-19: Turbidity at 350 nm during incubation of IgG over 6 days after seeding 
with CPG particles 
At pH 5.0 (A) and at pH 7.5 (B); a defined surface area per gram protein was 
seeded: 0 m²/g (black squares), 50 m²/g (white squares), 100 m²/g (black trian-
gles), 150 m²/g (plain triangles), 200 m²/g (black diamonds); experimental data is 
presented as mean values of three measurements ± SD. 
Since an increase in turbidity can be attributed to an increased number of larger protein 
aggregates of up to 1-2 µm in size (Mahler et al. 2005) the decrease in turbidity with in-
creasing CPG surface area present is considered to be the consequence of the initial ad-
sorption of these aggregates to the CPG surface. The IgG solutions seeded with CPG 
particles did not show an induction of aggregates monitored by turbidity measurements 
during incubation over 6 days, neither at pH 5.0, nor at pH 7.5. It has to be stated that the 
centrifugation procedure conducted to separate the seeded CPG particles from the protein 
solution can potentially remove or dissolve larger aggregates. 
3.3.2 Conformational stability 
Secondary structure of the IgG was investigated by using FT-IR spectroscopy. It was pos-
sible to obtain the spectrum of the protein directly attached to the surface of the CPG and 
the ProSep vA ultra particles at pH 5.0 by using the ATR technique. At pH 5.0 a sufficient 
adsorption of protein to both surfaces allowed to record the spectra. The protein covered 
chromatographic particles were washed two times with buffer at pH 5.0 until the washing 
solution was almost cleared from protein. Afterwards, the in buffer suspended particles 
were directly applied to the crystal of the ATR cell. The spectrum of the directly adsorbed 
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protein was compared to the spectrum of a protein sample which had no contact to the 
surface before (Figure VI-20). 
Figure VI-20: Second derivative ATR FT-IR spectra of the IgG at pH 5.0 
On CPG (bolded dashed line), on ProSep vA ultra (dotted line) and without con-
tact to the chromatographic surface (solid line). 
In general, differences in the second derivative spectra of the three samples were observed. 
The amid I band at a wave number of 1639 cm-1 in the native solution (without contact to 
the chromatographic surface) was slightly shifted to a lower wave number at 1637 cm-1 
when the IgG was directly adsorbed to the CPG surface. This shift was recognized as well 
when the IgG was bound to ProSep vA ultra. Moreover, a loss in intensity of the shifted 
amid I frequency at 1639 cm-1 was observed, when the protein was adsorbed to both sur-
faces. In addition, the band at a wave number of 1687 cm-1 showed an increased intensity 
in the second derivative spectrum when the protein was adsorbed to the surfaces. 
The described spectral changes in the amid I region were assigned to the formation of 
intermolecular ß-sheet structure (Chang et al. 2005; Cleland et al. 2001). A shift of the 
band at 1640 cm-1 to a lower wave number and a concomitantly reduced intensity of this 
band, as well as a weak intensity peak at 1690 cm-1 were related to changes in the secon-
dary structure elements of IgGs before (Matheus et al. 2006a; Pelton and McLean 2000). 
Interestingly, the protein attached to ProSep vA ultra being predominantly adsorbed 
via the Protein A ligand, seems to exhibit stronger alterations in secondary structure com-
pared to the protein adsorbed to the CPG surface. 
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After desorption from the surfaces, the transmission spectrum of the protein in solu-
tion was recorded. Desorption from CPG was achieved by using a buffer at pH 9.0 and by 
using a buffer at pH 3.0 to remove the protein from ProSep vA ultra (Figure VI-21A). 
Figure VI-21: Second derivative FT-IR spectra of the IgG 
After desorption at pH 9.0 from CPG (bolded dashed line), at pH 3.0 from 
ProSep vA ultra (dotted line) and without contact to the chromatographic surface 
at pH 5.0 (solid line) (A); after incubation without contact to the beads at pH 9.0 
(bolded dashed line), at pH 3.0 (dotted line) and at pH 5.0 (solid line). 
When the protein was desorbed from both surfaces only a decrease of the band at 
1639 cm-1 was observed. The decrease of the band was more pronounced for the protein 
which was desorbed from ProSep vA ultra at pH 3.0 compared to the protein which was 
desorbed from CPG at pH 9.0. The desorption experiments had to be conducted using a 
buffer at pH 9.0 in the case of CPG and a buffer at pH 3.0 in the case of the Protein A 
medium to ensure sufficient removal of the protein. Figure VI-21B shows the spectra ob-
tained from the protein which was solely incubated at pH 3.0 and at pH 9.0 without hav-
ing contact to the chromatographic surfaces before. Again, the decrease of the band at 
1639 cm-1 was more pronounced for the sample at pH 3.0 compared to the sample at 
pH 9.0. Thus, the potential conformational changes are rather ascribed to the buffer con-
ditions used than to the previous contact to the chromatographic beads. 
Potential changes in tertiary structure were monitored by using 2D-UV spectroscopy. 
The spectra of the desorbed protein were recorded and compared to those of a solution 
which was not exposed to the surfaces before. Moreover, the spectra were compared to 
structurally altered IgG molecules as a positive control. Therefore, the protein was incu-
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bated for 2 hours at 80 °C and for 10 min in 6 M guanidine hydrochloride. Figure VI-22 
summarizes all the recorded spectra. 
Figure VI-22: 2D-UV spectra of the IgG in solution 
Desorbed from CPG at pH 9.0 (black dashed line), from ProSep vA ultra at 
pH 3.0 (black dotted line) and without contact to the chromatographic surface at 
pH 5.0, pH 3.0 and pH 9.0 (black solid line); IgG at pH 5.0 incubated at 80 °C 
(dashed grey line) and in 6 M guanidinium hydrochloride (dotted grey line). 
No differences between the spectra of the desorbed protein and the protein which had no 
contact to the surface before were observed, since all spectra almost perfectly overlaid. 
The protein which was exposed to heat and guanidine hydrochloride showed a shift to 
lower wave lengths as expected (see chapter IV).  
After incubation with the beads, the protein remaining in the liquid supernatants after 
centrifugation was analyzed with FT-IR in transmission mode. The spectra in the amide I 
region were compared to the spectra of the protein which had no contact to the surface 
before. No differences were observed since all recorded spectra of the IgG in solution 
almost perfectly overlaid (Figure VI-23). 
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Figure VI-23: Second derivative FT-IR spectra of the IgG 
After contact to CPG (bolded dashed line), to ProSep vA ultra (dotted line) and 
without contact to the chromatographic surface (solid line). 
Summarizing, it can be concluded that the exposure of the IgG to CPG or CPG based 
Protein A particles did not result in detectable conformational alterations of the protein 
molecules as regards secondary and tertiary structure. 
3.4 Effect of host cell proteins on mAb aggregation 
As reported before, heterogeneous nucleation induced aggregation of proteins may not 
solely be induced by exogenous particles shed or abraded from several kinds of surfaces to 
which the protein solution is exposed during bioprocessing or storage. Indigenous protein 
species like host cell proteins (HCPs) present in solution are also suspected to induce ag-
gregation of the mAb. The HCPs, a typical process related impurity, have to be removed 
during the purification process of therapeutically used recombinantly derived proteins. 
Multiple separation steps have to be performed, since HCPs are a complex mixture of 
numerous proteins with divers physicochemical properties regarding IP and molecular 
weight (Jin et al. 2010; Rathore et al. 2003). The abundance and diversity of HCPs in the 
harvested product pool have been shown to depend on the protein of interest, the host 
organism and the cell culture and harvest conditions (Eaton 1995).  
In this study, the HCPs purified from a “null” CHO in-house master cell were char-
acterized and the potential of this HCP composition to induce mAb aggregation was in-
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vestigated afterwards by performing spiking experiments at different pHs and buffer con-
ditions. 
3.4.1 Host cell proteins from CHO cell culture 
The pattern of the HCP composition was analyzed by 2D-gel electrophoresis to resolve 
the complex protein mixture in charge (IEF) and size (SDS-PAGE). The protein proper-
ties molecular weight and IP can be obtained by this method. Figure VI-24 shows a 2D-gel 
image of the HCPs isolated from the “null” CHO cell culture harvest. 
Figure VI-24: 2D-gel image of HCPs from the HCP standard solution derived from a 
purified “null” CHO cell mock culture harvest 
First dimension: IEF pH 3-10 (horizontal); second dimension: SDS-PAGE (ver-
tical). 
An uneven distribution of protein species was observed across the molecular weight (Mw) 
and IP range investigated. A bias towards the lower to mid molecular weight proteins 
(< 70 kDa) was recognized. It has to be stated that the 2D-gels were operated under re-
ducing and denaturing conditions which dissociate disulfide bonds and protein complexes. 
Thus, the HCP standard may additionally contain protein species of higher molecular 
weight. Considering the IP of the proteins, divers species distributed over the acidic as well 
as the basic region were recognized. No major population located either in the acidic or 
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the basic region was identified. The abundance (spot volume) was shown to differ among 
the detected species (spots). Some big spots are obvious suggesting that a set of abundant 
proteins constitute a major portion of all HCPs in the harvested cell culture fluid. The 
reported pattern of HCP distribution in the used CHO cell culture fluid is somehow dif-
ferent from the pattern observed in other studies, where a bias of CHO dedicated extracel-
lular HCPs towards acidic proteins has been shown (Jin et al. 2010; Wimmer et al. 1994). 
However, intracellular HCPs are reported to be more uniformly distributed over a pH 
range of 3-10 (Krawitz et al. 2006). Both, intracellular as well as extracellular HCPs are a 
subset of the total CHO cell proteome. The secreted as well as the intracellular proteome 
of a specific cell may bias towards species with various properties and each contains in 
general thousands of different proteins. Moreover, lyzed and healthy cells can differ sig-
nificantly in their expressed proteome since they are in a very different physiological state 
(Jin et al. 2010). Furthermore, the harvested cell culture fluid can contain much more dif-
ferent protein species if the cells were destructed. Since engineered mammalian host cells 
are able to secrete the target protein of interest into the cell culture fluid, the cell mem-
brane is usually not disrupted deliberately to harvest the protein. However, it is known that 
death and disruption of the cells always occur during cultivation and harvesting and thus 
protein species which are normally not secreted into the fermentation broth may be re-
leased. Thus, the present population of HCPs is considered a representative mixture of 
HCPs derived from CHO cell culture which may occur in the harvested cell culture fluid 
and in the purification intermediates. 
In addition, the HCP standard solution was investigated by zeta potential measure-
ments at pH 2-12 to determine the average IP of all HCPs present in solution. Figure 
VI-25 shows that an IP of about 4.5 was determined for the HCP composition present in 
the standard solution. Since the charge of a protein depends not only on the environ-
mental pH but also on buffer electrolyte composition this method potentially allows for a 
more representative analysis of the proteins in solution compared to isoelectric gel electro-
phoresis (Winzor 2005). Moreover, the average IP of all HCPs accounts for the abundance 
of individual protein species with a defined IP. Thus, it is concluded that the major frac-
tion of the HCPs in the standard solutions are proteins with an IP in the acidic region. 
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Figure VI-25: Zeta potential titration curves of the IgG (black) and the HCP standard 
solution derived from a purified “null” CHO cell mock culture harvest 
(grey) 
Experimental data is presented as mean values of three measurements ± SD. 
Figure VI-25 also reveals the property differences between this defined HCP population 
and the IgG used in this study. Most IgGs are basic with an IP in the range of 8 and 9 (see 
in addition chapter V: Figure V-8 and Figure V-13V), as observed here. Thus, interactions 
between the HCPs and an IgG based on charge-charge interactions may potentially occur 
leading to aggregation. At a pH above 4.5 the surface charge of the major HCP fraction 
changes from positive to negative whereas the overall charge of the IgG remains positive 
at a pH below 8. Therefore, charge-charge based interactions of several HCP species and 
the IgG are considered to reach the maximum at a pH between 5 and 6 when both exhibit 
an oppositely charged surface. 
3.4.2 Seeding and aggregation 
Spiking experiments were conducted at pH 3.0, pH 5.0 and pH 7.5 covering both, the pH 
region of potential charge-charge based interaction (pH 5.0 and pH 7.5) and charge-charge 
based repulsion (pH 3.0) of the major fraction of HCPs and the IgG. 500 ng and 1000 ng 
HCP (derived from the HCP standard solution) per mg IgG (= 2.5 µg/ml HCP and 
5 µg/ml HCP) were spiked into the solutions and the samples were incubated on a rotary 
mixer at room temperature and at 40 °C. This HCP is considered representative for Pro-
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tein A and CEX purification intermediates. Results were compared to samples which were 
incubated without adding HCP standard solution (0 ng/mg HCP). Figure VI-26 shows the 
level of HMWs and LMWs in solution monitored with SE-HPLC during storage at 40 °C. 
Figure VI-26: Percent HMWs (A) and LMWs (B) in solution determined with SE-HPLC 
Incubation at room temperature for 24 hours after spiking with 0 ng/mg HCP 
(white), 500 ng/mg HCP (light grey) and 1000 ng/mg HCP (dark grey); for each 
sample about 20 mg IgG were applied; results are presented as mean values of three 
measurements ± SD. 
Differences in the level of HMWs considering the pH of the solutions were observed. At 
pH 3.0, the HMW level stepped up to about 16 % compared to solutions at pH 5.0 and 
pH 7.5 showing a HMW level below 2 %. A slight induction of HMWs in the presence of 
HCPs was only observed at pH 3.0. The percentage of LMWs was recognized to depend 
on the pH of the solutions as well (Figure VI-26B). At pH 3.0 an increase in LMWs up to 
about 6 % was observed. In general, the HCP concentrations applied in the experiments 
were sufficiently low enough to be not detectable by the SE-HPLC method used. This was 
evaluated by diluting the HCP standard solution with buffer and injecting 200 ng of HCP 
into the SE-column. This amount of HCP is about two times higher than the amount of 
HCP injected to the SE-column when the 1000 ng/mg HCP samples are analyzed. No 
peak was detected in the SE-chromatogram when this buffer diluted solution was ana-
lyzed. 
During storage at 40 °C a slight increase in the level of HMWs of the HCP spiked so-
lutions at pH 3.0 was recognized compared to the unspiked solutions after two weeks 
(Figure VI-27A). However, after four weeks no differences in the HMW level between the 
HCP spiked and unspiked solutions were observed. At pH 5.0 and pH 7.5 no differences 
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in the percentage of HMWs of the spiked and unspiked solutions were recognized over 
two weeks. However, the LMW level at pH 5.0 of about 0.2 % stepped up to 2 % after 
two weeks when 500 ng/mg HCP were present (Figure VI-27B). In the presence of 
1000 ng/mg HCP the percentage of LMWs further increased up to 3 %. This increase in 
LMWs at pH 5.0 in the presence of HCPs further proceeded over time. 
Figure VI-27: Percent HMWs (A) and LMWs (B) in solution determined with SE-HPLC 
Incubation at 40 °C for two week (solid bars) and four weeks (striped bars) after spik-
ing with 0 ng/mg HCP (white), 500 ng/mg HCP (light grey) and 1000 ng/mg HCP 
(dark grey); for each sample about 20 mg IgG were applied; results are presented as 
mean values of three measurements ± SD. 
By looking at the incubated samples at pH 7.5, no increase in HMWs or LMWs was rec-
ognized in the presence of 500 ng/mg or 1000 ng/mg HCP in comparison to the un-
spiked samples. 
Degradation of full-length antibodies can be the consequence of multiple causes en-
compassing physical, chemical and biological ones. Cleavage in the flexure point between 
the Fc and the Fv domain (hinge region), clippings in the sequence in general or breakage 
of disulfide bonds are known to result in fragmented molecules of different size and 
amino acid sequence. A variety of processing conditions is known to potentially accelerate 
mAb fragmentation, such as thermal treatment (Harrison et al. 1998; Liu et al. 2006), radia-
tion treatment (Caballero et al. 2004), exposure to light (Kerwin and Remmele 2007; Qi et 
al. 2008) or basic or acidic treatment (Daugherty and Mrsny 2006; Gaza-Bulseco and Liu 
2008; Usami et al. 1996). In this study, the degradation of the IgG was in fact enhanced at 
pH 3.0. However, an increase in fragments was solely observed at pH 5.0 when the HCP 
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standard solution was added. It is known that IgG degradation moreover occurs in the 
presence of proteolytic enzymes, whose activity can be controlled by temperature, pH or 
specific inhibitors and substrates (Robert et al. 2009). Papain and pepsin are the most 
prominent ones which are well known to cleave peptide bonds in the hinge and hinge 
proximal region of the CH2 domain of IgG. Since a variety of proteases are expressed dur-
ing cultivation of CHO cell lines which were shown to lead to degradation of the recom-
binant protein (Busby et al. 2000; Robert et al. 2009; Sandberg et al. 2006), it was con-
cluded that the HCP standard solution used contains at least one proteolytic protein spe-
cies resulting in IgG degradation at pH 5.0. 
SDS-PAGE of the solutions containing 1000 ng/mg HCP after storage for four 
weeks at 40 °C revealed that actually at pH 5.0 (lane 6) additional bands below 30 kDa 
appeared in the gel which were not observed in the absence of the spiked HCP standard 
(lane 5) (Figure VI-28A).  
Figure VI-28: SDS-PAGE silver stained gels of non-reduced IgG samples at pH 3.0 and 
pH 5.0 (A) and pH 7.5 (B) after incubation with 0 ng/mg and 1000 ng/mg 
HCP at 40 °C for four weeks 
Lane 1 and 7: molecular weight (Mw) standard; lane 2 and 8: buffer; lane 3: IgG 
at pH 3.0; lane 4: IgG + 1000 ng/mg at pH 3.0; lane 5: IgG at pH 5.0; lane 6: 
IgG + 1000 ng/mg at pH 5.0; lane 9: IgG at pH 7.5; lane 10: IgG + 1000 ng/mg 
at pH 7.5. 
Moreover, the bands at about 50 kDa which can be assigned to IgG heavy chain or Fab 
fragments (Mahler et al. 2009) showed an increase in intensity solely in the presence of 
HCP. The samples containing 1000 ng/mg HCP during storage at pH 3.0 and pH 7.5 did 
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not show any significant differences in the band composition compared to the unspiked 
ones (Figure VI-28B). The bands which are assignable to the HMWs showed a decreased 
intensity for the samples at pH 5.0 containing 1000 ng/mg HCPs, suggesting that HMWs 
were also degraded in the presence of the proteolytic proteins (Figure VI-28A). 
Beside the analysis of soluble aggregates detected by SE-HPLC, the HCP spiked and 
unspiked samples were investigated by turbidity measurements. Figure VI-29 shows that 
an induction of larger aggregates can be solely attributed to the environmental pH, since 
turbidity was shown to generally increase with increasing pH of the solutions. Incubation 
of the spiked solutions did not reveal any significant difference in turbidity depending on 
the HCP level, neither at room temperature, nor at 40 °C. 
Figure VI-29: Turbidity at 350 nm during storage at room temperature (A) and storage at 
40 °C (B) 
Incubation at room temperature for 24 hours (A) and at 40 °C for two week (solid 
bars) and four weeks (striped bars) (B) after spiking with 0 ng/mg HCP (white), 
500 ng/mg HCP (light grey) and 1000 ng/mg HCP (dark grey); for each sample 
about 20 mg IgG were applied; results are presented as mean values of three meas-
urements ± SD. 
The potential induction of aggregates in the presence of HCPs derived from CHO cells 
was moreover investigated in acetate buffer containing 10-250 mM sodium chloride at 
pH 5.0. It was expected that the level of aggregates may increase in the presence of salt 
and the addition of HCP may further promote the propensity of the IgG to aggregate. 
Figure VI-30A shows that the increasing molarity of NaCl at pH 5.0 results in an induction 
of HMWs determined by SE-HPLC after storage at 40 °C. This was expected, since it is 
known that repulsive electrostatic interactions between the protein molecules at non 
A B
0.000
0.020
0.040
0.060
0.080
0.100
pH 3.0 pH 5.0 pH 7.5
tu
rb
id
ity
 
35
0 
nm
 [A
U
]
0.000
0.020
0.040
0.060
0.080
0.100
pH 3.0 pH 5.0 pH 7.5
tu
rb
id
ity
 
35
0 
nm
 [
A
U
]
tu
rb
id
ity
 
35
0 
nm
 [A
U
]
tu
rb
id
ity
 
35
0 
nm
 [
A
U
]
Chapter VI Investigation of heterogeneous nucleation dependent aggregation of mAbs during purification 
204 
isoelectric pH are reduced leading to self-association (Chi et al. 2003b; Przybycien and 
Bailey 1989). The presence of HCPs in solution results in a decrease of the HMW level 
which was further pronounced with a higher salt molarity. The decrease in HMWs in the 
presence of HCP was already visible after 24 hours at room temperature (data not shown). 
Concomitantly, the level of LMWs increased in addition with increasing salt concentration 
(Figure VI-30B). The level of LMWs increased in addition with the concentration of HCPs 
and with storage time. 
Figure VI-30: Percent HMWs (A) and LMWs (B) in solution determined with SE-HPLC 
Incubation at 40 °C for two week (solid bars) and four weeks (striped bars) after spik-
ing with 0 ng/mg HCP (white), 500 ng/mg HCP (light grey) and 1000 ng/mg HCP 
(dark grey); for each sample about 20 mg IgG were applied; results are presented as 
mean values of three measurements ± SD. 
SDS-PAGE gels showed additional bands in the region of < 31 kDa in molecular weight 
which appeared only in the presence of HCPs (lane 7-8) (Figure VI-31). The number of 
bands which are assignable to small fragments of about 10-20 kDa increased with higher 
molarity of salt. Moreover, the intensity of the bands in the region of 50 kDa increased in 
the samples containing 1000 ng/mg HCP. The increased propensity of the IgG to form 
HMWs with increasing NaCl concentration was no longer obvious when 1000 ng/mg 
HCP were present in solution. The formation of differently sized fragments and the ab-
sence of HMWs during incubation with HCPs were assigned to a proteolytic activity at 
pH 5.0 of the HCPs being clearly enhanced in the presence of salt. Thus, it was concluded 
that potential formation of HMWs induced by HCPs does not appear under the selected 
conditions or was not detectable due to the proteolytic activity of at least one HCP species 
in the standard solution used. 
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Figure VI-31: SDS-PAGE silver stained gels of non-reduced IgG samples at pH 5.0 after 
incubation with 0 ng/mg and 1000 ng/mg HCP at 40 °C for four weeks 
Lane 1: molecular weight (Mw) standard; lane 2: buffer; lane 3: IgG in 10 mM 
NaCl; lane 4: IgG in 100 mM NaCl; lane 5: IgG in 150 mM NaCl; lane 6: IgG in 
250 mM NaCl; lane 7: IgG + 1000 ng/mg HCP in 10 mM NaCl; lane 8: IgG + 
1000 ng/mg HCP in 100 mM NaCl; lane 9: IgG + 1000 ng/mg HCP in 150 mM 
NaCl; lane 10: IgG + 1000 ng/mg HCP in 250 mM NaCl. 
Finally, turbidity measurements were conducted during storage at 40 °C (Figure VI-32). 
Turbidity did not increase in general with higher salt concentration. All samples which 
were not spiked with HCPs revealed a turbidity value of about 0.05 AU after storage for 
two weeks. In the presence of HCPs the turbidity increased after two weeks in a buffer 
containing 10 mM and 100 mM salt. Turbidity increased further with incubation time. 
After four weeks, turbidity values were found to step up from 0.05 AU to 0.23 AU in the 
presence of 500 ng/mg HCP and to 0.56 AU in the presence of 1000 ng/mg in the buffer 
containing 10 mM NaCl. A level of 0.78 AU was found after four weeks in 100 mM NaCl 
when 1000 ng/mg HCP were present in solution. At higher salt molarities exceeding 
100 mM this strong increase in turbidity during storage in the presence of HCPs was no 
longer observable. This was once more assigned to the proteolytic activity of the HCPs, 
which was shown to be enhanced at a higher salt concentration. During storage over four 
weeks in 250 mM salt, almost no differences in turbidity between the HCP spiked and 
unspiked samples were identified. 
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Figure VI-32: Turbidity at 350 nm during storage at 40 °C 
Incubation for two weeks (solid bars) and four week (striped bars) after spiking 
with 0 ng/mg HCP (white), 500 ng/mg HCP (light grey) and 1000 ng/mg HCP 
(dark grey); for each sample about 20 mg IgG were applied; results are presented 
as mean values of three measurements ± SD. 
In summary, HCPs from CHO cells were only partly involved in the formation of IgG 
aggregates. Solely at pH 3.0 an increase in the formation of aggregates monitored by SE-
HPLC and turbidity measurements was observed due to the presence of 500 ng/mg and 
1000 ng/mg HCP. At pH 5.0 an increase in turbidity due to the presence of HCPs was 
recognized in a buffer containing 10-100 mM salt. Both pH 3.0 and pH 5.0 with 10-
150 mM NaCl were shown to be the conditions reducing protease activity. In general, the 
spiking material applied in this study was shown to contain at least one proteolytic HCP 
species which was involved in the degradation of the IgG. 
4 Summary and conclusion 
It was shown that unfunctionalized macro-porous matrices adsorb soluble IgG molecules 
from liquid bulks. Especially, the surface of controlled pored glass (CPG) which is a com-
monly applied matrix material in Protein A chromatography, was shown to strongly adsorb 
the protein at different buffer conditions. A maximum adsorption of 2 mg IgG per m² 
CPG was observed at pH 5.0. The main driving forces for IgG adsorption to the CPG 
surface was found to be based on electrostatic and hydrophobic interactions between the 
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protein and the CPG. However, adsorption of protein molecules to interfaces and solid 
surfaces is in general reported to cause aggregation potentially entailed by conformational 
changes in secondary or tertiary structure, no induction of soluble IgG aggregates was 
observed after contact to the CPG surface in a pH range of 3.0 to 7.5. Moreover, CPG 
particles were shown to preferentially adsorb soluble aggregates, encompassing dimers as 
well as oligomeric species. 3 m² of CPG (about 0.1 g) were found to be sufficient to ad-
sorb nearly 95 % of the HMWs from a solution containing about 5 mg/ml IgG including 
6.8 % HMWs before incubation. Concomitantly, 20 % (about 4 mg) of total protein in 
solution was lost on the surface. In general, a surface area of 100-150 m² per gram IgG in 
solution is suitable to remove nearly 80-90 % of soluble aggregates from an IgG solution 
at pH 5.0, having concomitantly 80-85 % monomeric IgG remaining in solution. 
Soluble aggregates were shown to irreversibly bind to the CPG surface at pH 5.0 and 
pH 7.5 over 6 days. Furthermore, no induction of HMWs was recognized due to the expo-
sure of the IgG to the glass based surface. Here, exogenous micro- as well as nano-sized 
particles were shown to be capable to adsorb monomeric as well as aggregated IgG spe-
cies. However, an additional formation of aggregates potentially expected to occur via a 
heterogeneous nucleation dependent mechanism was not observed. After initial adsorption 
of monomeric and aggregated species no further loss of soluble protein was observed. 
Moreover, neither induction of larger aggregates monitored by turbidity measurements, 
nor precipitated protein was recognized. 
The protein being adsorbed to the porous material was shown to be only slightly per-
turbed with regards to secondary structure monitored by ATR FT-IR. The protein in the 
supernatant remaining in solution after incubation with the CPG based surface did not 
show any spectral differences compared to the native protein, with regards to secondary 
structure (FT-IR spectroscopy) as well as tertiary structure (UV spectroscopy). 
 Since the rate and onset of aggregation are usually not predictable and a limited re-
moval capacity of soluble aggregates is only possible during the purification process, it is 
considered useful to have additional capacity in place to reduce the aggregate level espe-
cially at the interface to final formulation or directly prior to or during parenteral admini-
stration. The application of unfunctionalized CPG particles is considered suitable to re-
move soluble aggregates from process intermediates as well as from fully purified bulks or 
formulated material. CPG is known to be a rigid material showing high chemical inertness. 
The material is reported to withstand heat sterilization and cleaning with hot nitric acid 
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(Schnabel and Langer 1991). Thus, actually the application in combination with prefilled 
devices is possible to remove aggregates potentially formed during storage prior to par-
enteral administration. During purification processes or at the interface to final formula-
tion, the unfunctionalized porous matrix can be simply added to the liquid protein solution 
in batch mode. After incubation, the aggregate-loaded particles can be removed from the 
bulk solution by centrifugation and micro-filtration. 
As regards IgG aggregation induced by HCPs derived from a CHO cell were shown 
to be only partially involved in IgG aggregation. It was assumed, that IgG aggregation may 
be induced in the presence of HCPs at pH 5-6 were attractive electrostatic interaction be-
tween the major HCP fraction and the IgG were expected. However, at pH 3.0 a slight 
increase in the formation of aggregates monitored by SE-HPLC and turbidity measure-
ments was observed due to the presence of 500 ng/mg and 1000 ng/mg HCP. At pH 5.0 
an increase in turbidity due to the presence of HCPs was recognized in a buffer containing 
10-100 mM salt. In general, the spiking material applied in this study was shown to contain 
at least one proteolytic HCP species which was involved in the degradation of the mono-
meric as well as the aggregated IgG. 
For further investigations regarding the potential induction of IgG aggregates due to 
the presence of HCPs, it is recommended to suppress the proteolytic activity of the spik-
ing material. Proteolytic enzymes are organized in type, clan and family depending on 
which amino acid is envolved in the catalytic site, e.g. serine-, cystein or aspartic proteases 
are known (Barrett et al. 2004). Moreover, if a metal ion is required as co-factor the en-
zyme is identified as a metallo-protease. The different types of proteases have specific in-
hibitors, like aprotinin, pepstatin or EDTA which are detailed elsewhere (Barrett et al. 
2004; Cordoba et al. 2005; Robert et al. 2009) and compositions of them are considered 
useful to be tested in future experiments to control degradation of the IgG caused by the 
proteases. 
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Chapter VII Final summary of the thesis 
Monoclonal antibodies represent one of the fastest growing segments in biotechnology 
and due to enormous progress in recombinant DNA technology a large number of phar-
maceutically relevant peptides and proteins became accessible as therapeutic products. 
Although, the structure of IgGs is well known, all recombinant derived molecules of this 
class have unique sources of heterogeneity due to different structure and glycosylation, 
heterologous expression systems and impurity profiles, processing conditions and degrada-
tion processes. Thus, during the development of each new therapeutic candidate all char-
acteristics of the molecule have to be elucidated considering their effect on potency, stabil-
ity or immunogenicity. Since substantial progress was made in all fields of therapeutic 
mAb generation, encompassing cell culture, purification, analytic and formulation devel-
opment, this triumphal procession of mAbs as treatments for numerous human diseases in 
the last decades was possible. A crucial problem of protein based biopharmaceuticals is 
still their stability, since proteins are inherently prone to degradation. Factors influencing 
protein stability are of special importance during formulation development to ensure long-
term stability of the formulated drug product. However, the integrity of the molecule is of 
utmost importance during all stages of bioprocessing and the focus of this thesis was to 
gain more insight in mainly physical instability occurring during the purification process of 
therapeutic mAbs and at its interface to final formulation. The evaluation of critical factors 
leading to aggregation as well as the development of strategies to improve the quality of 
the purified bulk was focused. 
 
Chapter I provides an introduction into the field of therapeutic antibodies especially focus-
ing on purification techniques being applicable at lab scale as well as at manufacturing 
scale. An overview encompassing different chromatographic principles, as well as several 
filtration techniques is given. Applied manufacturing strategies and their influence on pro-
tein aggregation were presented and a general overview on different factors leading to pro-
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tein aggregation was summarized. Conformational and colloidal aspects, as well as concen-
tration and nucleation dependent aggregation were accounted for. 
 
The main objectives of the present work are detailed in chapter II. 
 
In chapter III the effect of operational parameters during tangential UF was evaluated 
regarding their potential to adversely affect the physical stability of concentrated IgGs in 
the retentate. The influence of flow and pressure conditions as well as of the protein con-
centration during processing was examined. A previously described correlation between 
shear stress and applied pressure and flow conditions showed that wall shear stress has to 
be limited to avoid an increased level of mainly insoluble and structurally perturbed aggre-
gates in the concentrated bulk. Concomitantly, a minimal shear stress was shown to be 
necessary to ensure sufficient back transport of deposited solutes from the membrane into 
the retentate leading to sufficient permeate flux over time. 
In general, permeate flux was recognized to strongly decrease with increasing protein 
concentration. Therefore, a systematic variation of process conditions was performed at 
different protein concentrations in the retentate. It was shown that the defined variation of 
retentate flow and TMP during the process was successful in achieving a high end-
concentration exceeding 100 mg/ml. Additionally, a 20 % reduction in process time was 
recognized when this optimized method was used in comparison to two UF methods op-
erating at constant pressure and flow conditions. Concomitantly, a decreased level of con-
formationally altered aggregates in the concentrated solutions was shown for three differ-
ent mAbs. 
Finally, the operational parameters applied during UF were shown to impact subse-
quent processing steps. The concentrates derived from the optimized UF method showed 
an improved flow rate during sterile filtration processing due to improved bulk quality in 
terms of aggregation. This is important because this essential final manufacturing step is 
already adversely affected by the high viscosity of the concentrated protein solution. 
 
Chapter IV deals with the stability of highly concentrated IgG solutions generated by ap-
plying different UF methods. A reduced level of insoluble aggregates before and during 
storage of the concentrated solutions was recognized when the optimized UF method was 
applied. These aggregates were completely removed by 0.22 µm filtration and did not re-
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appear during storage. A significant reduction of the HMW level was not that pronounced 
when the optimized method was used. Interestingly, filtration of the concentrated solu-
tions was observed to facilitate the formation of soluble aggregates during storage. In the 
presence of large particulate aggregates the formation of HMWs was repressed. The pro-
tein aggregation behavior in highly concentrated solutions was shown to be rather con-
trolled by a homogeneous nucleation and growth process than by partially unfolded mole-
cules, since the protein was recognized to be in general protected against conformational 
changes at a higher total protein concentration. The increase in the melting temperature 
(Tm) at a high protein concentration of 90 mg/ml did not result in a decreased formation 
of aggregates during storage below Tm. The applied UF method seemed to significantly 
affect the conformational stability of the protein, however these results did not correspond 
to the aggregation behavior during stability studies, since no significant differences regard-
ing the level of several types of aggregates in the differently processed concentrates were 
observed during storage below Tm. In general, storage at 2-8 °C was clearly shown to be 
the best choice for unformulated highly concentrated IgG solutions to circumvent the 
formation of aggregates. 
 
At the interface of downstream processing and final formulation of highly concentrated 
mAb solutions a significant deviation in solute concentration, pH and conductivity was ob-
served with increasing protein concentration during UF processing (chapter V). It was 
known from current literature that during dialysis of non-IgG proteins the concentration of 
the diffusible buffer forming solutes changes on the retentate side compared to the permeate 
side. This thermodynamic non-ideality, based on electrostatic interactions of the solutes and 
the protein at non isoelectric pH leads to unequal partitioning of charged solutes across the 
membrane. The so-called Donnan-effect was investigated and evaluated for two different 
IgGs during the UF concentration process adequately reflecting process conditions at manu-
facturing scale. It was shown that post-diafiltration as well as post-concentration assays of 
200 mg/ml IgG revealed up to 50 % lower molar histidine concentrations than those of the 
diafiltration buffer. Deviations were also observed when the IgG was dialyzed and concen-
trated in an acetate buffered environment. Here, up to 100 % higher molar acetate concen-
trations were found. The Donnan-equation was shown to adequately reflect the partitioning 
characteristics of the small solutes during UF of IgGs depending mainly on protein charge 
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and concentration. The partitioning behavior was successfully correlated to pH and conduc-
tivity characteristics observed during UF processing. 
Since it was known, that pH as well as the solute composition and concentration of 
the buffer system are important factors to provide sufficient stability of the protein in so-
lution, the relevance of the altered solution conditions as a consequence of the UF proc-
essing was evaluated. It was shown, that chemical and physical stability of the concentrated 
bulk were compromized in the case of a histidine buffer at a protein concentration of 
200 mg/ml. Moreover, pH corrections in the concentrated solutions were observed to 
contribute to an increased level of differently sized aggregates. Therefore, the Donnan-
equation was applied for the feasible prediction of the molar histidine concentration re-
quired before UF in order to achieve the desired molarities after UF and to circumvent 
concomitantly deviations in pH. An increase in the histidine molarity to 31 mM before UF 
as predicted by the Donnan-equation was suitable to end up with 20 mM histidine at pH 5 
after UF up to 200 mg/ml IgG concentration. It was shown that this feasible approach led 
to a reduced level of protein aggregates as well as of deamidated Fab fragments in the con-
centrated bulk solutions. Moreover, an improved chemical and physical stability of the 
concentrated protein was recognized during storage which was related again to the higher 
histidine molarity and the stable pH conditions during and after UF. 
In addition, the add-on of histidine before UF contributed to a decrease in viscosity 
of the concentrated protein solutions. This is of special interest since a higher viscosity of 
the solutions can introduce divers issues during manufacturing, filling and administration 
to the patient. 
 
In chapter VI the potential role of exogenous impurities on the physical stability of mAb 
purification intermediates was investigated. An IgG was shown to strongly adsorb to an 
unfunctionalized chromatographic matrix based on controlled pored glass (CPG). The 
main driving forces for adsorption were found to be based on electrostatic and hydropho-
bic interactions between the CPG surface and the protein molecules. No induction of pro-
tein aggregates at different buffer conditions was recognized, however the adsorption of 
protein molecules to surfaces is generally known to facilitate their aggregation. ATR FT-IR 
spectroscopy was successfully used to access the secondary structure of the IgG directly 
adsorbed to the CPG surface and the exposure to CPG particles did not result in detect-
able conformational alterations of the protein molecules as regards secondary and tertiary 
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structure (UV-spectroscopy). Furthermore, no induction of aggregates was observed when 
micro- and nano-sized particles were incubated with IgG solutions for one week. After 
initial adsorption of monomeric and aggregated species no further loss of soluble mono-
meric protein was observed. However, an additional formation of aggregates potentially 
expected due to a heterogeneous nucleation dependent mechanism was not recognized. 
Since the CPG matrix was shown to have the potential to irreversibly adsorb protein 
aggregates it was assumed to utilize the particles specifically to reduce the aggregate level 
of IgG solutions. It was recognized that soluble aggregates, encompassing dimers and oli-
gomers, were favorably adsorbed to the CPG surface. After incubation of the glass sur-
faces with the IgG solution at pH 5, the aggregate loaded CPG particles were removed by 
simple centrifugation and nearly 80-90 % of the soluble aggregates were cleared from the 
protein bulk, when 100-150 m² CPG per gram protein were applied. Concomitantly, about 
80-85 % of the monomer remained in solution. In spite of this unavoidable loss of 
monomeric protein, the quite simple procedure of incubation and the removal of the ag-
gregate-loaded surface provides for convenient capacity for aggregate clearance during 
purification processing, storage or prior to parenteral administration. 
In the course of evaluating the potential role of exogenous impurities on the stability 
of mAbs, a typical process related impurity, the indigenous proteins expressed by the re-
combinant host cells, was chosen. Purified host cell proteins (HCPs) derived from a spe-
cific CHO master cell were shown to be a complex mixture of numerous proteins with 
divers physicochemical properties regarding IP and molecular weight. This specific HCP 
composition was shown to be partly involved in the formation of IgG aggregates under 
specific conditions. Unfortunately, the HCPs applied were shown to encompass at least 
one proteolytic species which was shown to be involved in the degradation of the IgG 
monomer as well as its aggregates. For further investigations regarding the potential induc-
tion of IgG aggregates due to the presence of HCPs, it is recommended to suppress the 
proteolytic activity of the HCP material by applying specific protease inhibitors. 
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Chapter VIII Addendum 
1 List of abbreviations 
∆p Pressure drop 
ADCC Antibody dependent cytotoxicity 
AEX Anion exchange chromatography 
API Active pharmaceutical ingredient 
ATR Attenuated total reflection 
BHK Baby hamster kidney 
BSA Bovine serum albumin 
CCL Continuous cell line 
CDC Complement dependent cytotoxicity 
CEX Cation exchange chromatography 
cGMP Current good manufacturing practice 
CHO Chinese hamster ovary 
ConcF Concentration factor 
DLS Dynamic light scattering 
DSP Downstream processing 
FT-IR Fourier transformed infrared spectroscopy 
HCP Host cell protein 
HIC Hydrophobic interaction chromatography 
HMWs Higher molecular weight species 
IEF Isoelectric focusing 
IEX Ion-exchange chromatography 
IgG Immunoglobulin G 
IP Isoelectric point 
J Permeate flux 
kDa Kilodalton 
LMWs Lower molecular weight species 
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LO Light obscuration 
mAb Monoclonal antibody 
NFF Normal flow filtration 
NMWC Normal molecular weight cut-off 
NWF Normalized water flow 
Mw Molecular weight 
PES Polyethersulfone 
PS Polysulfone 
Q Feed flow rate 
Qr Retentate flow rate 
RC Regenerated cellulose 
Re Reynolds number 
Rpm Rounds per minute 
SD Standard deviation 
SDS-PAGE 
Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
SE-HPLC 
Size exclusion high pressure liquid 
chromatography 
SEM Scanning electron microscopy 
TFF Tangential flow filtration 
Tm Melting temperature 
TMP Transmembrane pressure 
UF Ultrafiltration 
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